| 1 |
Awan UA, Khattak AA, Haq M, Saadia Z, Marwat M, Khalid S, Kamran S, Haseeb A, Ahmed B, Irfani MA, Nadeem MF, Javed F. Frequency, distribution and determinants of Helicobacter pylori infection in adults and adolescents with gastric symptoms: cross-sectional epidemiological inquiry in district Haripur, Pakistan. Braz J Biol 2024;84. [DOI: 10.1590/1519-6984.248913] [Reference Citation Analysis]
|
| 2 |
Wang X, Wang X, Wen M, Li X. Bibliometric analysis of literature on prevention and treatment of gastric ulcer with natural medicines. Journal of Future Foods 2023;3:225-233. [DOI: 10.1016/j.jfutfo.2023.02.004] [Reference Citation Analysis]
|
| 3 |
Chen M, Chen K, Hou H, Li W, Wang X, Dao Q, Wang Z. Incidence and mortality trends in gastric cancer in the United States, 1992-2019. Int J Cancer 2023;152:1827-36. [PMID: 36562305 DOI: 10.1002/ijc.34415] [Reference Citation Analysis]
|
| 4 |
Hassuna NA, Hussien SS, Abdelhakeem M, Aboalela A, Ahmed E, Abdelrahim SS. Regulatory B cells (Bregs) in Helicobacter pylori chronic infection. Helicobacter 2023;28:e12951. [PMID: 36661205 DOI: 10.1111/hel.12951] [Reference Citation Analysis]
|
| 5 |
Sáenz JB. Early Re"cag"nition: CagA-specific CD8(+) T Cells Shape the Immune Response to Helicobacter pylori. Gastroenterology 2023;164:520-1. [PMID: 36708789 DOI: 10.1053/j.gastro.2023.01.024] [Reference Citation Analysis]
|
| 6 |
Zou W, Zhang Q, Sun R, Li X, He S. Study on TFF1 and PALB2 gene variants associated with gastric carcinoma risk in the Chinese Han population. Cancer Epidemiol 2023;83:102333. [PMID: 36758349 DOI: 10.1016/j.canep.2023.102333] [Reference Citation Analysis]
|
| 7 |
Han Z, Liu J, Zhang W, Kong Q, Wan M, Lin M, Lin B, Ding Y, Duan M, Li Y, Zuo X, Li Y. Cardia and non-cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta-analysis, and estimation of population attributable fraction. Helicobacter 2023;28:e12950. [PMID: 36645649 DOI: 10.1111/hel.12950] [Reference Citation Analysis]
|
| 8 |
Zhai K, Gong Y, Sun L, He L, Xue Z, Yang Y, Fang M, Zhang J. DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection. Helicobacter 2023;28:e12955. [PMID: 36775815 DOI: 10.1111/hel.12955] [Reference Citation Analysis]
|
| 9 |
Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol 2023. [PMID: 36959359 DOI: 10.1038/s41571-023-00747-0] [Reference Citation Analysis]
|
| 10 |
Kim SB, Kim N, Park J, Hwang IC, Lim SH, Song DH, Choi Y, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. Helicobacter 2023;:e12969. [PMID: 36946460 DOI: 10.1111/hel.12969] [Reference Citation Analysis]
|
| 11 |
Suerbaum S, Ailloud F. Genome and population dynamics during chronic infection with Helicobacter pylori. Curr Opin Immunol 2023;82:102304. [PMID: 36958230 DOI: 10.1016/j.coi.2023.102304] [Reference Citation Analysis]
|
| 12 |
Sheng C, Sun L, Lyu Z, Li L, Zhang Y, Zhang Y, Zhang Y, Dai H, Huang Y, Song F, Yuan Y, Chen K. Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test-negative individuals. Helicobacter 2023;:e12966. [PMID: 36941759 DOI: 10.1111/hel.12966] [Reference Citation Analysis]
|
| 13 |
Luo Q, Liu N, Pu S, Zhuang Z, Gong H, Zhang D. A review on the research progress on non-pharmacological therapy of Helicobacter pylori. Front Microbiol 2023;14. [DOI: 10.3389/fmicb.2023.1134254] [Reference Citation Analysis]
|
| 14 |
Park E, Nishimura M, Simoes P. Endoscopic advances in the management of gastric cancer and premalignant gastric conditions. World J Gastrointest Endosc 2023; 15(3): 114-121 [DOI: 10.4253/wjge.v15.i3.114] [Reference Citation Analysis]
|
| 15 |
Shu C, Xu Z, He C, Xu X, Zhou Y, Cai B, Zhu Y. Application of biomaterials in the eradication of Helicobacter pylori: A bibliometric analysis and overview. Front Microbiol 2023;14. [DOI: 10.3389/fmicb.2023.1081271] [Reference Citation Analysis]
|
| 16 |
Cao X, Yang Y, Zhang Y, Ji R, Zhao X, Zheng W, Yang A. Impact of Helicobacter pylori on the gastric microbiome in patients with chronic gastritis: a systematic review and meta-analysis protocol. BMJ Open 2023;13:e050476. [PMID: 36927582 DOI: 10.1136/bmjopen-2021-050476] [Reference Citation Analysis]
|
| 17 |
Forooghi Nia F, Rahmati A, Ariamanesh M, Saeidi J, Ghasemi A, Mohtashami M. The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice. World J Microbiol Biotechnol 2023;39:119. [PMID: 36918449 DOI: 10.1007/s11274-023-03555-x] [Reference Citation Analysis]
|
| 18 |
Zhang YH, Chen XL, Wang YR, Hou YW, Zhang YD, Wang KJ. Prevention of malignant digestive system tumors should focus on the control of chronic inflammation. World J Gastrointest Oncol 2023; 15(3): 389-404 [DOI: 10.4251/wjgo.v15.i3.389] [Reference Citation Analysis]
|
| 19 |
Vasapolli R, Ailloud F, Suerbaum S, Neumann J, Koch N, Macke L, Schirra J, Mayerle J, Malfertheiner P, Schulz C. Intraprocedural gastric juice analysis as compared to rapid urease test for real-time detection of Helicobacter pylori. World J Gastroenterol 2023; 29(10): 1638-1647 [DOI: 10.3748/wjg.v29.i10.1638] [Reference Citation Analysis]
|
| 20 |
Vasapolli R, Ailloud F, Suerbaum S, Neumann J, Koch N, Macke L, Schirra J, Mayerle J, Malfertheiner P, Schulz C. Intraprocedural gastric juice analysis as compared to rapid urease test for real-time detection of Helicobacter pylori. World J Gastroenterol 2023; 29(10): 1494-1503 [DOI: 10.3748/wjg.v29.i10.1494] [Reference Citation Analysis]
|
| 21 |
Ji X, He G, Wang K, Zhang Y, Yin J, Wang K. Estimation of gastric cancer burden attributable to Helicobacter pylori infection in Asia. J Public Health (Oxf) 2023;45:40-6. [PMID: 35137200 DOI: 10.1093/pubmed/fdab410] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Shrestha AB, Pokharel P, Sapkota UH, Shrestha S, Mohamed SA, Khanal S, Jha SK, Mohanty A, Padhi BK, Asija A, Sedhai YR, Rijal R, Singh K, Chattu VK, Rodriguez-morales AJ, Barboza JJ, Sah R. Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Helicobacter pylori Infection among South Asian Countries: A Systematic Review and Meta-Analysis. TropicalMed 2023;8:172. [DOI: 10.3390/tropicalmed8030172] [Reference Citation Analysis]
|
| 23 |
Ba DM, Ssentongo P, Pelucchi C, Negri E, Palli D, Ferraroni M, Zhang ZF, Yu GP, Tsugane S, Hidaka A, Hamada GS, Zaridze D, Maximovich D, Obón-Santacana M, Álvarez-Álvarez L, Vioque J, Garcia de la Hera M, López-Carrillo L, López-Cervantes M, Mu L, Lagiou A, Lagiou P, Boffetta P, Camargo MC, Curado MP, Lunet N, La Vecchia C, Muscat J. Mushroom consumption and risk of gastric cancer: a pooled analysis within the stomach cancer pooling project and a combined meta-analysis with other observational studies. Eur J Cancer Prev 2023. [PMID: 36912187 DOI: 10.1097/CEJ.0000000000000754] [Reference Citation Analysis]
|
| 24 |
Sundqvist MO, Wärme J, Hofmann R, Pawelzik S, Bäck M. Helicobacter Pylori Virulence Factor Cytotoxin-Associated Gene A (CagA) Induces Vascular Calcification in Coronary Artery Smooth Muscle Cells. IJMS 2023;24:5392. [DOI: 10.3390/ijms24065392] [Reference Citation Analysis]
|
| 25 |
Srisuphanunt M, Wilairatana P, Kooltheat N, Duangchan T, Katzenmeier G, Rose JB. Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections. TropicalMed 2023;8:163. [DOI: 10.3390/tropicalmed8030163] [Reference Citation Analysis]
|
| 26 |
Liu X, Li M, Han Q, Zuo Z, Wang Q, Su D, Fan M, Chen T. Exploring a shared genetic signature and immune infiltration between spontaneous intracerebral hemorrhage and Helicobacter pylori infection. Microb Pathog 2023;178:106067. [PMID: 36914055 DOI: 10.1016/j.micpath.2023.106067] [Reference Citation Analysis]
|
| 27 |
Ma L, Guo W, Zeng Z, Yang F, Tang S, Ling Y. Colorectal cancer risk in East Asian patients with Helicobacter pylori infection: A systematic review and meta-analysis. Medicine (Baltimore) 2023;102:e33177. [PMID: 36897722 DOI: 10.1097/MD.0000000000033177] [Reference Citation Analysis]
|
| 28 |
Yang F, Li L, Zhou Y, Pan W, Liang X, Huang L, Huang J, Cheng Y, Geng L, Xu W, Gong S. Rabeprazole destroyed gastric epithelial barrier function through FOXF1/STAT3-mediated ZO-1 expression. Clin Exp Pharmacol Physiol 2023. [PMID: 36897043 DOI: 10.1111/1440-1681.13769] [Reference Citation Analysis]
|
| 29 |
Palacios E, Lobos-González L, Guerrero S, Kogan MJ, Shao B, Heinecke JW, Quest AFG, Leyton L, Valenzuela-Valderrama M. Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-κappa B activation and cause neuronal damage in vivo in a murine model. J Neuroinflammation 2023;20:66. [PMID: 36895046 DOI: 10.1186/s12974-023-02728-7] [Reference Citation Analysis]
|
| 30 |
Shekri A, dayoub K, Ali A. Studying the Awareness of Syrian Private University Students About H. Pylori.. [DOI: 10.21203/rs.3.rs-2661071/v1] [Reference Citation Analysis]
|
| 31 |
Abdelhamid SM, Edris AE, Sadek Z. Novel approach for the inhibition of Helicobacter pylori contamination in yogurt using selected probiotics combined with eugenol and cinnamaldehyde nanoemulsions. Food Chem 2023;417:135877. [PMID: 36933424 DOI: 10.1016/j.foodchem.2023.135877] [Reference Citation Analysis]
|
| 32 |
Fekadu S, Engiso H, Seyfe S, Iizasa H, Godebo A, Deyno S, Yoshiyama H. Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis. BMC Gastroenterol 2023;23:55. [PMID: 36882697 DOI: 10.1186/s12876-023-02707-5] [Reference Citation Analysis]
|
| 33 |
Kountouras J, Doulberis M, Papaefthymiou A, Polyzos SA, Zavos C, Kazakos E, Arapoglou S, Kyrailidi F, Mouratidou MC, Boziki M, Vardaka E. Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration. Medicina 2023;59:504. [DOI: 10.3390/medicina59030504] [Reference Citation Analysis]
|
| 34 |
Han YH, Zhang W, Wang YT, Xiong ZJ, Du Q, Xie Y, Lu H. Performance evaluation of a novel 14C-urea breath test (solid scintillation) for the diagnosis of helicobacter pylori infection. Medicine (Baltimore) 2023;102:e33107. [PMID: 36862867 DOI: 10.1097/MD.0000000000033107] [Reference Citation Analysis]
|
| 35 |
Lee JY, Son HG, Koo Y, Jung SH, Park SD, Shim JJ, Lee JL, Lee YH. Protective Effects of Cudrania tricuspidata Against Helicobacter pylori-Induced Inflammation in C57BL/6 Mice. J Med Food 2023. [PMID: 36862521 DOI: 10.1089/jmf.2022.K.0133] [Reference Citation Analysis]
|
| 36 |
Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications. Cancer Discov 2023;13:538-51. [PMID: 36757194 DOI: 10.1158/2159-8290.CD-22-1038] [Reference Citation Analysis]
|
| 37 |
Du P, Zhang C, Wang A, Ma Z, Shen S, Li X. Association of Alcohol Drinking and Helicobacter pylori Infection : A Meta-analysis. J Clin Gastroenterol 2023;57:269-77. [PMID: 34907920 DOI: 10.1097/MCG.0000000000001638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Miftahussurur M, Alfaray RI, Fauzia KA, Dewayani A, Doohan D, Waskito LA, Rezkitha YAA, Utomo DH, Somayana G, Fahrial Syam A, Lubis M, Akada J, Matsumoto T, Yamaoka Y. Low-grade intestinal metaplasia in Indonesia: Insights into the expression of proinflammatory cytokines during Helicobacter pylori infection and unique East-Asian CagA characteristics. Cytokine 2023;163:156122. [PMID: 36640695 DOI: 10.1016/j.cyto.2022.156122] [Reference Citation Analysis]
|
| 39 |
Fischbach W. Helicobacter pylori – Update 2022. Gastroenterologie up2date 2023;19:61-74. [DOI: 10.1055/a-1950-5221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Hakami OA, Alsubaie RA, Albaqami BA, Almutlaq HM, Alqahtani NM, Alkhonezan M, Almuqrin FF, Alghamdi AH, Alaryni AA, Qutob RA. Knowledge and Perception of Physicians of Different Specialties in Saudi Arabia Toward Helicobacter pylori. JMDH 2023;Volume 16:763-771. [DOI: 10.2147/jmdh.s403999] [Reference Citation Analysis]
|
| 41 |
Zhao L, Luo JL, Ali MK, Spiekerkoetter E, Nicolls MR. The Human Respiratory Microbiome: Current Understandings and Future Directions. Am J Respir Cell Mol Biol 2023;68:245-55. [PMID: 36476129 DOI: 10.1165/rcmb.2022-0208TR] [Reference Citation Analysis]
|
| 42 |
Yakovleva NV, Smirnova GI, Korsunsky AA. Modern aspects of Helicobacter pylori infection. RPJ 2023;26:67-74. [DOI: 10.46563/1560-9561-2023-26-1-67-74] [Reference Citation Analysis]
|
| 43 |
Ekundayo TC, Swalaha FM, Ijabadeniyi OA. Global and regional prevalence of Helicobacter pylori in drinking waters: A sustainable, human development and socio-demographic indices based meta-regression-modelling. Sci Total Environ 2023;861:160633. [PMID: 36481137 DOI: 10.1016/j.scitotenv.2022.160633] [Reference Citation Analysis]
|
| 44 |
Ren X, Shi Y, Suo B, Yao X, Lu H, Li C, Zhang Y, Zhou L, Tian X, Song Z. Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta-analysis. Helicobacter 2023;:e12958. [PMID: 36828668 DOI: 10.1111/hel.12958] [Reference Citation Analysis]
|
| 45 |
Macedo Silva V, Lima Capela T, Freitas M, Boal Carvalho P, Magalhães J, Cotter J. A "new" option in Helicobacter pylori eradication: High-dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting. Helicobacter 2023;:e12962. [PMID: 36828647 DOI: 10.1111/hel.12962] [Reference Citation Analysis]
|
| 46 |
Ariño-Pérez I, Martínez-Domínguez SJ, Alfaro Almajano E, Carrera-Lasfuentes P, Lanas Á. Mistakes in the diagnosis and treatment of Helicobacter pylori infection in daily clinical practice. Helicobacter 2023;:e12957. [PMID: 36828666 DOI: 10.1111/hel.12957] [Reference Citation Analysis]
|
| 47 |
Nikolić I, Chua EG, Tay ACY, Kostrešević A, Pavlović B, Jončić Savić K. Savory, Oregano and Thyme Essential Oil Mixture (HerbELICO(®)) Counteracts Helicobacter pylori. Molecules 2023;28. [PMID: 36903396 DOI: 10.3390/molecules28052138] [Reference Citation Analysis]
|
| 48 |
Jardim SR, de Souza LMP, de Souza HSP. The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress? Int J Environ Res Public Health 2023;20. [PMID: 36834334 DOI: 10.3390/ijerph20043640] [Reference Citation Analysis]
|
| 49 |
Grosen AK, Mikkelsen S, Baunwall SMD, Dahlerup JF, Erikstrup LT, Hvas CL, Erikstrup C. Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules. Clin Microbiol Infect 2023:S1198-743X(23)00081-2. [PMID: 36805882 DOI: 10.1016/j.cmi.2023.02.011] [Reference Citation Analysis]
|
| 50 |
Loh JT, Struttmann EL, Favret N, Harvey ML, Pakala SB, Chopra A, McClain MS, Cover TL. A Positively Selected fur-R88H Mutation Enhances Helicobacter pylori Fitness in a High-Salt Environment and Alters Fur-Dependent Regulation of Gene Expression. Infect Immun 2023;91:e0042022. [PMID: 36633416 DOI: 10.1128/iai.00420-22] [Reference Citation Analysis]
|
| 51 |
Karmakar BC, Paul S, Basak S, Ghosh M, Mukherjee P, Das R, Chaudhuri S, Dutta S, Mukhopadhyay AK. Development and evaluation of a simple PCR assay and nested PCR for rapid detection of clarithromycin-resistant Helicobacter pylori from culture and directly from the biopsy samples in India. Gut Pathog 2023;15:7. [PMID: 36782212 DOI: 10.1186/s13099-023-00530-7] [Reference Citation Analysis]
|
| 52 |
Rojas A, Lindner C, Schneider I, González I, Morales MA. Contributions of the receptor for advanced glycation end products axis activation in gastric cancer. World J Gastroenterol 2023; 29(6): 997-1010 [DOI: 10.3748/wjg.v29.i6.997] [Reference Citation Analysis]
|
| 53 |
Meinhardt C, List S, Chamieh AE, Fehrendt H, Meves V, Mohamed M, Müller J, Deneke T, Geismann C, Elsässer A, Arlt A, Halbfass P. High prevalence of incidental endoscopic findings at routine endoscopy after atrial fibrillation ablation: Do we need a screening endoscopy for the upper gastrointestinal tract in the general population? Eur J Intern Med 2023:S0953-6205(23)00049-3. [PMID: 36797118 DOI: 10.1016/j.ejim.2023.02.011] [Reference Citation Analysis]
|
| 54 |
Zhang J, Ning J, Fu W, Shi Y, Zhang J, Ding S. CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection. Gut Pathog 2023;15:6. [PMID: 36782312 DOI: 10.1186/s13099-023-00533-4] [Reference Citation Analysis]
|
| 55 |
Leta V, Klingelhoefer L, Longardner K, Campagnolo M, Levent HÇ, Aureli F, Metta V, Bhidayasiri R, Chung-Faye G, Falup-Pecurariu C, Stocchi F, Jenner P, Warnecke T, Ray Chaudhuri K; International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group. Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease. Eur J Neurol 2023. [PMID: 36757008 DOI: 10.1111/ene.15734] [Reference Citation Analysis]
|
| 56 |
Elhodhod MA, Hamdy AM, Fahmy PO, Awad YM. Diagnostic yield of esophagogastroduodenoscopy in upper gastrointestinal bleeding in pediatrics: a cross-sectional study at a tertiary center. Egypt Pediatric Association Gaz 2023;71:6. [DOI: 10.1186/s43054-022-00153-8] [Reference Citation Analysis]
|
| 57 |
Koseki M, Sheu MJ, Tsai KT, Ho CH, Liu HH, Lin HJ, Lin CL, Huang CC. Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan. BMC Gastroenterol 2023;23:36. [PMID: 36755235 DOI: 10.1186/s12876-023-02664-z] [Reference Citation Analysis]
|
| 58 |
Liu L, Li F, Shi H, Nahata MC. The Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Infection: A Systematic Review and Network Meta-Analysis. Antibiotics (Basel) 2023;12. [PMID: 36830257 DOI: 10.3390/antibiotics12020346] [Reference Citation Analysis]
|
| 59 |
Pham C, Nguyen Wenker T, El-serag HB. Epidemiology of Gastric Intestinal Metaplasia and Gastric Cancer. Foregut: The Journal of the American Foregut Society 2023. [DOI: 10.1177/26345161231154024] [Reference Citation Analysis]
|
| 60 |
Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. Int J Mol Sci 2023;24. [PMID: 36769214 DOI: 10.3390/ijms24032895] [Reference Citation Analysis]
|
| 61 |
Alarcón-Millán J, Bonilla-Delgado J, Fernández-Tilapa G, Nieto-Velázquez NG, Sierra-Martínez M, Alvarado-Castro VM, Cortés-Malagón EM. Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens 2023;12. [PMID: 36839506 DOI: 10.3390/pathogens12020234] [Reference Citation Analysis]
|
| 62 |
Mégraud F, Graham DY, Howden CW, Trevino E, Weissfeld A, Hunt B, Smith N, Leifke E, Chey WD. Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe. Am J Gastroenterol 2023;118:269-75. [PMID: 36191284 DOI: 10.14309/ajg.0000000000002045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 63 |
Magdy H, Rady MH, Salama MS, Sayed HAE, Hamza D, Azzam M, Essa EE. Isolation of Multidrug-Resistant Helicobacter pylori from Wild Houseflies Musca domestica with a New Perspective for the Treatment. Vector Borne Zoonotic Dis 2023;23:63-74. [PMID: 36577051 DOI: 10.1089/vbz.2022.0033] [Reference Citation Analysis]
|
| 64 |
Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, Malfertheiner P, Mégraud F, Piscoya A, Quach D, Vakil N, Vaz Coelho LG, LeMair A, Melberg J. Helicobacter pylori World Gastroenterology Organization Global Guideline. J Clin Gastroenterol 2023;57:111-26. [PMID: 36598803 DOI: 10.1097/MCG.0000000000001719] [Reference Citation Analysis]
|
| 65 |
Lu L, Wang Y, Ye J, Han Y, Lou G, Li Y, Yan H, Du Q. Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial. Helicobacter 2023;28:e12940. [PMID: 36458325 DOI: 10.1111/hel.12940] [Reference Citation Analysis]
|
| 66 |
Liu H, Wang J, Hu X, Tang X, Zhang C. A rapid and high-throughput Helicobacter pylori RPA-CRISPR/Cas12a-based nucleic acid detection system. Clin Chim Acta 2023;540:117201. [PMID: 36572137 DOI: 10.1016/j.cca.2022.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Rokkas T, Ekmektzoglou K, Graham DY. Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis. Helicobacter 2023;28:e12936. [PMID: 36458328 DOI: 10.1111/hel.12936] [Reference Citation Analysis]
|
| 68 |
Chitapanarux T, Kongkarnka S, Wannasai K, Sripan P. Prevalence and factors associated with atrophic gastritis and intestinal metaplasia: A multivariate, hospital-based, statistical analysis. Cancer Epidemiol 2023;82:102309. [PMID: 36470067 DOI: 10.1016/j.canep.2022.102309] [Reference Citation Analysis]
|
| 69 |
Gobert AP, Asim M, Smith TM, Williams KJ, Barry DP, Allaman MM, McNamara KM, Hawkins CV, Delgado AG, Blanca Piazuelo M, Rathmacher JA, Wilson KT. The nutraceutical electrophile scavenger 2-hydroxybenzylamine (2-HOBA) attenuates gastric cancer development caused by Helicobacter pylori. Biomed Pharmacother 2023;158:114092. [PMID: 36493697 DOI: 10.1016/j.biopha.2022.114092] [Reference Citation Analysis]
|
| 70 |
Ma L, Lin Z, Wang J, Ye R, Li Y, Chen P, Yuan Z, Yang L, Miao L, Li J. Association between short-term exposure to ambient air pollution and number of outpatient Helicobacter pylori infection visits. Environ Sci Pollut Res Int 2023;30:22808-15. [PMID: 36306069 DOI: 10.1007/s11356-022-23826-8] [Reference Citation Analysis]
|
| 71 |
Muranaka F, Kise E, Tokumaru S, Kitazawa M, Miyagawa Y, Suga T, Uehara T, Iwaya M, Kobayashi S, Sato M, Gomi D, Yamada H, Sugimura H, Kosho T, Soejima Y, Koizumi T. Hereditary diffuse gastric cancer in a Japanese family with CDH1 mutation three case reports. Discov Oncol 2023;14:14. [PMID: 36719602 DOI: 10.1007/s12672-023-00623-4] [Reference Citation Analysis]
|
| 72 |
Shah S, Cappell K, Sedgley R, Pelletier C, Jacob R, Bonafede M, Yadlapati R. Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016-2019. Sci Rep 2023;13:1375. [PMID: 36697470 DOI: 10.1038/s41598-023-28200-3] [Reference Citation Analysis]
|
| 73 |
Conti CB, Agnesi S, Scaravaglio M, Masseria P, Dinelli ME, Oldani M, Uggeri F. Early Gastric Cancer: Update on Prevention, Diagnosis and Treatment. Int J Environ Res Public Health 2023;20. [PMID: 36767516 DOI: 10.3390/ijerph20032149] [Reference Citation Analysis]
|
| 74 |
Johnson KS, Yang C, Carter JE, Worthington AK, Robinson EK, Lopez-Magaña R, Salgado F, Arnold I, Ottemann KM. Helicobacter pylori Chronic-Stage Inflammation Undergoes Fluctuations That Are Altered in tlpA Mutants. Infect Immun 2023;91:e0032222. [PMID: 36533917 DOI: 10.1128/iai.00322-22] [Reference Citation Analysis]
|
| 75 |
Huang RJ, Laszkowska M, In H, Hwang JH, Epplein M. Controlling Gastric Cancer in a World of Heterogeneous Risk. Gastroenterology 2023:S0016-5085(23)00051-3. [PMID: 36706842 DOI: 10.1053/j.gastro.2023.01.018] [Reference Citation Analysis]
|
| 76 |
Asiimwe D, Bangi I, Esanyu J, Ojok D, Okot B, Olong C, Wagubi R, Kisembo G, Sempijja F, Muwanguzi E, Okongo B. Association Between Helicobacter pylori Infection and Anemia Among Adult Dyspeptic Patients Attending Kiryandongo General Hospital, Uganda. J Blood Med 2023;14:57-66. [PMID: 36718427 DOI: 10.2147/JBM.S392146] [Reference Citation Analysis]
|
| 77 |
Zhou XZ, Lyu NH, Zhu HY, Cai QC, Kong XY, Xie P, Zhou LY, Ding SZ, Li ZS, Du YQ; National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology and Chinese Alliance for Helicobacter pylori Study. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut 2023:gutjnl-2022-328965. [PMID: 36690433 DOI: 10.1136/gutjnl-2022-328965] [Reference Citation Analysis]
|
| 78 |
Huang J, Yang X, Zhang J, Wang F, Tang X. The Correlation between Helicobacter pylori Immunoglobulin G Seropositivity and Plasma Homocysteine Levels in Adults. Mediators Inflamm 2023;2023:7590549. [PMID: 36714243 DOI: 10.1155/2023/7590549] [Reference Citation Analysis]
|
| 79 |
Zhang Y, Feng X, Bian L, Zhang Y, Li Q, Xu Y, She Q, Yan C, Lu G, Wu J, Xiao W, Ding Y, Deng B. Antibiotic Resistance of Helicobacter pylori and Related Risk Factors in Yangzhou, China: A Cross-Sectional Study. J Clin Med 2023;12. [PMID: 36769465 DOI: 10.3390/jcm12030816] [Reference Citation Analysis]
|
| 80 |
Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, Almuzaini AM, Rawway M, Alfadhel A, Draz A, Abu-Okail A. Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges. Antibiotics (Basel) 2023;12. [PMID: 36830102 DOI: 10.3390/antibiotics12020191] [Reference Citation Analysis]
|
| 81 |
Park J, Kim N, Kim WS, Lim SH, Choi Y, Jo HH, Ji E, Yoon H, Shin CM, Park YS, Lee DH. Long-term Effects of the Eradication of Helicobacter pylori on Metabolic Parameters, Depending on Sex, in South Korea. Gut Liver 2023;17:58-68. [PMID: 35770660 DOI: 10.5009/gnl210588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Quach DT, Mai BH, Tran MK, Dao LV, Tran HV, Vu KT, Vu KV, Pham HT, Bui HH, Ho DD, Trinh DT, Nguyen VT, Duong TH, Tran TT, Nguyen HT, Nguyen TT, Nguyen TD, Nguyen LC, Dao HV, Thai KD, Phan NT, Le LT, Vo CH, Ho PT, Nguyen TL, Le QD, Le NV, Phan HQ, Nguyen BC, Tran TT, Tran TV, Ta L. Vietnam Association of Gastroenterology (VNAGE) consensus on the management of Helicobacter pylori infection. Front Med (Lausanne) 2022;9:1065045. [PMID: 36714104 DOI: 10.3389/fmed.2022.1065045] [Reference Citation Analysis]
|
| 83 |
Huang J, Lucero-Prisno DE 3rd, Zhang L, Xu W, Wong SH, Ng SC, Wong MCS. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol 2023. [PMID: 36631716 DOI: 10.1038/s41575-022-00726-3] [Reference Citation Analysis]
|
| 84 |
Galoș F, Boboc C, Ieșanu MI, Anghel M, Ioan A, Iana E, Coșoreanu MT, Boboc AA. Antibiotic Resistance and Therapeutic Efficacy of Helicobacter pylori Infection in Pediatric Patients-A Tertiary Center Experience. Antibiotics (Basel) 2023;12. [PMID: 36671347 DOI: 10.3390/antibiotics12010146] [Reference Citation Analysis]
|
| 85 |
Pérez-Cano HJ, Ceja-Martínez J, Tellezgiron-Lara V, Voorduin-Ramos S, Morales-López O, Somilleda-Ventura SA. Relationship between Helicobacter pylori and undifferentiated non-granulomatous anterior uveitis. Infection 2023. [PMID: 36630044 DOI: 10.1007/s15010-022-01970-0] [Reference Citation Analysis]
|
| 86 |
Seo JY, Hong H, Ryu WS, Kim D, Chun J, Kwak MS. Development and validation of a convolutional neural network model for diagnosing Helicobacter pylori infections with endoscopic images: a multicenter study. Gastrointest Endosc 2023:S0016-5107(23)00010-X. [PMID: 36641124 DOI: 10.1016/j.gie.2023.01.007] [Reference Citation Analysis]
|
| 87 |
Guo Y, Cao XS, Zhou MG, Yu B. Gastric microbiota in gastric cancer: Different roles of Helicobacter pylori and other microbes. Front Cell Infect Microbiol 2022;12:1105811. [PMID: 36704105 DOI: 10.3389/fcimb.2022.1105811] [Reference Citation Analysis]
|
| 88 |
Zhou BG, Mei YZ, Zhang M, Jiang X, Li YY, Ding YB. High-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis. Therap Adv Gastroenterol 2023;16:17562848221147756. [PMID: 36644129 DOI: 10.1177/17562848221147756] [Reference Citation Analysis]
|
| 89 |
Braendli T, Schindler V, Braun DL, Murray FR, Hente JM, Pohl D. Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland. Swiss Med Wkly 2023;153:40024. [PMID: 36652712 DOI: 10.57187/smw.2023.40024] [Reference Citation Analysis]
|
| 90 |
Yu X, Peng W, Wang Y, Xu W, Chen W, Huang L, Xu H, He X, Wang S, Sun Q, Lu W, Xu Y. Palmitic Acid Inhibits the Growth and Metastasis of Gastric Cancer by Blocking the STAT3 Signaling Pathway. Cancers (Basel) 2023;15. [PMID: 36672337 DOI: 10.3390/cancers15020388] [Reference Citation Analysis]
|
| 91 |
chen H, Zhang F. Depletion of TAFIB Gene Inhibits Ribosome Biosynthesis and Proliferation of Gastric Tumor through Enhancing c-MYC mRNA Degradation.. [DOI: 10.21203/rs.3.rs-2389898/v1] [Reference Citation Analysis]
|
| 92 |
Yang L, Sun H, Bai Y, Sun S, Wu X, Gan Z, Du J, Du J. Trends and Projections of Stomach Cancer Incidence in Hong Kong: A Population-Based Study. Cancer Invest 2023;:1-11. [PMID: 36416488 DOI: 10.1080/07357907.2022.2126982] [Reference Citation Analysis]
|
| 93 |
Wang Q, Yao C, Li Y, Luo L, Xie F, Xiong Q, Feng P. Effect of polyphenol compounds on Helicobacter pylori eradication: a systematic review with meta-analysis. BMJ Open 2023;13:e062932. [PMID: 36604137 DOI: 10.1136/bmjopen-2022-062932] [Reference Citation Analysis]
|
| 94 |
Wang X, Wei H. Animal Models in the Study of Microbiome in Gastrointestinal Cancer. Microbiome in Gastrointestinal Cancer 2023. [DOI: 10.1007/978-981-19-4492-5_12] [Reference Citation Analysis]
|
| 95 |
Nguyen QA, Schmitt L, Mejías-Luque R, Gerhard M. Effects of Helicobacter pylori adhesin HopQ binding to CEACAM receptors in the human stomach. Front Immunol 2023;14:1113478. [PMID: 36891299 DOI: 10.3389/fimmu.2023.1113478] [Reference Citation Analysis]
|
| 96 |
Liang M, Zhu C, Zhao P, Zhu X, Shi J, Yuan B. Comparison of multiple treatment regimens in children with Helicobacter pylori infection: A network meta-analysis. Front Cell Infect Microbiol 2023;13:1068809. [PMID: 36909732 DOI: 10.3389/fcimb.2023.1068809] [Reference Citation Analysis]
|
| 97 |
Wang Z, Shao SL, Xu XH, Zhao X, Wang MY, Chen A, Cong HY. Helicobacter pylori and gastric microbiota homeostasis: progress and prospects. Future Microbiol 2023;18:137-57. [PMID: 36688318 DOI: 10.2217/fmb-2022-0102] [Reference Citation Analysis]
|
| 98 |
Schulz C, Kalali B, Link A, Gerhard M, Malfertheiner P. New Rapid Helicobacter Pylori Blood Test Based on Dual Detection of FliD and CagA Antibodies for On-Site Testing. Clin Gastroenterol Hepatol 2023;21:229-231.e1. [PMID: 34793965 DOI: 10.1016/j.cgh.2021.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 99 |
Ardekani A, Sepidarkish M, Mollalo A, Afradiasbagharani P, Rouholamin S, Rezaeinejad M, Farid-Mojtahedi M, Mahjour S, Almukhtar M, Nourollahpour Shiadeh M, Rostami A. Worldwide prevalence of human papillomavirus among pregnant women: A systematic review and meta-analysis. Rev Med Virol 2023;33:e2374. [PMID: 35678261 DOI: 10.1002/rmv.2374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 100 |
Lee ME, Katz PO. Gastroesophageal reflux disease and the role of Helicobacter pylori. Esophageal Disease and the Role of the Microbiome 2023. [DOI: 10.1016/b978-0-323-95070-1.00007-2] [Reference Citation Analysis]
|
| 101 |
Zhang J, Hai X, Wang S, Zhu F, Gu Y, Meng G, Zhang Q, Liu L, Wu H, Zhang S, Zhang T, Wang X, Sun S, Zhou M, Jia Q, Song K, Niu K. Helicobacter pylori infection increase the risk of subclinical hyperthyroidism in middle-aged and elderly women independent of dietary factors: Results from the Tianjin chronic low-grade systemic inflammation and health cohort study in China. Front Nutr 2023;10:1002359. [PMID: 36950328 DOI: 10.3389/fnut.2023.1002359] [Reference Citation Analysis]
|
| 102 |
Zhang M, Pan J, Lin J, Xu M, Zhang L, Shang R, Yao L, Li Y, Zhou W, Deng Y, Dong Z, Zhu Y, Tao X, Wu L, Yu H. An explainable artificial intelligence system for diagnosing Helicobacter Pylori infection under endoscopy: a case-control study. Therap Adv Gastroenterol 2023;16:17562848231155023. [PMID: 36895279 DOI: 10.1177/17562848231155023] [Reference Citation Analysis]
|
| 103 |
Bucci P, Barbaglia Y, Tedeschi F, Zalazar F. Helicobacter pylori infection: A balance between bacteria and host. Rev Argent Microbiol 2023;55:60-7. [PMID: 35773060 DOI: 10.1016/j.ram.2022.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 104 |
Xiong C, Zhao R, Xu J, Liang H, Zhang J, Huang Y, Luo X. Is Helicobacter pylori infection associated with osteoporosis? a systematic review and meta-analysis. J Bone Miner Metab 2023;41:74-87. [PMID: 36348162 DOI: 10.1007/s00774-022-01379-7] [Reference Citation Analysis]
|
| 105 |
Nga WTB, Bagnaka SAFE, Halle-ekane N, Ndam AN, Ndjapa GRS, Fouda H, Ngande LPJE, Malongue A, Noah DN, Kowo M, Andoulo FA, Luma HN, Halle-ekane MP. <i>Helicobacter Pylori</i> Infection and Gastroduodenal Lesions in Patients with Chronic Kidney Disease: A Comparative Study. OJGas 2023;13:49-60. [DOI: 10.4236/ojgas.2023.131006] [Reference Citation Analysis]
|
| 106 |
Vedantam S, Katona BW, Sussman DA, Kumar S. Outcomes of upper endoscopy screening in Lynch syndrome: a meta-analysis. Gastrointest Endosc 2023;97:2-10.e1. [PMID: 36084717 DOI: 10.1016/j.gie.2022.08.040] [Reference Citation Analysis]
|
| 107 |
Alaridah N, F Jarrar R, M Joudeh R, Aljarawen M, Jum'ah M, Nassr H, Riad AlHmoud R, Allouzi A, M Wadi E, H A Abu-Humaidan A. Knowledge and information sources towards Helicobacter pylori in Jordan. PLoS One 2023;18:e0278078. [PMID: 36888626 DOI: 10.1371/journal.pone.0278078] [Reference Citation Analysis]
|
| 108 |
Dascălu RI, Bolocan A, Păduaru DN, Constantinescu A, Mitache MM, Stoica AD, Andronic O. Multidrug resistance in Helicobacter pylori infection. Front Microbiol 2023;14:1128497. [PMID: 36922977 DOI: 10.3389/fmicb.2023.1128497] [Reference Citation Analysis]
|
| 109 |
Pizzato M, La Vecchia C, Malvezzi M, Levi F, Boffetta P, Negri E, Dalmartello M. Cancer mortality and predictions for 2022 in selected Australasian countries, Russia, and Ukraine with a focus on colorectal cancer. Eur J Cancer Prev 2023;32:18-29. [PMID: 35822596 DOI: 10.1097/CEJ.0000000000000762] [Reference Citation Analysis]
|
| 110 |
Brun LVC, Alassan KS, Pognon M, Togbenon N, Zomahoun M, Gomez R, Hodonou MA, Boukari O, Ahouanse P, Akpo W, Seidou F, Akpo MTA. Epidemiological and Histopathological Aspects of Chronic Gastritis at the Departmental University Teaching Hospital of Borgou Alibori (CHUD-BA) from 2011 to 2021. OJPathology 2023;13:54-71. [DOI: 10.4236/ojpathology.2023.131006] [Reference Citation Analysis]
|
| 111 |
Lacy BE, Chase RC, Cangemi DJ. The treatment of functional dyspepsia: present and future. Expert Rev Gastroenterol Hepatol 2023;17:9-20. [PMID: 36588474 DOI: 10.1080/17474124.2023.2162877] [Reference Citation Analysis]
|
| 112 |
Bindayna KM, Al-salman J. Infections of the gastrointestinal and hepatobiliary system. Problem-Based Learning Approach in Microbiology 2023. [DOI: 10.1016/b978-0-323-95092-3.00009-3] [Reference Citation Analysis]
|
| 113 |
Zhang H, Shen H, Zhou L, Xie L, Kong D, Wang H. Mucosal-Associated Invariant T Cells in the Digestive System: Defender or Destroyer? Cell Mol Gastroenterol Hepatol 2023;15:809-19. [PMID: 36584816 DOI: 10.1016/j.jcmgh.2022.12.014] [Reference Citation Analysis]
|
| 114 |
Njenga P, Njau A, Moloo Z, Revathi G, Tshibangu E, Yamaoka Y. Pattern and trends of Helicobacter pylori genotypes in gastric cancer: A Kenyan 8-year study. Front Med (Lausanne) 2023;10:1119513. [PMID: 36873876 DOI: 10.3389/fmed.2023.1119513] [Reference Citation Analysis]
|
| 115 |
Kim I, Maeng L, Kim JS, Kim B, Cheung DY, Kim JI, Park S. Quantitative Multiplex Real-Time Polymerase Chain Reaction Assay for the Detection of Helicobacter pylori and Clarithromycin Resistance.. [DOI: 10.21203/rs.3.rs-2375894/v1] [Reference Citation Analysis]
|
| 116 |
Cui MY, Cui ZY, Zhao MQ, Zhang MJ, Jiang QL, Wang JJ, Lu LG, Lu YY. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota. BMC Microbiol 2022;22:321. [PMID: 36581836 DOI: 10.1186/s12866-022-02732-6] [Reference Citation Analysis]
|
| 117 |
de Paula MN, Ribeiro TDVR, Isolani R, de Medeiros Araújo DC, Borges AS, Philippsen GS, de Cássia Ribeiro Gonçalves R, Kitagawa RR, Seixas FAV, de Mello JCP. An In Vitro and In Silico Investigation about Monteverdia ilicifolia Activity against Helicobacter pylori. Antibiotics (Basel) 2022;12. [PMID: 36671247 DOI: 10.3390/antibiotics12010046] [Reference Citation Analysis]
|
| 118 |
Mei H, Guo Y, Zhao JT, Yang J, Sun WJ, Zhang DK, He P, Shi G, Su NY, Han R, Lan CH. Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial. Therap Adv Gastroenterol 2022;15:17562848221142925. [PMID: 36600686 DOI: 10.1177/17562848221142925] [Reference Citation Analysis]
|
| 119 |
Kowada A. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening. Dig Dis Sci 2022. [DOI: 10.1007/s10620-022-07795-z] [Reference Citation Analysis]
|
| 120 |
Maulahela H, Doohan D, Rezkhita YAA, Syam AF, Waskito LA, Savitri CMA, Richardo M, Rahman A, Namara YS, Shatri H, Sanityoso A, Siregar GA, Sudarmo E, Uchida T, Vilaichone R, Yamaoka Y, Miftahussurur M. Helicobacter pylori prevalence in Indonesia: Higher infection risk in Eastern region population. F1000Res 2022;11:1581. [DOI: 10.12688/f1000research.127094.1] [Reference Citation Analysis]
|
| 121 |
Lee YJ, Ssekalo I, Kazungu R, Blackwell TS Jr, Muwereza P, Wu Y, Sáenz JB. Community prevalence of Helicobacter pylori and dyspepsia and efficacy of triple therapy in a rural district of eastern Uganda. Heliyon 2022;8:e12612. [PMID: 36593846 DOI: 10.1016/j.heliyon.2022.e12612] [Reference Citation Analysis]
|
| 122 |
Miftahussurur M, Waskito LA, Syam AF, Nusi IA, Wibawa IDN, Rezkitha YAA, Fauzia KA, Siregar GA, Akil F, Waleleng BJ, Saudale AMJ, Abubakar A, Maulahela H, Richardo M, Rahman A, Namara YS, Sudarmo E, Adi P, Maimunah U, Setiawan PB, Doohan D, Uchida T, Dewayani A, Rejeki PS, Sugihartono T, Yamaoka Y. Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia. J Res Med Sci 2022;27:90. [PMID: 36685023 DOI: 10.4103/jrms.jrms_983_21] [Reference Citation Analysis]
|
| 123 |
Fu HW, Lai YC. The Role of Helicobacter pylori Neutrophil-Activating Protein in the Pathogenesis of H. pylori and Beyond: From a Virulence Factor to Therapeutic Targets and Therapeutic Agents. Int J Mol Sci 2022;24. [PMID: 36613542 DOI: 10.3390/ijms24010091] [Reference Citation Analysis]
|
| 124 |
Sepulveda Copete M, Maldonado Gutiérrez C, Bravo Ocaña JC, Satizabal N, Gempeler Rojas A, Castro Llanos AM, Escobar Stein J, Herrera Mayor J, Rosso Suárez F, Rojas Rojas NE, Rojas Rodríguez CA. Prevalencia de Helicobacter pylori en pacientes llevados a endoscopia de vías digestivas altas en un hospital de referencia en Cali, Colombia, en 2020. Rev colomb Gastroenterol 2022;37:355-361. [DOI: 10.22516/25007440.868] [Reference Citation Analysis]
|
| 125 |
Zhou M, Zeng Y, Xi Y, Luo S, Qi J, Zhao G, Sun Y, Guo Y, Cheng F. School-based Hygiene Intervention to Prevent HelicObacter Pylori infection among childrEn (SHIP HOPE): protocol for a cluster-randomised controlled trial. BMJ Open 2022;12:e064207. [PMID: 36600426 DOI: 10.1136/bmjopen-2022-064207] [Reference Citation Analysis]
|
| 126 |
Ding Y, Li Y, Liu J, Wang J, Wan M, Lin M, Lin B, Zhang W, Kong Q, Wang S, Mu Y, Duan M, Han Z, Zuo X, Li Y. The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00953-7] [Reference Citation Analysis]
|
| 127 |
Shah SF, Paracha SA, Ullah W, Muhammad I, Iqbal S, Gul A, Hussain M, Ullah H, Zaman S. Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district. Drug Target Insights 2022;16:49-53. [PMID: 36582782 DOI: 10.33393/dti.2022.2481] [Reference Citation Analysis]
|
| 128 |
Wang Y, Liu L, Liu X, Wu K, Zhu X, Ma L, Su J. An Ultrasensitive PCR-Based CRISPR-Cas13a Method for the Detection of Helicobacter pylori. J Pers Med 2022;12. [PMID: 36556302 DOI: 10.3390/jpm12122082] [Reference Citation Analysis]
|
| 129 |
Wang H, Lu Y, Wang M, Shen A, Wu Y, Xu X, Li Y. Src inhibitor dasatinib sensitized gastric cancer cells to cisplatin. Med Oncol 2022;40:49. [DOI: 10.1007/s12032-022-01879-6] [Reference Citation Analysis]
|
| 130 |
Kefang Sun, Yishu Chen, Zhenzhen Wang, Yi Liu, Yue Pan, Xinli Mao, Lei Xu, Chaohui Jin, Ming Chen, Chaohui Yu, Lan Li. Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study. BMC Gastroenterol 2022;22:520. [PMID: 36522612 DOI: 10.1186/s12876-022-02614-1] [Reference Citation Analysis]
|
| 131 |
Petrov VI, Ponomareva AV, Ivakhnenko IV, Razvalyaeva OV, Dotsenko AM. PROBLEMS OF ERADICATION THERAPY AND WAYS TO OVERCOME THEM: R EVIEW OF MODERN RECOMMENDATIONS AND REAL PRACTICE. Journal of Volgograd State Medical University 2022;19:22-33. [DOI: 10.19163/1994-9480-2022-19-4-22-33] [Reference Citation Analysis]
|
| 132 |
Luo M, Su T, Wang S, Chen J, Lin T, Cheng Q, Chen Y, Gong M, Yang H, Li F, Zhang Y. Proteomic Landscape of Human Spermatozoa: Optimized Extraction Method and Application. Cells 2022;11. [PMID: 36552826 DOI: 10.3390/cells11244064] [Reference Citation Analysis]
|
| 133 |
Yunusa I, Love BL. Cost-Effectiveness of Vonoprazan- and Rifabutin-Based vs. Other Regimens as First-Line Treatment of Helicobacter Pylori Infection in the United States. Am J Gastroenterol 2022. [PMID: 36693030 DOI: 10.14309/ajg.0000000000002146] [Reference Citation Analysis]
|
| 134 |
Akbari Rad M, Goshayeshi L, Moodi Ghalibaf AA, Mehrad Majd H, Soleimani G, Kolahi Ahari R. Helicobacter pylori Standard Triple Therapy Outcomes in Iranian Population: A Retrospective Population-based Study in Mashhad, Northeast of Iran. Jundishapur J Microbiol 2022;15. [DOI: 10.5812/jjm-127842] [Reference Citation Analysis]
|
| 135 |
Setshedi M, Watermeyer G. The impact of Helicobacter pylori and intestinal helminth infections on gastric adenocarcinoma and inflammatory bowel disease in Sub-Saharan Africa. Front Med (Lausanne) 2022;9:1013779. [PMID: 36569142 DOI: 10.3389/fmed.2022.1013779] [Reference Citation Analysis]
|
| 136 |
Ma Z, Chu X, Yan X, Wang W. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis. Front Public Health 2022;10:1062942. [PMID: 36568787 DOI: 10.3389/fpubh.2022.1062942] [Reference Citation Analysis]
|
| 137 |
Zhu X, Zhu C, Zhao Y, Liu X, Sa R, Wang Y, Wu K, Su J. Prevalence of Helicobacter pylori Virulence Genes and Their Association with Chronic Gastritis in Beijing, China. Curr Microbiol 2022;80:33. [PMID: 36482124 DOI: 10.1007/s00284-022-03135-6] [Reference Citation Analysis]
|
| 138 |
Zhou J, Shen Y, Song X, Zhou L, Tang H, Li H. Evaluation of a Molecular Mosprie Assay for Detection of Helicobacter pylori and Resistance to Clarithromycin and Levofloxacin. J Infect Dis 2022;226:S503-9. [PMID: 36478246 DOI: 10.1093/infdis/jiac402] [Reference Citation Analysis]
|
| 139 |
Pezhman Alavinejad, Eskandar Hajiani, Abazar Parsi, Azam Satari, Mohammad Javad Rezaei, Morteza Nayebi, Ahmad Hormati, Omid Eslami, Mohammed Hussien Ahmed, Quang Trung Tran, Masoud Arshadzadeh, Siamak Baghaei, Samira Mohammadi, Seyed Jalal Hashemi, Alireza Sedaghat. Effect of Helicobacter pylori eradication on metabolic profile: an international, multicenter, case-control study. BMC Gastroenterol 2022;22:507. [PMID: 36482315 DOI: 10.1186/s12876-022-02604-3] [Reference Citation Analysis]
|
| 140 |
Tang X, Shen Y, Song X, Benghezal M, Marshall BJ, Tang H, Li H. Reassessment of the Broth Microdilution Method for Susceptibility Testing of Helicobacter pylori. J Infect Dis 2022;226:S486-92. [PMID: 36478248 DOI: 10.1093/infdis/jiac389] [Reference Citation Analysis]
|
| 141 |
Borraccino AV, Celiberto F, Pricci M, Girardi B, Iannone A, Rendina M, Ierardi E, Di Leo A, Losurdo G. Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties. World J Gastroenterol 2022; 28(45): 6356-6362 [DOI: 10.3748/wjg.v28.i45.6356] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 142 |
Roberts LT, Issa PP, Sinnathamby ES, Granier M, Mayeux H, Eubanks TN, Malone K, Ahmadzadeh S, Cornett EM, Shekoohi S, Kaye AD. Helicobacter Pylori: A Review of Current Treatment Options in Clinical Practice. Life (Basel) 2022;12. [PMID: 36556402 DOI: 10.3390/life12122038] [Reference Citation Analysis]
|
| 143 |
Alfaro E, Martínez-Domínguez SJ, Laredo V, Lanas Á, Sostres C. Evaluation of Different Strategies to Improve the Management of Helicobacter pylori Infection at the Primary Care Level: Training Sessions Increase Prescription Appropriateness of Treatment Regimens. Antibiotics (Basel) 2022;11. [PMID: 36551403 DOI: 10.3390/antibiotics11121746] [Reference Citation Analysis]
|
| 144 |
Qian HS, Li WJ, Dang YN, Li LR, Xu XB, Yuan L, Zhang WF, Yang Z, Gao X, Zhang M, Li X, Zhang GX. Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy. Am J Gastroenterol 2022. [PMID: 36729890 DOI: 10.14309/ajg.0000000000002086] [Reference Citation Analysis]
|
| 145 |
Wernly S, Wernly B, Semmler G, Völkerer A, Rezar R, Semmler L, Stickel F, Aigner E, Niederseer D, Datz C. Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort. Minerva Med 2022;113:936-49. [PMID: 35384436 DOI: 10.23736/S0026-4806.22.07928-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 146 |
Luo Q, Yang H, Hu B. Application of artificial intelligence in the endoscopic diagnosis of early gastric cancer, atrophic gastritis, and Helicobacter pylori infection. J Dig Dis 2022;23:666-74. [PMID: 36661411 DOI: 10.1111/1751-2980.13154] [Reference Citation Analysis]
|
| 147 |
Patrad E, Khalighfard S, Amiriani T, Khori V, Alizadeh AM. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy. Cell Oncol (Dordr) 2022. [PMID: 36149600 DOI: 10.1007/s13402-022-00715-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 148 |
Asgari S, Nikkam N, Saniee P. Metallic Nanoparticles as promising tools to eradicate H. pylori: A comprehensive review on recent advancements. Talanta Open 2022;6:100129. [DOI: 10.1016/j.talo.2022.100129] [Reference Citation Analysis]
|
| 149 |
Dargenio VN, Castellaneta S, Panico S, Papagni ME, Dargenio C, Schettini F, Francavilla R, Cristofori F. Probiotics and gastrointestinal diseases. Minerva Pediatr (Torino) 2022;74:703-23. [PMID: 36315413 DOI: 10.23736/S2724-5276.22.07031-8] [Reference Citation Analysis]
|
| 150 |
Arjmandi D, Abdollahi A, Ardekani A, Razavian I, Razavian E, Sartip B, Mahjour S, Parsa H, Kyvanani NA, Marhoommirzabak E, Kountouras J, Rostami A. Helicobacter pylori infection and risk of multiple sclerosis: An updated meta-analysis. Helicobacter 2022;27:e12927. [PMID: 36046943 DOI: 10.1111/hel.12927] [Reference Citation Analysis]
|
| 151 |
Ajeigbe K, Aibangbee K, Saeed S, Ajeigbe O, Onifade A. Folic acid protects and heals gastric mucosa: role of acid output, inflammatory cytokines, angiogenic and growth factors. JoBAZ 2022;83:15. [DOI: 10.1186/s41936-022-00280-z] [Reference Citation Analysis]
|
| 152 |
Shome S, Talukdar AD, Upadhyaya H. Antibacterial activity of curcumin and its essential nanoformulations against some clinically important bacterial pathogens: A comprehensive review. Biotechnol Appl Biochem 2022;69:2357-86. [PMID: 34826356 DOI: 10.1002/bab.2289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 153 |
Azrad M, Vazana D, On A, Paritski M, Rohana H, Roshrosh H, Agay-Shay K, Peretz A. Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study. Helicobacter 2022;27:e12932. [PMID: 36110057 DOI: 10.1111/hel.12932] [Reference Citation Analysis]
|
| 154 |
Vita NA, Anderson SM, LaFleur MD, Lee RE. Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics. Curr Opin Microbiol 2022;70:102203. [PMID: 36156373 DOI: 10.1016/j.mib.2022.102203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 155 |
Wang Z, Han W, Xue F, Zhao Y, Wu P, Chen Y, Yang C, Gu W, Jiang J. Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation. Gut 2022;71:2391-400. [PMID: 35902213 DOI: 10.1136/gutjnl-2021-325948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 156 |
Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 2022;126:1413-22. [PMID: 36063148 DOI: 10.1002/jso.27084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 157 |
Hu Y, Zhu Y, Lu NH. The management of Helicobacter pylori infection and prevention and control of gastric cancer in China. Front Cell Infect Microbiol 2022;12:1049279. [PMID: 36530421 DOI: 10.3389/fcimb.2022.1049279] [Reference Citation Analysis]
|
| 158 |
Abdulkarim D, Mattsson F, Lagergren J. Recent incidence trends of oesophago-gastric cancer in Sweden. Acta Oncol 2022;61:1490-8. [PMID: 36594265 DOI: 10.1080/0284186X.2022.2163592] [Reference Citation Analysis]
|
| 159 |
Wu D, Li X, Li T, Xie W, Liu Y, Tan Q, Wu W, Sun Z, Chen T, Jiang H, Li J, Qin J, Zhao Y, Chen W. The Effect of Quadruple Therapy with Polaprezinc or Bismuth on Gut Microbiota after Helicobacter pylori Eradication: A Randomized Controlled Trial. J Clin Med 2022;11. [PMID: 36498624 DOI: 10.3390/jcm11237050] [Reference Citation Analysis]
|
| 160 |
Yu D, Ou Z, Zhang W, He H, Li Y, He W, Zhang M, Gao Y, Wu F, Chen Q. Global and national trends in years of life lost and years lived with disability caused by three common gastrointestinal cancers from 1990 to 2019. BMC Gastroenterol 2022;22:493. [DOI: 10.1186/s12876-022-02567-5] [Reference Citation Analysis]
|
| 161 |
Liang B, Yuan Y, Peng XJ, Liu XL, Hu XK, Xing DM. Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics. Front Cell Infect Microbiol 2022;12:1042070. [PMID: 36506013 DOI: 10.3389/fcimb.2022.1042070] [Reference Citation Analysis]
|
| 162 |
Yu C, Qiu J, Xiong M, Ou C, Zeng M, Song H. Trends in Helicobacter pylori-related gastric ulcer research from 2012 to 2022: A bibliometric and visual analysis. Front Med (Lausanne) 2022;9:1027534. [PMID: 36507534 DOI: 10.3389/fmed.2022.1027534] [Reference Citation Analysis]
|
| 163 |
Aumpan N, Mahachai V, Vilaichone RK. Management of Helicobacter pylori infection. JGH Open 2023;7:3-15. [PMID: 36660052 DOI: 10.1002/jgh3.12843] [Reference Citation Analysis]
|
| 164 |
Helicobacter pylori Primary and Secondary Antimicrobial Resistance through 22 Years of Culture Experience (2000-2021).. [DOI: 10.21203/rs.3.rs-2196259/v2] [Reference Citation Analysis]
|
| 165 |
Şen O, Oray Ş, Gökhan Türkçapar A. Is There a Relationship Between Helicobacter Pylori and GERD Before Laparoscopic Sleeve Gastrectomy? Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2022;32:692-695. [DOI: 10.1097/sle.0000000000001122] [Reference Citation Analysis]
|
| 166 |
Akpoigbe K, Culpepper-morgan J, Nwankwo O, Genao A. Predicting Gastric Intestinal Metaplasia in a High-Risk Population. Cureus 2022. [DOI: 10.7759/cureus.31502] [Reference Citation Analysis]
|
| 167 |
Zhao M, Wei F, Sun G, Wen Y, Xiang J, Su F, Zhan L, Nian Q, Chen Y, Zeng J. Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1004383] [Reference Citation Analysis]
|
| 168 |
Che TH, Nguyen TC, Ngo DTT, Nguyen HT, Vo KT, Ngo XM, Truong DQ, Bontems P, Robert A, Nguyen PNV. High Prevalence of Helicobacter pylori Infection Among School-Aged Children in Ho Chi Minh City, VietNam. Int J Public Health 2022;67. [DOI: 10.3389/ijph.2022.1605354] [Reference Citation Analysis]
|
| 169 |
Mathebela P, Damane BP, Mulaudzi TV, Mkhize-Khwitshana ZL, Gaudji GR, Dlamini Z. Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer. Int J Mol Sci 2022;23. [PMID: 36430229 DOI: 10.3390/ijms232213750] [Reference Citation Analysis]
|
| 170 |
Fekadu S, Engiso H, Seyfe S, Iizasa H, Godebo A, Deyno S, Yoshiyama H. Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: A systematic review and meta-analysis.. [DOI: 10.21203/rs.3.rs-2078777/v1] [Reference Citation Analysis]
|
| 171 |
Shi Y, Ning J, Norbu K, Hou X, Zheng H, Zhang H, Yu W, Zhou F, Li Y, Ding S, Zhang Q. The tibetan medicine Zuozhu-Daxi can prevent Helicobacter pylori induced-gastric mucosa inflammation by inhibiting lipid metabolism. Chin Med 2022;17:126. [DOI: 10.1186/s13020-022-00682-9] [Reference Citation Analysis]
|
| 172 |
Almeida RS, Wisnieski F, Takao Real Karia B, Smith MAC. CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer. Genes 2022;13:2029. [DOI: 10.3390/genes13112029] [Reference Citation Analysis]
|
| 173 |
Gong Y, Luo Y, Chen Z, Sui Y, Zheng Y. Longitudinal analysis of factors related to Helicobacter pylori infection in Chinese adults. Open Medicine 2022;17:1742-1749. [DOI: 10.1515/med-2022-0564] [Reference Citation Analysis]
|
| 174 |
Liu Y, Xu H, Zhao Z, Dong Y, Wang X, Niu J. No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Front Microbiol 2022;13:1018322. [PMID: 36406444 DOI: 10.3389/fmicb.2022.1018322] [Reference Citation Analysis]
|
| 175 |
Koseki M, Sheu M, Tsai K, Ho C, Liu H, Lin H, Lin C, Huang C. Comparison of the incidence of immune thrombocytopenia between adult patients infected with Helicobacter pylori with and without eradication therapy: A retrospective cohort study in Taiwan.. [DOI: 10.21203/rs.3.rs-2196609/v1] [Reference Citation Analysis]
|
| 176 |
Song MY, Lee DY, Han YM, Kim EH. Anti-Inflammatory Effect of Korean Propolis on Helicobacter pylori-Infected Gastric Mucosal Injury Mice Model. Nutrients 2022;14. [PMID: 36364906 DOI: 10.3390/nu14214644] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 177 |
Shah SC, Tarassishin L, Eisele C, Rendon A, Debebe A, Hawkins K, Hillenbrand C, Agrawal M, Torres J, Peek RM Jr, Stone J, Dubinsky M, Colombel JF, Peter I, Hu J. Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant Cohort. Dig Dis Sci 2022;67:5149-57. [PMID: 35119598 DOI: 10.1007/s10620-021-07371-x] [Reference Citation Analysis]
|
| 178 |
An SJ, Davis D, Kayange L, Gallaher J, Charles A. Predictors of mortality for perforated peptic ulcer disease in Malawi. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.11.029] [Reference Citation Analysis]
|
| 179 |
Simões AM, Araújo D, Teixeira PM, Antunes H. Effect of Helicobacter pylori Infection on Macromineral and Trace Element Status-Systematic Review and Meta-Analysis. J Pediatr Gastroenterol Nutr 2022;75:661-5. [PMID: 35815889 DOI: 10.1097/MPG.0000000000003559] [Reference Citation Analysis]
|
| 180 |
Luo J, Cao S, Ding N, Liao X, Peng L, Xu C. A deep learning method to assist with chronic atrophic gastritis diagnosis using white light images. Dig Liver Dis 2022;54:1513-9. [PMID: 35610166 DOI: 10.1016/j.dld.2022.04.025] [Reference Citation Analysis]
|
| 181 |
Noor ., Mansoor H, Ud Din R, Asif Farooq M, Asghar A, Siddique M. The Association of Helicobacter pylori With Portal Hypertensive Gastropathy in Patients With and Without Cirrhosis. Cureus 2022. [DOI: 10.7759/cureus.31183] [Reference Citation Analysis]
|
| 182 |
Zhong Z, Wang X, Li J, Zhang B, Yan L, Xu S, Chen G, Gao H. A study on the diagnosis of the Helicobacter pylori coccoid form with artificial intelligence technology. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1008346] [Reference Citation Analysis]
|
| 183 |
Reshetnyak VI, Maev IV. Maintaining the metabolic homeostasis of Helicobacter pylori through chronic hyperglycemia in diabetes mellitus: A hypothesis. World J Meta-Anal 2022; 10(5): 238-243 [DOI: 10.13105/wjma.v10.i5.238] [Reference Citation Analysis]
|
| 184 |
Bisht N, P. Garg A. Helicobacter pylori Gastric Infection: Pathogenesis and Clinical Management. Helicobacter pylori Infection - An Up to Date on the Pathogenic Mechanisms, Diagnosis and Clinical Management [Working Title] 2022. [DOI: 10.5772/intechopen.106783] [Reference Citation Analysis]
|
| 185 |
de Arbulo MG, Tamayo E, Bujanda L, Mendibil L, Mendiola J, Cilla G, Montes M. Helicobacter pylori Primary and Secondary Antimicrobial Resistance through 22 Years of Culture Experience (2000-2021).. [DOI: 10.21203/rs.3.rs-2196259/v1] [Reference Citation Analysis]
|
| 186 |
Khan M, Lin J, Wang B, Chen C, Huang Z, Tian Y, Yuan Y, Bu J. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.968165] [Reference Citation Analysis]
|
| 187 |
He Y, Koido M, Sutoh Y, Shi M, Otsuka-yamasaki Y, Munter HM, Morisaki T, Nagai A, Murakami Y, Tanikawa C, Hachiya T, Matsuda K, Shimizu A, Kamatani Y. East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease.. [DOI: 10.1101/2022.10.25.22281344] [Reference Citation Analysis]
|
| 188 |
Wang D, Chen Y, Ding Y, Tu J. Inverse association between Helicobacter pylori infection and childhood asthma in a physical examination population: a cross-sectional study in Chongqing, China. BMC Pediatr 2022;22:615. [PMID: 36289457 DOI: 10.1186/s12887-022-03682-8] [Reference Citation Analysis]
|
| 189 |
Shu X, Ye D, Hu C, Peng K, Zhao H, Li H, Jiang M. Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years. Sci Rep 2022;12:17754. [PMID: 36272980 DOI: 10.1038/s41598-022-21661-y] [Reference Citation Analysis]
|
| 190 |
Yang H, Guan L, Hu B, Moreira L. Detection and Treatment of Helicobacter pylori: Problems and Advances. Gastroenterology Research and Practice 2022;2022:1-10. [DOI: 10.1155/2022/4710964] [Reference Citation Analysis]
|
| 191 |
Nista EC, Pellegrino A, Giuli L, Candelli M, Schepis T, De Lucia SS, Ojetti V, Franceschi F, Gasbarrini A. Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature. Antibiotics (Basel) 2022;11. [PMID: 36290110 DOI: 10.3390/antibiotics11101452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 192 |
Sousa C, Ferreira R, Santos SB, Azevedo NF, Melo LDR. Advances on diagnosis of Helicobacter pylori infections. Crit Rev Microbiol 2022;:1-22. [PMID: 36264672 DOI: 10.1080/1040841X.2022.2125287] [Reference Citation Analysis]
|
| 193 |
Nguyen Wenker T, Peng FB, Emelogu I, Mallepally N, Kanwal F, El-Serag HB, Tan MC. The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00971-5. [PMID: 36270616 DOI: 10.1016/j.cgh.2022.10.009] [Reference Citation Analysis]
|
| 194 |
Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, Narh CT, Abedi-Ardekani B, Morgan E, de Martel C, McCormack V, Arnold M. Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut 2022:gutjnl-2022-328233. [PMID: 36241389 DOI: 10.1136/gutjnl-2022-328233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 195 |
He X, Qian W, Zhao S, Qi W. Knowledge of early gastric cancer screening among adults ≥45 years in China: Who, when, and how.. [DOI: 10.21203/rs.3.rs-2107113/v1] [Reference Citation Analysis]
|
| 196 |
Wang Z, Wang F. Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis. Therap Adv Gastroenterol 2022;15:17562848221125308. [PMID: 36268270 DOI: 10.1177/17562848221125308] [Reference Citation Analysis]
|
| 197 |
Matsui H, Rimbara E, Suzuki M, Tokunaga K, Suzuki H, Sano M, Ueda T, Tsugawa H, Nanjo S, Takeda A, Sasaki M, Terao S, Suda T, Aoki S, Shibayama K, Ota H, Mabe K. Development of a serological assay to simultaneously identifyHelicobacter suisandHelicobacter pyloriinfection.. [DOI: 10.1101/2022.10.10.22280809] [Reference Citation Analysis]
|
| 198 |
Habbash F, Alalwan TA, Perna S, Ahmed N, Sharif O, Al Sayyad A, Gasparri C, Ferraris C, Rondanelli M. Association between Dietary Habits and Helicobacter pylori Infection among Bahraini Adults. Nutrients 2022;14. [PMID: 36235867 DOI: 10.3390/nu14194215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 199 |
Sung Y, Yin J, Lee K, Tsai C, Lin Y, Chen S, Chung C, Chien W, Lee J, Chou C. Increased risk of sleep-related movement disorder in patients with Helicobacter pylori infection: A nationwide population-based study. Front Neurol 2022;13:953821. [DOI: 10.3389/fneur.2022.953821] [Reference Citation Analysis]
|
| 200 |
Morgan AD, Seely KD, Hagenstein LD, Florey GM, Small JM. Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach. Cancers 2022;14:4886. [DOI: 10.3390/cancers14194886] [Reference Citation Analysis]
|
| 201 |
Huard K, Haddad K, Saada Y, Nguyen J, Banon D, Matteau A, Mansour S, Potter BJ. Prevalence of H. pylori among patients undergoing coronary angiography (The HP-DAPT prevalence study). Sci Rep 2022;12:16591. [PMID: 36198683 DOI: 10.1038/s41598-022-17034-0] [Reference Citation Analysis]
|
| 202 |
Mahmoud A, Abuelazm M, Ahmed AAS, Abdalshafy H, Abdelazeem B, Brašić JR. Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2022;14:4126. [PMID: 36235778 DOI: 10.3390/nu14194126] [Reference Citation Analysis]
|
| 203 |
Chen Y, Tang Z, Fu L, Liu R, Yang L, Wang B. Inhibitory and Injury-Protection Effects of O-Glycan on Gastric Epithelial Cells Infected with Helicobacter pylori. Infect Immun 2022;:e0039322. [PMID: 36190255 DOI: 10.1128/iai.00393-22] [Reference Citation Analysis]
|
| 204 |
Alsohaibani F, Peedikayil M, Alshahrani A, Somily A, Alsulaiman R, Azzam N, Almadi M. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi J Gastroenterol 2022. [PMID: 36204804 DOI: 10.4103/sjg.sjg_288_22] [Reference Citation Analysis]
|
| 205 |
Kong Q, Li Y, Li R, Li Z, Zheng X, Wang Z, Song K, Zhang X, Liu J, Han Z, Duan M, Ding Y, Zhang W, Lin M, Wang J, Wan M, Lin B, Wang S, Zuo X, Li Y. Low compliance to post-screening recommendations in a family-based Helicobacter pylori screening and treatment program: A prospective cohort study. Helicobacter 2022;27:e12912. [PMID: 35816511 DOI: 10.1111/hel.12912] [Reference Citation Analysis]
|
| 206 |
Chen MJ, Bair MJ, Chen PY, Lee JY, Yang TH, Fang YJ, Chen CC, Chang AT, Hsiao WD, Yu JJ, Kuo CC, Chiu MC, Lin KP, Tsai MH, Hsu YC, Chou CK, Chen CY, Lin JT, Lee YC, Wu MS, Liou JM; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis. Helicobacter 2022;27:e12914. [PMID: 35848363 DOI: 10.1111/hel.12914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 207 |
Hu Y, Xu X, Ouyang YB, He C, Li NS, Xie C, Peng C, Zhu ZH, Xie Y, Shu X, Lu NH, Zhu Y. Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter 2022;27:e12923. [PMID: 36036087 DOI: 10.1111/hel.12923] [Reference Citation Analysis]
|
| 208 |
Akazawa Y, Ueyama H, Hayashi T, Utsunomiya H, Uchida R, Abe D, Oki S, Suzuki N, Ikeda A, Yatagai N, Komori H, Takeda T, Matsumoto K, Ueda K, Matsumoto K, Asaoka D, Hojo M, Saito T, Yao T, Nagahara A. Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma. J Gastroenterol 2022;57:725-34. [PMID: 35939123 DOI: 10.1007/s00535-022-01906-3] [Reference Citation Analysis]
|
| 209 |
Bordin D, Morozov S, Plavnik R, Bakulina N, Voynovan I, Skibo I, Isakov V, Bakulin I, Andreev D, Maev I. Helicobacter pylori infection prevalence in ambulatory settings in 2017-2019 in RUSSIA: The data of real-world national multicenter trial. Helicobacter 2022;27:e12924. [PMID: 35971900 DOI: 10.1111/hel.12924] [Reference Citation Analysis]
|
| 210 |
Inamasu Y, Ogawa M, Saito M, Harada M, Fukuda K. Helicobacter pylori results in lysis and death after exposure to water. Helicobacter 2022;27:e12921. [PMID: 36089840 DOI: 10.1111/hel.12921] [Reference Citation Analysis]
|
| 211 |
Zhang Y, Liu C, Chen H, Chen J, Li J, Teng Y. Metagenomic insights into resistome coalescence in an urban sewage treatment plant-river system. Water Res 2022;224:119061. [PMID: 36096031 DOI: 10.1016/j.watres.2022.119061] [Reference Citation Analysis]
|
| 212 |
Han YY, Long H, Lin Y, He Q, Chen WG, Ding XW, Zhou L, An P, Wang F, Zhang ZY, Hu YL, Li PY. Optimized dual therapy for treatment-naive patients of Helicobacter pylori infection: A large-scale prospective, multicenter, open-label, randomized controlled study. Helicobacter 2022;27:e12922. [PMID: 35939559 DOI: 10.1111/hel.12922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 213 |
Zhang Y, Wang M, Zhang K, Zhang J, Yuan X, Zou G, Cao Z, Zhang C. 6'-O-Galloylpaeoniflorin attenuates Helicobacter pylori-associated gastritis via modulating Nrf2 pathway. Int Immunopharmacol 2022;111:109122. [PMID: 35964411 DOI: 10.1016/j.intimp.2022.109122] [Reference Citation Analysis]
|
| 214 |
Wang JW, Hsu PI, Lin MH, Kao J, Tsay FW, Wu IT, Shie CB, Wu DC. The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection: A real-world clinical experience. J Gastroenterol Hepatol 2022;37:1928-34. [PMID: 35816187 DOI: 10.1111/jgh.15942] [Reference Citation Analysis]
|
| 215 |
Shi Y, Zheng H, Guo Z, Deng R, Yu W, Song Y, Ding S. Effect of Helicobacter pylori on immunotherapy is gaining more attention. Helicobacter 2022;27:e12925. [PMID: 36036113 DOI: 10.1111/hel.12925] [Reference Citation Analysis]
|
| 216 |
Tamjid N, Eskandari S, Karimi Z, Nezafat N, Negahdaripour M. Vaccinomics strategy to design an epitope peptide vaccine against Helicobacter pylori. Process Biochemistry 2022;121:380-95. [DOI: 10.1016/j.procbio.2022.07.007] [Reference Citation Analysis]
|
| 217 |
Huang RJ, Epplein M, Hamashima C, Choi IJ, Lee E, Deapen D, Woo Y, Tran T, Shah SC, Inadomi JM, Greenwald DA, Hwang JH. An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States. Clin Gastroenterol Hepatol 2022;20:2218-2228.e2. [PMID: 34624563 DOI: 10.1016/j.cgh.2021.09.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 218 |
Sawada H, Czech T, Silangcruz K, Kozai L, Obeidat A, Wien EA, Nishimura MF, Nishikori A, Sato Y, Nishimura Y. Clinicopathological characteristics of gastric IgG4-related disease: Systematic scoping review. J Gastroenterol Hepatol 2022;37:1865-72. [PMID: 35949057 DOI: 10.1111/jgh.15980] [Reference Citation Analysis]
|
| 219 |
Tanner S, Katz J, Cominelli F, Regueiro M, Cooper G, Mansoor E. Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present? Inflamm Bowel Dis 2022:izac202. [PMID: 36169397 DOI: 10.1093/ibd/izac202] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 220 |
Nikbazm R, Rahimi Z, Moradi Y, Alipour M, Shidfar F. The effect of cranberry supplementation on Helicobacter pylori eradication in H. pylori positive subjects: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr 2022;128:1090-9. [PMID: 34670631 DOI: 10.1017/S0007114521004256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 221 |
Zhao Q, Wang W, Zhou S, Su J, Sun H, Zhai J, Hu Y. Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Front Pharmacol 2022;13:959184. [DOI: 10.3389/fphar.2022.959184] [Reference Citation Analysis]
|
| 222 |
Dinat S, Orchard A, Van Vuuren S. A systematic review of African natural products against gastric ulcers and Helicobacter pylori. J Ethnopharmacol 2022;:115698. [PMID: 36174808 DOI: 10.1016/j.jep.2022.115698] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 223 |
Gudra D, Silamikelis I, Pjalkovskis J, Danenberga I, Pupola D, Skenders G, Ustinova M, Megnis K, Leja M, Vangravs R, Fridmanis D. Development and use of an ESBL coding gene panel in patients undergoing first-line eradication therapy for Helicobacter pylori.. [DOI: 10.21203/rs.3.rs-2080077/v1] [Reference Citation Analysis]
|
| 224 |
Wang Y, Xiang Y, Liao O, Wu Y, Li Y, Du Q, Ye J. Short-term outcomes and intermediate-term follow-up of Helicobacter pylori infection treatment for naïve patients: a retrospective observational study. BMJ Open 2022;12:e062096. [PMID: 36115671 DOI: 10.1136/bmjopen-2022-062096] [Reference Citation Analysis]
|
| 225 |
Fagni Njoya ZL, Mbiantcha M, Djuichou Nguemnang SF, Matah Marthe VM, Yousseu Nana W, Madjo Kouam YK, Ngoufack Azanze E, Tsafack EG, Ateufack G, Husain K. Anti-Helicobacter pylori, anti-Inflammatory, and Antioxidant Activities of Trunk Bark of Alstonia boonei (Apocynaceae). BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/9022135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 226 |
Tuan HM, Duy HP, Anh NT, Tung LV. Association between active Helicobacter pylori infection and iron deficiency anaemia: a case-control study.. [DOI: 10.21203/rs.3.rs-2032634/v1] [Reference Citation Analysis]
|
| 227 |
Chen YC, Li YD, Yu BH, Chen YC. A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease. BMC Gastroenterol 2022;22:416. [PMID: 36096732 DOI: 10.1186/s12876-022-02498-1] [Reference Citation Analysis]
|
| 228 |
Lai Y, Wei W, Du Y, Gao J, Li Z. Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microbes 2022;14:2120747. [PMID: 36070564 DOI: 10.1080/19490976.2022.2120747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 229 |
Jiang Z, Qian X, Wang Z, Dong Y, Pan Y, Zhang Z, Wang S. Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021. Front Cell Infect Microbiol 2022;12:970630. [DOI: 10.3389/fcimb.2022.970630] [Reference Citation Analysis]
|
| 230 |
Li P, Jin J, Chen Y, Ma J, Du Q, Han Y. Susceptibility-guided vs. empirical 10-day quadruple treatment for Helicobacter pylori-infected patients: A prospective clinical trial of first-line therapy. Front Microbiol 2022;13:973975. [DOI: 10.3389/fmicb.2022.973975] [Reference Citation Analysis]
|
| 231 |
Ebrahimi Z, Masoodi M, Aslani Z, Naghshi S, Khalighi Sikaroudi M, Shidfar F. Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: a case-control study. BMC Gastroenterol 2022;22:413. [PMID: 36068529 DOI: 10.1186/s12876-022-02488-3] [Reference Citation Analysis]
|
| 232 |
Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, Kawachi I, Campbell PT, Giovannucci EL, Weiderpass E, Rebbeck TR, Ogino S. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol 2022. [PMID: 36068272 DOI: 10.1038/s41571-022-00672-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 233 |
Borka Balas R, Meliț LE, Mărginean CO. Worldwide Prevalence and Risk Factors of Helicobacter pylori Infection in Children. Children 2022;9:1359. [DOI: 10.3390/children9091359] [Reference Citation Analysis]
|
| 234 |
Park AM, Tsunoda I. Helicobacter pylori infection in the stomach induces neuroinflammation: the potential roles of bacterial outer membrane vesicles in an animal model of Alzheimer's disease. Inflamm Regen 2022;42:39. [PMID: 36058998 DOI: 10.1186/s41232-022-00224-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 235 |
Lenka S, Bhuyan R. Management of H. pylori Induced Peptic ulcer – A Phytotherapeutic Approach. J Pure Appl Microbiol 2022;16:1530-1537. [DOI: 10.22207/jpam.16.3.36] [Reference Citation Analysis]
|
| 236 |
Sadat-ebrahimi SE, Bigdelou A, Sooreshjani RH, Montazer MN, Zomorodian K, Irajie C, Yahya-meymandi A, Biglar M, Larijani B, Amanlou M, Iraji A, Mahdavi M. Novel phenylurea-pyridinium derivatives as potent urease inhibitors: Synthesis, in vitro, and in silico studies. Journal of Molecular Structure 2022;1263:133078. [DOI: 10.1016/j.molstruc.2022.133078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 237 |
Ouyang Y, Wang M, Xu YL, Zhu Y, Lu NH, Hu Y. Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. J Gastroenterol Hepatol 2022;37:1666-72. [PMID: 35716370 DOI: 10.1111/jgh.15917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 238 |
Romano M, Gravina AG, Eusebi LH, Pellegrino R, Palladino G, Frazzoni L, Dajti E, Gasbarrini A, Di Mario F, Zagari RM; Members of SIGE, Members of SIED National Council. Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED). Dig Liver Dis 2022;54:1153-61. [PMID: 35831212 DOI: 10.1016/j.dld.2022.06.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 239 |
Shah SC, Bonnet K, Schulte R, Peek RM Jr, Schlundt D, Roumie CL. Helicobacter pylori Management Is Associated with Predominantly Negative Patient Experiences: Results from a Focused Qualitative Analysis. Dig Dis Sci 2022;67:4387-94. [PMID: 35034240 DOI: 10.1007/s10620-021-07320-8] [Reference Citation Analysis]
|
| 240 |
Carlos ABM, Costa VE, Kobayasi R, Rodrigues MAM. Prevalence of Helicobacter pylori infection among asymptomatic children in southeastern Brazil: a cross-sectional study. Sao Paulo Med J 2022;140:719-22. [PMID: 36043666 DOI: 10.1590/1516-3180.2021.0721.R2.03032022] [Reference Citation Analysis]
|
| 241 |
Azhari H, King JA, Coward S, Windsor JW, Ma C, Shah SC, Ng SC, Mak JWY, Kotze PG, Ben-Horin S, Loftus EV Jr, Lees CW, Gearry R, Burisch J, Lakatos PL, Calvet X, Bosques Padilla FJ, Underwood FE, Kaplan GG. The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD). Am J Gastroenterol 2022;117:1419-27. [PMID: 35973143 DOI: 10.14309/ajg.0000000000001843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 242 |
Ivyna de Araújo Rêgo R, Guedes Silvestre GF, Ferreira de Melo D, Albino SL, Pimentel MM, Silva Costa Cruz SB, Silva Wurzba SD, Rodrigues WF, Goulart de Lima Damasceno BP, Cançado Castellano LR. Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer. Front Pharmacol 2022;13:951125. [DOI: 10.3389/fphar.2022.951125] [Reference Citation Analysis]
|
| 243 |
Ailloud F, Estibariz I, Pfaffinger G, Suerbaum S. The Helicobacter pylori UvrC Nuclease Is Essential for Chromosomal Microimports after Natural Transformation. mBio 2022;13:e0181122. [PMID: 35876509 DOI: 10.1128/mbio.01811-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 244 |
Shatila M, Thomas AS. Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection. JCM 2022;11:5086. [DOI: 10.3390/jcm11175086] [Reference Citation Analysis]
|
| 245 |
Panthangi V, Cyril Kurupp AR, Raju A, Luthra G, Shahbaz M, Almatooq H, Foucambert P, Esbrand FD, Zafar S, Khan S. Association Between Helicobacter pylori Infection and the Risk of Pancreatic Cancer: A Systematic Review Based on Observational Studies. Cureus 2022. [DOI: 10.7759/cureus.28543] [Reference Citation Analysis]
|
| 246 |
Shah SAR, Rahman H, Qasim M, Akram MS, Saygideger Y, Puspita N, Saygıdeğer Demir B, Alzahrani KJ, Rehman MFU, Alzahrani FM, Alblihd MA. Differential Proteomics of Helicobacter pylori Isolates from Gastritis, Ulcer, and Cancer Patients: First Study from Northwest Pakistan. Medicina (Kaunas) 2022;58:1168. [PMID: 36143845 DOI: 10.3390/medicina58091168] [Reference Citation Analysis]
|
| 247 |
Casado J, Lanas Á, González A. Two-component regulatory systems in Helicobacter pylori and Campylobacter jejuni: Attractive targets for novel antibacterial drugs. Front Cell Infect Microbiol 2022;12:977944. [DOI: 10.3389/fcimb.2022.977944] [Reference Citation Analysis]
|
| 248 |
Hou X, Wang J, Du Q, Tian D, Hu N, Liu D, Zhou F, Xie L, Gu L, Kudou K, Zhang S. Efficacy and safety of vonoprazan-based quadruple therapy for the eradication of Helicobacter pylori in patients with peptic ulcers: a pooled analysis of two randomized, double-blind, double-dummy, phase 3 trials.. [DOI: 10.21203/rs.3.rs-1837897/v1] [Reference Citation Analysis]
|
| 249 |
Nyssen OP, Moreira L, García-morales N, Cano-català A, Puig I, Mégraud F, O’morain C, Gisbert JP. European Registry on Helicobacter pylori Management (Hp-EuReg): Most relevant results for clinical practice. Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.965982] [Reference Citation Analysis]
|
| 250 |
Zhou J, Liu C, Liu B, Wang Y, Benghezal M, Marshall BJ, Tang H, Li H. Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test. Front Cell Infect Microbiol 2022;12:980399. [DOI: 10.3389/fcimb.2022.980399] [Reference Citation Analysis]
|
| 251 |
Lu J, Van Hoang D, Hayashi Y, Hashimoto M, Kubo S, Kajio H, Mizoue T, Siemianowicz K. Negative-High Titer of Helicobacter pylori Antibody and Lipid Profiles. BioMed Research International 2022;2022:1-5. [DOI: 10.1155/2022/9984255] [Reference Citation Analysis]
|
| 252 |
Chelleng N, Puzari M, Chetia P, Tamuly C. Phenolic compounds of Zanthoxylum armatum DC as potential inhibitors of urease and SARS-CoV2 using molecular docking approach and with simulation study. Nat Prod Res 2022;:1-5. [PMID: 35968637 DOI: 10.1080/14786419.2022.2110096] [Reference Citation Analysis]
|
| 253 |
Fakharian F, Asgari B, Nabavi-rad A, Sadeghi A, Soleimani N, Yadegar A, Zali MR. The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Front Cell Infect Microbiol 2022;12:953718. [DOI: 10.3389/fcimb.2022.953718] [Reference Citation Analysis]
|
| 254 |
Feng T, Zheng Z, Xu J, Cao P, Gao S, Yu X. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China. Int J Environ Res Public Health 2022;19:9986. [PMID: 36011621 DOI: 10.3390/ijerph19169986] [Reference Citation Analysis]
|
| 255 |
Lou D, Fu R, Gu L, Su H, Guan L. Association between statins exposure with incidence and prognosis of gastric cancer: an updated meta-analysis. Expert Rev Clin Pharmacol 2022. [PMID: 35947078 DOI: 10.1080/17512433.2022.2112178] [Reference Citation Analysis]
|
| 256 |
Zou X, Hu J, Zhao M, Qin C, Zhu Y, Tian G, Cai J, Seeberger PH, Yin J. Chemical Synthesis of the Highly Sterically Hindered Core Undecasaccharide of Helicobacter pylori Lipopolysaccharide for Antigenicity Evaluation with Human Serum. J Am Chem Soc 2022. [PMID: 35939326 DOI: 10.1021/jacs.2c03068] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 257 |
Chen J, Razzouk J, Martinez P, Kohler R, Morrow E, Ibele A, Volckmann E. The utility of endoscopy prior to bariatric surgery: an 11-year retrospective analysis of 885 patients. Surg Endosc 2022. [PMID: 35941309 DOI: 10.1007/s00464-022-09485-3] [Reference Citation Analysis]
|
| 258 |
Nhu LTT, Nguyen VL, Tran VD, Tran NA, Nguyen VT. Evaluation of the Antibiotic Resistance Rate of Helicobacter pylori in Peptic Ulcer Patients in Tien Giang Central General Hospital, Tien Giang Province, Vietnam. Open Access Maced J Med Sci 2022;10:1835-1839. [DOI: 10.3889/oamjms.2022.10216] [Reference Citation Analysis]
|
| 259 |
Johnson KS, Yang C, Carter JE, Worthington AK, Robinson EK, Lopez-magaña R, Salgado F, Arnold I, Ottemann KM. Helicobacter chronic stage inflammation undergoes fluctuations that are altered in tlpA mutants.. [DOI: 10.1101/2022.08.01.502425] [Reference Citation Analysis]
|
| 260 |
He J, Liu Y, Ouyang Q, Li R, Li J, Chen W, Hu W, He L, Bao Q, Li P, Hu C. Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications. Front Microbiol 2022;13:972777. [DOI: 10.3389/fmicb.2022.972777] [Reference Citation Analysis]
|
| 261 |
Kim T, Seo SI, Lee KJ, Park CH, Kim TJ, Kim J, Shin WG. Decreasing Incidence of Gastric Cancer with Increasing Time after Helicobacter pylori Treatment: A Nationwide Population-Based Cohort Study. Antibiotics (Basel) 2022;11. [PMID: 36009921 DOI: 10.3390/antibiotics11081052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 262 |
Li J, Yu H, Wang Y, Wang B, Zhang R, Chen S, Duan G. A meta-analysis of the association between Helicobacter pylori infection and risk of hepatic encephalopathy. J Public Health (Oxf) 2022:fdac078. [PMID: 35924861 DOI: 10.1093/pubmed/fdac078] [Reference Citation Analysis]
|
| 263 |
Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2022;117:1221-30. [PMID: 35509128 DOI: 10.14309/ajg.0000000000001828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 264 |
Jiang Y, Huang L, Zhou L. Association between obesity and helicobacter pylori infection. Nutrition Clinique et Métabolisme 2022. [DOI: 10.1016/j.nupar.2022.07.003] [Reference Citation Analysis]
|
| 265 |
Ang D, Koo SH, Chan YH, Tan TY, Soon GH, Tan CK, Lin KW, Krishnasamy-Balasubramanian JK, Wong YJ, Kumar R, R R, Tan Y, Ong PJ, Tan YJ, Li JW, Kwek AB, Ang TL. Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication. Aliment Pharmacol Ther 2022;56:436-49. [PMID: 35665947 DOI: 10.1111/apt.17070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 266 |
Sorge F, Miller L. Prise en charge pédiatrique d’un enfant adopté. Journal de Pédiatrie et de Puériculture 2022;35:162-178. [DOI: 10.1016/j.jpp.2022.05.009] [Reference Citation Analysis]
|
| 267 |
Su H, Bak E, Kim A, Tissera K, Cha J, Jang S. Helicobacter pylori-mediated gastric pathogenesis is attenuated by treatment of 2-deoxyglucose and metformin. J Microbiol 2022;60:849-858. [DOI: 10.1007/s12275-022-2130-z] [Reference Citation Analysis]
|
| 268 |
Joseph AO, Tsai Y, Liu C, Ji D. Prevalence, diversity and public health implications of Helicobacter species in pet and stray dogs. One Health 2022. [DOI: 10.1016/j.onehlt.2022.100430] [Reference Citation Analysis]
|
| 269 |
Reyes D, Ortiz J, Fuentes-lópez E, Budnik S, Gándara V, Gallardo A, Seydewitz MF, Candia R, Vargas JI, Rollan MP, Godoy J, Rollan A, Mansilla R, Arenas A, Chahuán J, Espino A, Pizarro M, Riquelme A. Quadruple therapies are superior to standard triple therapy for Helicobacter pylori first-line eradication in Chile. Gastroenterología y Hepatología (English Edition) 2022;45:515-523. [DOI: 10.1016/j.gastre.2022.07.004] [Reference Citation Analysis]
|
| 270 |
Xiao W, Ma ZS. Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development. Helicobacter 2022;27:e12899. [PMID: 35678078 DOI: 10.1111/hel.12899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 271 |
Chuah KH, Wong MS, Tan PO, Lim SZ, Beh KH, Chong SCS, Zulkifli KK, Thalha AM, Mahadeva S, Lee YY. Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case-Control Study. Dig Dis Sci 2022;67:3881-9. [PMID: 34417923 DOI: 10.1007/s10620-021-07227-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 272 |
Inokuchi K, Mori H, Matsuzaki J, Hirata K, Harada Y, Saito Y, Suzuki H, Kanai T, Masaoka T. Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen. Helicobacter 2022;27:e12900. [PMID: 35644041 DOI: 10.1111/hel.12900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 273 |
Sukati S, Sama-ae I, Katzenmeier G, Wisessombat S. Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin. The Scientific World Journal 2022;2022:1-12. [DOI: 10.1155/2022/8924023] [Reference Citation Analysis]
|
| 274 |
Ren Z, Li J, Du X, Shi W, Guan F, Wang X, Wang L, Wang H. Helicobacter pylori-Induced Progranulin Promotes the Progression of the Gastric Epithelial Cell Cycle by Regulating CDK4. J Microbiol Biotechnol 2022;32:844-54. [PMID: 35880418 DOI: 10.4014/jmb.2203.03053] [Reference Citation Analysis]
|
| 275 |
Namasivayam V, Koh CJ, Tsao S, Lee J, Ling KL, Khor C, Lim T, Li JW, Yip BC, Hussain I, Chua TS, Toh BC, Ong HS, Wang LM, So JB, Teh M, Yeoh KG, Ang TL. Academy of Medicine, Singapore clinical guideline on endoscopic surveillance and management of gastric premalignant lesions. Ann Acad Med Singap 2022;51:417-435. [DOI: 10.47102/annals-acadmedsg.2021433] [Reference Citation Analysis]
|
| 276 |
Pichon M, Luzarraga V, Burucoa C. Mutations Associated to Antibiotic-Resistant Helicobacter pylori: It Is Time to Validate Sequencing Observations. JCM 2022;11:4293. [DOI: 10.3390/jcm11154293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 277 |
Reshetnyak VI, Burmistrov AI. On the 40<sup>th</sup> anniversary of the discovery of Helicobacter pylori. jour 2022. [DOI: 10.52888/0514-2515-2022-353-2-121-134] [Reference Citation Analysis]
|
| 278 |
Wu SL, Zhang Y, Fu Y, Li J, Wang JS. Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA. BMJ Open 2022;12:e061038. [PMID: 35863834 DOI: 10.1136/bmjopen-2022-061038] [Reference Citation Analysis]
|
| 279 |
Loh JT, Shuman JHB, Lin AS, Favret N, Piazuelo MB, Mallal S, Chopra A, McClain MS, Cover TL. Positive Selection of Mutations in the Helicobacter pylori katA 5' Untranslated Region in a Mongolian Gerbil Model of Gastric Disease. Infect Immun 2022;90:e0000422. [PMID: 35652648 DOI: 10.1128/iai.00004-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 280 |
Bi H, Chen X, Chen Y, Zhao X, Wang S, Wang J, Lyu T, Han S, Lin T, Li M, Yuan D, Liu J, Shi Y. Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial. Chin Med J (Engl) 2022;135:1707-15. [PMID: 36193978 DOI: 10.1097/CM9.0000000000002289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 281 |
Pei Y, Ang D, Kwek ABE, Ang TL. The changing profile of Helicobacter pylori primary antibiotic resistance in Singapore over two decades. J Dig Dis 2022. [PMID: 35849105 DOI: 10.1111/1751-2980.13115] [Reference Citation Analysis]
|
| 282 |
Ferreira R, Sousa C, Gonçalves RFS, Pinheiro AC, Oleastro M, Wagemans J, Lavigne R, Figueiredo C, Azeredo J, Melo LDR. Characterization and Genomic Analysis of a New Phage Infecting Helicobacter pylori. Int J Mol Sci 2022;23:7885. [PMID: 35887231 DOI: 10.3390/ijms23147885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 283 |
Xu T, Tian Y, Wang Y, Yi Z, Li C, Wang S, Fan Y, Yao C, Peng G, Lu H, M'koma A. Effects of Autologous Platelet-Rich Plasma on Healing of Peptic Ulcers: A Randomized Controlled Trial. Gastroenterology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/7944849] [Reference Citation Analysis]
|
| 284 |
Sun C, Chen Y, Kim NH, Lowe S, Ma S, Zhou Z, Bentley R, Chen Y, Tuason MW, Gu W, Bhan C, Tuason JPW, Thapa P, Cheng C, Zhou Q, Zhu Y. Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis. Front Genet 2022;13:911740. [DOI: 10.3389/fgene.2022.911740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 285 |
Fu YL, Wu YH, Cao DH, Jia ZF, Shen A, Jiang J, Cao XY. Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients. World J Gastrointest Oncol 2022; 14(7): 1295-1306 [DOI: 10.4251/wjgo.v14.i7.1295] [Reference Citation Analysis]
|
| 286 |
Qu P, Liu X, Xia X, Xie X, Luo J, Cheng S, Chi J, Liu P, Li H, Zhao W, Yang H, Xu C. Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study. Front Cell Infect Microbiol 2022;12:903002. [DOI: 10.3389/fcimb.2022.903002] [Reference Citation Analysis]
|
| 287 |
Oylumlu E, Uzel G, Durmus L, Tas M, Gunes D, Ciraci C. Pattern Recognition Receptor-Mediated Regulatory T Cell Functions in Diseases. Regulatory T Cells [Working Title] 2022. [DOI: 10.5772/intechopen.105693] [Reference Citation Analysis]
|
| 288 |
Song Y, Liu X, Cheng W, Li H, Zhang D. The global, regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019. Sci Rep 2022;12:11542. [PMID: 35798837 DOI: 10.1038/s41598-022-15839-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 289 |
Guo L, Zhang F, Wang S, Li R, Zhang L, Zhang Z, Yin R, Liu H, Liu K. Oral Immunization With a M Cell-Targeting Recombinant L. Lactis Vaccine LL-plSAM-FVpE Stimulate Protective Immunity Against H. Pylori in Mice. Front Immunol 2022;13:918160. [DOI: 10.3389/fimmu.2022.918160] [Reference Citation Analysis]
|
| 290 |
Zhang M, Pang M, Zhang M. Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials. Clinics (Sao Paulo) 2022;77:100058. [PMID: 35810638 DOI: 10.1016/j.clinsp.2022.100058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 291 |
Liu L, Zhang Y, Chen H, Teng Y. Fate of resistome components and characteristics of microbial communities in constructed wetlands and their receiving river. Sci Total Environ 2022;:157226. [PMID: 35809723 DOI: 10.1016/j.scitotenv.2022.157226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 292 |
Cho JH, Jin SY. Current guidelines for Helicobacter pylori treatment in East Asia 2022: Differences among China, Japan, and South Korea. World J Clin Cases 2022; 10(19): 6349-6359 [DOI: 10.12998/wjcc.v10.i19.6349] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 293 |
Gonzalez-Pons M, Torres-Cintrón CR, Soto-Salgado M, Vargas-Ramos Y, Perez-Portocarrero L, Morgan DR, Cruz-Correa M. Racial/ethnic disparities in gastric cancer: A 15-year population-based analysis. Cancer Med 2023;12:1860-8. [PMID: 35785449 DOI: 10.1002/cam4.4997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 294 |
Hou X, Meng F, Wang J, Sha W, Chiu CT, Chung WC, Gu L, Kudou K, Chong CF, Zhang S. Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients. J Gastroenterol Hepatol 2022;37:1275-83. [PMID: 35342997 DOI: 10.1111/jgh.15837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 295 |
Cho HY, Cho H, Song WS, Yoon S. Structural analysis of the virulence gene protein IceA2 from Helicobacter pylori. Biochemical and Biophysical Research Communications 2022;612:162-8. [DOI: 10.1016/j.bbrc.2022.04.090] [Reference Citation Analysis]
|
| 296 |
Shankar U, Mishra SK, Jain N, Tawani A, Yadav P, Kumar A. Ni+2 permease system of Helicobacter pylori contains highly conserved G-quadruplex motifs. Infection, Genetics and Evolution 2022;101:105298. [DOI: 10.1016/j.meegid.2022.105298] [Reference Citation Analysis]
|
| 297 |
Sadjadi A, Akbarpour E, Alimohammadian M, Masoudi S, Ghanbari R, Rajabi Pour Z, Mohmmad Akbari F, Jafari MD, Feiz-Sani A, Hakimi H, Siavooshi F, Massarrat S, Malekzadeh R. A Population-Based Cross-sectional Study on the Prevalence and Associated Risk Factors of Helicobacter pylori Infection in Rafsanjan, a Low Gastric Cancer Area in Southeast Iran. Middle East J Dig Dis 2022;14:287-93. [PMID: 36619268 DOI: 10.34172/mejdd.2022.285] [Reference Citation Analysis]
|
| 298 |
In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M. Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. Cancer Epidemiol Biomarkers Prev 2022;31:1426-32. [PMID: 35534235 DOI: 10.1158/1055-9965.EPI-21-1328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 299 |
Yu XQ, Feletto E, Smith MA, Yuill S, Baade PD. Cancer Incidence in Migrants in Australia: Patterns of Three Infection-Related Cancers. Cancer Epidemiol Biomarkers Prev 2022;31:1394-401. [PMID: 35322272 DOI: 10.1158/1055-9965.EPI-21-1349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 300 |
Cerrato-Izaguirre D, Chirino YI, García-Cuellar CM, Santibáñez-Andrade M, Prada D, Hernández-Guerrero A, Larraga OA, Camacho J, Sánchez-Pérez Y. Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine. Genes Dis 2022;9:928-40. [PMID: 35685475 DOI: 10.1016/j.gendis.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 301 |
Hung KW, Maratt JK, Cho WK, Shah BJ, Anjou CI, Leiman DA. AGA Institute Quality Measure Development for the Management of Gastric Intestinal Metaplasia With Helicobacter pylori. Gastroenterology 2022;163:3-7. [PMID: 35337856 DOI: 10.1053/j.gastro.2022.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 302 |
Mărginean CO, Meliț LE, Săsăran MO. Traditional and Modern Diagnostic Approaches in Diagnosing Pediatric Helicobacter pylori Infection. Children 2022;9:994. [DOI: 10.3390/children9070994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 303 |
Wang Y, Li Y, Luan Z, Zhao Y, Zhang P, Ma C, Shi C. Multiplex Accelerated PCR System for One-Step Helicobacter pylori cagA + Genotypes Detection: A Guide for Clinical Testing. Curr Microbiol 2022;79:235. [PMID: 35767084 DOI: 10.1007/s00284-022-02931-4] [Reference Citation Analysis]
|
| 304 |
Korbecki J, Szatkowska I, Kupnicka P, Żwierełło W, Barczak K, Poziomkowska-gęsicka I, Wójcik J, Chlubek D, Baranowska-bosiacka I. The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs. IJMS 2022;23:7151. [DOI: 10.3390/ijms23137151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 305 |
Karbalaei M, Talebi Bezmin Abadi A, Keikha M. Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis. BMC Infect Dis 2022;22:573. [PMID: 35752757 DOI: 10.1186/s12879-022-07546-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 306 |
Grosso R, de-Paz M. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations. Pharmaceutics 2022;14:1340. [DOI: 10.3390/pharmaceutics14071340] [Reference Citation Analysis]
|
| 307 |
Imai Y, Lee SW, Sakaguchi S, Kato-Kogoe N, Taniguchi K, Omori M, Tanaka R, Honda K, Osumi W, Nakano T, Ueno T, Uchiyama K. Comparison of the gastric microbiome in Billroth I and Roux-en-Y reconstructions after distal gastrectomy. Sci Rep 2022;12:10594. [PMID: 35732881 DOI: 10.1038/s41598-022-14886-4] [Reference Citation Analysis]
|
| 308 |
Nasseri-Moghaddam S, Mousavian AH, Kasaeian A, Kanno T, Yuan Y, Ford AC, Moayyedi P. What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00594-8. [PMID: 35738355 DOI: 10.1016/j.cgh.2022.05.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 309 |
Abdi S, Ataei S, Abroon M, Majma Sanaye P, Abbasinazari M, Farrokhian A. A Comprehensive Review of the Role of Complementary and Dietary Medicines in Eradicating Helicobacter pylori. Iran J Pharm Res 2022;21. [DOI: 10.5812/ijpr-127030] [Reference Citation Analysis]
|
| 310 |
Yamamichi N, Shimamoto T, Takahashi Y, Takahashi M, Takeuchi C, Wada R, Fujishiro M. Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan. PLoS ONE 2022;17:e0270252. [DOI: 10.1371/journal.pone.0270252] [Reference Citation Analysis]
|
| 311 |
Gupta I, Pedersen S, Vranic S, Al Moustafa AE. Implications of Gut Microbiota in Epithelial-Mesenchymal Transition and Cancer Progression: A Concise Review. Cancers (Basel) 2022;14:2964. [PMID: 35740629 DOI: 10.3390/cancers14122964] [Reference Citation Analysis]
|
| 312 |
Nyssen OP, Espada M, Gisbert JP. Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Front Microbiol 2022;13:913436. [DOI: 10.3389/fmicb.2022.913436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 313 |
Zhang X, Sang S, Guan Q, Tao H, Wang Y, Liu C. Oral Administration of a Shigella 2aT32-Based Vaccine Expressing UreB-HspA Fusion Antigen With and Without Parenteral rUreB-HspA Boost Confers Protection Against Helicobacter pylori in Mice Model. Front Immunol 2022;13:894206. [DOI: 10.3389/fimmu.2022.894206] [Reference Citation Analysis]
|
| 314 |
Taillieu E, Chiers K, Amorim I, Gärtner F, Maes D, Van Steenkiste C, Haesebrouck F. Gastric Helicobacter species associated with dogs, cats and pigs: significance for public and animal health. Vet Res 2022;53:42. [PMID: 35692057 DOI: 10.1186/s13567-022-01059-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 315 |
Wasielica-berger J, Gugnacki P, Mlynarczyk M, Rogalski P, Swidnicka-siergiejko A, Antonowicz S, Krzyzak M, Maslach D, Dabrowski A, Daniluk J. Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland. IJERPH 2022;19:6921. [DOI: 10.3390/ijerph19116921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 316 |
Zhou Y, Zhong Z, Hu S, Wang J, Deng Y, Li X, Chen X, Li X, Tang Y, Li X, Hao Q, Liu J, Sang T, Bo Y, Bai F. A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China. Antimicrob Agents Chemother 2022;:e0218821. [PMID: 35652644 DOI: 10.1128/aac.02188-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 317 |
Gudina EK, Amare H, Ali S, Berhane Arefayine M, Tewolde D, Tesfaye Eshete M, Jebena MG, Wieser A, Froeschl G, Tesfaye M, Desalegn H, Gashaw M. Diagnostic Challenges of Helicobacter pylori Infection in Ethiopia: A Community-Based Cross-Sectional Study. Can J Gastroenterol Hepatol 2022;2022:4013020. [PMID: 36247045 DOI: 10.1155/2022/4013020] [Reference Citation Analysis]
|
| 318 |
Li C, Yue J, Ding Z, Zhang Q, Xu Y, Wei Q, Wang J, Ning X, Zeng H, Cao J. Prevalence and predictors of Helicobacter pylori infection in asymptomatic individuals: a hospital-based cross-sectional study in Shenzhen, China. Postgrad Med 2022. [PMID: 35653281 DOI: 10.1080/00325481.2022.2085950] [Reference Citation Analysis]
|
| 319 |
Song Z, Chen Y, Lu H, Zeng Z, Wang W, Liu X, Zhang G, Du Q, Xia X, Li C, Jiang S, Wu T, Li P, He S, Zhu Y, Zhang G, Xu J, Li Y, Huo L, Lan C, Miao Y, Jiang H, Chen P, Shi L, Tuo B, Zhang D, Jiang K, Wang J, Yao P, Huang X, Yang S, Wang X, Zhou L. Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study. Helicobacter 2022;27:e12889. [PMID: 35363917 DOI: 10.1111/hel.12889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 320 |
Nabavizadeh R, Sohouli MH, Santos HO, Roustaei M, Fatahi S, Ghodoosi N, Saeidi R. Higher dietary total antioxidant capacity is inversely associated with Helicobacter pylori infection among adults: A case-control study. Indian J Gastroenterol 2022;41:258-65. [PMID: 35930142 DOI: 10.1007/s12664-022-01246-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 321 |
Zhang Y, Hu S, Li J, Shi D, Luo B. The promoter aberrant methylation status of TMEM130 is associated with gastric cancer. Dig Liver Dis 2022;54:819-25. [PMID: 34162508 DOI: 10.1016/j.dld.2021.05.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 322 |
Yang H, Zhou X, Hu B. The 'reversibility' of chronic atrophic gastritis after the eradication of Helicobacter pylori. Postgrad Med 2022;134:474-9. [PMID: 35382697 DOI: 10.1080/00325481.2022.2063604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 323 |
D'ambrosio S, Ventrone M, Fusco A, Casillo A, Dabous A, Cammarota M, Corsaro MM, Donnarumma G, Schiraldi C, Cimini D. Limosilactobacillus fermentum from buffalo milk is suitable for potential biotechnological process development and inhibits Helicobacter pylori in a gastric epithelial cell model. Biotechnology Reports 2022;34:e00732. [DOI: 10.1016/j.btre.2022.e00732] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 324 |
Saif N, Jensen N, Farrar E, Blackstone S, Hauck FR. Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States. Helicobacter 2022;27:e12894. [PMID: 35484785 DOI: 10.1111/hel.12894] [Reference Citation Analysis]
|
| 325 |
Kowada A, Asaka M. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis. Helicobacter 2022;27:e12886. [PMID: 35343031 DOI: 10.1111/hel.12886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 326 |
Congedi J, Williams C, Baldock KL. Epidemiology of Helicobacter pylori in Australia: a scoping review. PeerJ 2022;10:e13430. [PMID: 35669956 DOI: 10.7717/peerj.13430] [Reference Citation Analysis]
|
| 327 |
Aanniz T, Bakri W, El Mazouri S, Wakrim H, Kandoussi I, Belyamani L, Ouadghiri M, Ibrahimi A. Biofilm and Quorum Sensing in Helicobacter pylori. Bacterial Biofilms [Working Title] 2022. [DOI: 10.5772/intechopen.104568] [Reference Citation Analysis]
|
| 328 |
Erdemir G, Özkan T, Özgür T, Arsoy HA, Çakar S. The risk factors and clinical findings in pediatric helicobacter pylori Infection. CBU-SBED 2022. [DOI: 10.34087/cbusbed.1060153] [Reference Citation Analysis]
|
| 329 |
Zhu X, Su T, Wang S, Zhou H, Shi W. New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer. Front Oncol 2022;12:834934. [PMID: 35619913 DOI: 10.3389/fonc.2022.834934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 330 |
Han B, Kim HJ, Yhim H, Oh D, Bae SH, Shin H, Lee W, Kwon J, Lee J, Kim HJ, Bang S. Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study. Ann Hematol. [DOI: 10.1007/s00277-022-04782-2] [Reference Citation Analysis]
|
| 331 |
Mazumder S, Rahman F, Akter F, Khatun R, Akter S, Saha S, Jilani MS, Sayeed M, Haq J. Asymptomatic Helicobacter pylori infection among rural children and adolescents in Bangladesh. IMC Journal of Medical Science. [DOI: 10.55010/imcjms.16.017] [Reference Citation Analysis]
|
| 332 |
González A, Casado J, Gündüz MG, Santos B, Velázquez-campoy A, Sarasa-buisan C, Fillat MF, Montes M, Piazuelo E, Lanas Á. 1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori. Front Microbiol 2022;13:874709. [DOI: 10.3389/fmicb.2022.874709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 333 |
Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, Hu H, Xu M, Guo X, Liu Y. Human organoids in basic research and clinical applications. Signal Transduct Target Ther 2022;7:168. [PMID: 35610212 DOI: 10.1038/s41392-022-01024-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 334 |
Sheu N, Huang S, Wu D, Kao JY, Lin K. Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus. PLoS ONE 2022;17:e0265323. [DOI: 10.1371/journal.pone.0265323] [Reference Citation Analysis]
|
| 335 |
Hadji M, Mortazavi M, Saberi S, Esmaieli M, Amini N, Akrami R, Daroudian R, Shakeri F, Khedmat H, Pukkala E, Mohammadi M, Zendehdel K. Helicobacter pylori acquisition rates and the associated risk factors amongst newlywed couples; a prospective cohort study in Tehran, Iran. Microbes Infect 2022;:104974. [PMID: 35618156 DOI: 10.1016/j.micinf.2022.104974] [Reference Citation Analysis]
|
| 336 |
Wang Y, Wu S, Wang L, Wang Y, Liu D, Fu Y, Xie Y. The Activity of Liposomal Linolenic Acid Against Helicobacter pylori In Vitro and Its Impact on Human Fecal Bacteria. Front Cell Infect Microbiol 2022;12:865320. [DOI: 10.3389/fcimb.2022.865320] [Reference Citation Analysis]
|
| 337 |
Li RJ, Qin C, Huang GR, Liao LJ, Mo XQ, Huang YQ. Phillygenin Inhibits Helicobacter pylori by Preventing Biofilm Formation and Inducing ATP Leakage. Front Microbiol 2022;13:863624. [PMID: 35572695 DOI: 10.3389/fmicb.2022.863624] [Reference Citation Analysis]
|
| 338 |
Liatsos C, Papaefthymiou A, Kyriakos N, Galanopoulos M, Doulberis M, Giakoumis M, Petridou E, Mavrogiannis C, Rokkas T, Kountouras J. Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle. World J Gastrointest Oncol 2022; 14(5): 959-972 [DOI: 10.4251/wjgo.v14.i5.959] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 339 |
Nath AN, Retnakumar RJ, Francis A, Chhetri P, Thapa N, Chattopadhyay S. Peptic Ulcer and Gastric Cancer: Is It All in the Complex Host-Microbiome Interplay That Is Encoded in the Genomes of "Us" and "Them"? Front Microbiol 2022;13:835313. [PMID: 35547123 DOI: 10.3389/fmicb.2022.835313] [Reference Citation Analysis]
|
| 340 |
Chen N, Zhang XY, Ma LL, Zhao GD, Yan YX. Trends of cancer mortality in Xi'an City, China: 2005-2020. J Cancer Res Clin Oncol 2022. [PMID: 35567625 DOI: 10.1007/s00432-022-04046-6] [Reference Citation Analysis]
|
| 341 |
Sánchez-alonzo K, Arellano-arriagada L, Bernasconi H, Parra-sepúlveda C, Campos VL, Silva-mieres F, Sáez-carrillo K, Smith CT, García-cancino A. An Anaerobic Environment Drives the Harboring of Helicobacter pylori within Candida Yeast Cells. Biology 2022;11:738. [DOI: 10.3390/biology11050738] [Reference Citation Analysis]
|
| 342 |
Tsegaye N, Diriba R, Araya S. Magnitude of H. pylori and Its Association with Preeclampsia Among Pregnant Women in Ethiopia: A Case Control Study. Int J Womens Health 2022;14:635-42. [PMID: 35535149 DOI: 10.2147/IJWH.S363137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 343 |
Antoniciello F, Roncarati D, Zannoni A, Chiti E, Scarlato V, Chiappori F. Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning Study. Front Mol Biosci 2022;9:887564. [DOI: 10.3389/fmolb.2022.887564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 344 |
Jang S, Hansen LM, Su H, Solnick JV, Cha JH. Host immune response mediates changes in cagA copy number and virulence potential of Helicobacter pylori. Gut Microbes 2022;14:2044721. [PMID: 35289715 DOI: 10.1080/19490976.2022.2044721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 345 |
Yao P, Millwood I, Kartsonaki C, Mentzer AJ, Allen N, Jeske R, Butt J, Guo Y, Chen Y, Walters R, Lv J, Yu C, Plummer M, de Martel C, Clifford G, Li LM, Waterboer T, Yang L, Chen Z. Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study. BMJ Open 2022;12:e058353. [PMID: 35534062 DOI: 10.1136/bmjopen-2021-058353] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 346 |
Fejerman L, Ramirez AG, Nápoles AM, Gomez SL, Stern MC. Cancer Epidemiology in Hispanic Populations: What Have We Learned and Where Do We Need to Make Progress? Cancer Epidemiol Biomarkers Prev 2022;31:932-41. [PMID: 35247883 DOI: 10.1158/1055-9965.EPI-21-1303] [Reference Citation Analysis]
|
| 347 |
Abd El-Wahab EW, Youssef EI, Hassouna E. Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt. BMJ Open 2022;12:e057214. [PMID: 35504642 DOI: 10.1136/bmjopen-2021-057214] [Reference Citation Analysis]
|
| 348 |
Dai B, Xiang A, Qu D, Chen G, Wang L, Wang W, Zhai D, Wang L, Lu Z. Rapid and Sensitive Assay of Helicobacter pylori With One-Tube RPA-CRISPR/Cas12 by Portable Array Detector for Visible Analysis of Thermostatic Nucleic Acid Amplification. Front Microbiol 2022;13:858247. [DOI: 10.3389/fmicb.2022.858247] [Reference Citation Analysis]
|
| 349 |
Chen X, Zou Y, Zhang S, Fang P, Li S, Li P, Sun Y, Yuan G, Hu H. Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 350 |
Alkhaldi NK, Alghamdi WK, Alharbi MH, Almutairi AS, Alghamdi FT. The Association Between Oral Helicobacter pylori and Gastric Complications: A Comprehensive Review. Cureus 2022;14:e24703. [PMID: 35663643 DOI: 10.7759/cureus.24703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 351 |
Lam SY, Mommersteeg MC, Yu B, Broer L, Spaander MCW, Frost F, Weiss S, Völzke H, Lerch MM, Schöttker B, Zhang Y, Stocker H, Brenner H, Levy D, Hwang SJ, Wood AC, Rich SS, Rotter JI, Taylor KD, Tracy RP, Kabagambe EK, Leja M, Klovins J, Peculis R, Rudzite D, Nikitina-Zake L, Skenders G, Rovite V, Uitterlinden A, Kuipers EJ, Fuhler GM, Homuth G, Peppelenbosch MP. Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti-Helicobacter pylori IgG Titers. Gastroenterology 2022;162:1705-15. [PMID: 35031300 DOI: 10.1053/j.gastro.2022.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 352 |
Lin BS, Li YY, Qiao C, Liu J, Wang J, Wan M, Lin MJ, Zhang WL, Ding YM, Kong QZ, Duan M, Zuo XL, Li YQ. Implementation of WeChat-based patient-doctor interaction in the management of Helicobacter pylori infection: A propensity score matching analysis. J Dig Dis 2022;23:280-7. [PMID: 35821639 DOI: 10.1111/1751-2980.13114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 353 |
Elshair M, Ugai T, Oze I, Kasugai Y, Koyanagi YN, Hara K, Ito H, Matsuo K. Impact of socioeconomic status and sibling number on the prevalence of Helicobacter pylori infection: a cross-sectional study in a Japanese population. Nagoya J Med Sci 2022;84:374-87. [PMID: 35967946 DOI: 10.18999/nagjms.84.2.374] [Reference Citation Analysis]
|
| 354 |
Leontiadis GI, Longstreth GF. Evolutionary Medicine Perspectives: Helicobacter pylori, Lactose Intolerance, and 3 Hypotheses for Functional and Inflammatory Gastrointestinal and Hepatobiliary Disorders. Am J Gastroenterol 2022;117:721-8. [PMID: 35169106 DOI: 10.14309/ajg.0000000000001681] [Reference Citation Analysis]
|
| 355 |
Lu TL, Zhang JM, Li SR, Chen CW. Spatial-temporal Distribution and Influencing Factors of Helicobacter pylori Infection in Chinese Mainland, 2001-2020: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2022;56:e273-82. [PMID: 35324486 DOI: 10.1097/MCG.0000000000001691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 356 |
Zheng L, Wei F, Li G. The crosstalk between bacteria and host autophagy: host defense or bacteria offense. J Microbiol 2022;60:451-460. [DOI: 10.1007/s12275-022-2009-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 357 |
Abouwarda AM, Ismail TA, Abu El-Wafa WM, Faraag AHI. Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori. World J Microbiol Biotechnol 2022;38:102. [PMID: 35486219 DOI: 10.1007/s11274-022-03289-2] [Reference Citation Analysis]
|
| 358 |
Cai Y, Wu S, Jia Y, Pan X, Li C, Cui D. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/1249290] [Reference Citation Analysis]
|
| 359 |
Ginter GM. Indications for esophagogastroduodenoscopy in anemic patients without overt signs of upper gastrointestinal bleeding. Clin Res Pract 2022;8. [DOI: 10.22237/crp/1640995560] [Reference Citation Analysis]
|
| 360 |
Ismail MB, Osman M, Bou Raad E, Achkar M, Hamze M. Seroprevalence of Helicobacter pylori among dyspeptic patients in northern Lebanon: a 6-year retrospective study in two tertiary hospitals. Access Microbiology 2022;4. [DOI: 10.1099/acmi.0.000337] [Reference Citation Analysis]
|
| 361 |
Khan H, Rauf F, Muhammad N, Javaid M, Alam S, Nasir S. Comparison of special stains (Giemsa stain and Modified Toluidine Blue stain) with immunohistochemistry as gold standard for the detection of H. pylori in gastric biopsies. Arab J Gastroenterol 2022:S1687-1979(21)00101-5. [PMID: 35484045 DOI: 10.1016/j.ajg.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 362 |
Darmadi D, Habriel Ruslie R. Immunology of Helicobacter pylori Infection. Immunology of the GI Tract [Working Title] 2022. [DOI: 10.5772/intechopen.104592] [Reference Citation Analysis]
|
| 363 |
Jaramillo-trujillo G, Otero-regino WA, Estrada-orozco KP. Efectividad y seguridad del uso de probióticos como adyuvantes en la erradicación de Helicobacter pylori. Revisión sistemática y metaanálisis. Rev Fac Med 2022;71:e98018. [DOI: 10.15446/revfacmed.v71n2.98018] [Reference Citation Analysis]
|
| 364 |
Choe Y, Kim JS, Choi HH, Kim DB, Park JM, Oh JH, Kim TH, Cheung DY, Chung WC, Kim BW, Kim SS. The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication. Front Microbiol 2022;13:857569. [PMID: 35401472 DOI: 10.3389/fmicb.2022.857569] [Reference Citation Analysis]
|
| 365 |
Yan J, Zhang H, Hu Z, Zhang X, Niu J, Luo B, Wang H, Li X. Association among Helicobacter pylori Infection, Tooth Loss, and Heavy Medal Exposure in a Chinese Rural Population. Int J Environ Res Public Health 2022;19. [PMID: 35457441 DOI: 10.3390/ijerph19084569] [Reference Citation Analysis]
|
| 366 |
Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clin Microbiol Rev 2022;:e0025821. [PMID: 35404105 DOI: 10.1128/cmr.00258-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 367 |
Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol 2022;13:833424. [PMID: 35222423 DOI: 10.3389/fimmu.2022.833424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 368 |
Zhang J, Rong C, Yan C, Chen J, Yang W, Yu L, Dai H. Risk factors of furazolidone-associated fever. PLoS ONE 2022;17:e0266763. [DOI: 10.1371/journal.pone.0266763] [Reference Citation Analysis]
|
| 369 |
Romario-silva D, Akira Souza Sakaguchi O, Cristina Barbosa da Silva A, Orlandi Sardi J, Parolina de Carvalho R, Magri Roque S, Pires Silva Borges L, Barros Esteves Lins R, Targino Campos L, Maria Melo de Brito Costa E. Probiotics as Potential Antimicrobials for the Treatment of Infections: Current Reality or Remote Future? Prebiotics and Probiotics - From Food to Health 2022. [DOI: 10.5772/intechopen.98865] [Reference Citation Analysis]
|
| 370 |
Syahniar R, Swasti Kharisma D, Rayhana. Helicobacter pylori Challenge Vaccine for Humans. Vaccine Development 2022. [DOI: 10.5772/intechopen.101157] [Reference Citation Analysis]
|
| 371 |
Sichel SR, Bratton BP, Salama NR. Distinct regions of H. pylori’s bactofilin CcmA regulate protein-protein interactions to control helical cell shape.. [DOI: 10.1101/2022.04.05.487110] [Reference Citation Analysis]
|
| 372 |
Mentzer AJ, Brenner N, Allen N, Littlejohns TJ, Chong AY, Cortes A, Almond R, Hill M, Sheard S, McVean G, Collins R, Hill AVS, Waterboer T; UKB Infection Advisory Board. Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank. Nat Commun 2022;13:1818. [PMID: 35383168 DOI: 10.1038/s41467-022-29307-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 373 |
Assefa B, Tadesse A, Abay Z, Abebe A, Tesfaye T, Tadesse M, Molla A. Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia. BMC Gastroenterol 2022;22:164. [PMID: 35382748 DOI: 10.1186/s12876-022-02245-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 374 |
Moro L, Pomari E, Leonardi M, La Marca G, Pajola B, Mazzi C, Piubelli C, Beltrame A. Tropheryma whipplei, Helicobacter pylori, and Intestinal Protozoal Co-Infections in Italian and Immigrant Populations: A Cross-Sectional Study. Microorganisms 2022;10. [PMID: 35456819 DOI: 10.3390/microorganisms10040769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 375 |
Mohammadi A, Khanbabaei H, Zandi F, Ahmadi A, Haftcheshmeh SM, Johnston TP, Sahebkar A. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 376 |
Zha J, Li YY, Qu JY, Yang XX, Han ZX, Zuo X. Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta-analysis. Helicobacter 2022;27:e12880. [PMID: 35150600 DOI: 10.1111/hel.12880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 377 |
Shi Y, Zheng H, Wang M, Ding S. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention. Helicobacter 2022;27:e12878. [PMID: 35112435 DOI: 10.1111/hel.12878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 378 |
Li Y, Huang Z, Shang Y, Xie X, Yang R, Chen H, Wang Z, Xue L, Pang R, Zhang J, Ding Y, Chen M, Wang J, Chen J, Wu Q. Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole-genome sequencing-based study in Southern China. Helicobacter 2022;27:e12879. [PMID: 35124867 DOI: 10.1111/hel.12879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 379 |
Shah S, Hubscher E, Pelletier C, Jacob R, Vinals L, Yadlapati R. Helicobacter pylori infection treatment in the United States: clinical consequences and costs of eradication treatment failure. Expert Rev Gastroenterol Hepatol 2022;16:341-57. [PMID: 35315732 DOI: 10.1080/17474124.2022.2056015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 380 |
Altanbayar O, Amgalanbaatar A, Battogtokh C, Bayarjargal N, Belick D, Kohns Vasconcelos M, Mackenzie CR, Pfeffer K, Henrich B. Characterization of the cagA-gene in Helicobacter pylori in Mongolia and detection of two EPIYA-A enriched CagA types. International Journal of Medical Microbiology 2022;312:151552. [DOI: 10.1016/j.ijmm.2022.151552] [Reference Citation Analysis]
|
| 381 |
Vanden Bulcke A, Waked B, Haems L, Lambrecht G, Hervent AS, Alliet G, Baert F, Vervaeke S. Antimicrobial resistance of Helicobacter pylori in West Flanders - Belgium: an observational cross-sectional study. Acta Clin Belg 2022;77:360-7. [PMID: 33502281 DOI: 10.1080/17843286.2021.1872307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 382 |
Xie D, Sun MY. Mechanism of action of NF-κB related cell signaling pathways in progression of gastritis to carcinoma. Shijie Huaren Xiaohua Zazhi 2022; 30(6): 255-259 [DOI: 10.11569/wcjd.v30.i6.255] [Reference Citation Analysis]
|
| 383 |
Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol 2022; 28(12): 1187-1203 [DOI: 10.3748/wjg.v28.i12.1187] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 384 |
Kim SJ, Choi CW, Hwang CS. [Diagnosis and Treatment of Eosinophilic Esophagitis]. Korean J Gastroenterol 2022;79:99-108. [PMID: 35342167 DOI: 10.4166/kjg.2021.119] [Reference Citation Analysis]
|
| 385 |
Krzyżek P, Migdał P, Grande R, Gościniak G. Biofilm Formation of Helicobacter pylori in Both Static and Microfluidic Conditions Is Associated With Resistance to Clarithromycin. Front Cell Infect Microbiol 2022;12:868905. [DOI: 10.3389/fcimb.2022.868905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 386 |
Morais S, Costa A, Albuquerque G, Araújo N, Pelucchi C, Rabkin CS, Liao LM, Sinha R, Zhang ZF, Hu J, Johnson KC, Palli D, Ferraroni M, Bonzi R, Yu GP, López-Carrillo L, Malekzadeh R, Tsugane S, Hidaka A, Hamada GS, Zaridze D, Maximovitch D, Vioque J, de la Hera MG, Moreno V, Vanaclocha-Espi M, Ward MH, Pakseresht M, Hernández-Ramirez RU, López-Cervantes M, Pourfarzi F, Mu L, Kurtz RC, Boccia S, Pastorino R, Lagiou A, Lagiou P, Boffetta P, Camargo MC, Curado MP, Negri E, La Vecchia C, Lunet N. Salt intake and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project. Cancer Causes Control 2022;33:779-91. [PMID: 35304655 DOI: 10.1007/s10552-022-01565-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 387 |
Duan X, Chen P, Xu X, Han M, Li J, Cantore S. Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric Diseases. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/6263423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 388 |
Tomasicchio G, Picciariello A, Dibra R, Lantone G, Trigiante G, De Fazio M, Martines G. Histopathologic findings on removed stomach after sleeve gastrectomy. Do they influence the outcome? Open Medicine 2022;17:485-91. [DOI: 10.1515/med-2022-0450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 389 |
Naghibzadeh N, Salmani F, Nomiri S, Tavakoli T. Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial. BMC Gastroenterol 2022;22:107. [PMID: 35255819 DOI: 10.1186/s12876-022-02187-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 390 |
Özden H. A Surgeon's Endoscopy Experience. Turkish Journal of Science and Health 2022. [DOI: 10.51972/tfsd.1062352] [Reference Citation Analysis]
|
| 391 |
Delon C, Brown KF, Payne NWS, Kotrotsios Y, Vernon S, Shelton J. Differences in cancer incidence by broad ethnic group in England, 2013-2017. Br J Cancer 2022. [PMID: 35233092 DOI: 10.1038/s41416-022-01718-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 392 |
Wang Q, Jiang J, Gao L. Catalytic antimicrobial therapy using nanozymes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1769. [PMID: 34939348 DOI: 10.1002/wnan.1769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 393 |
Al-Marhabi A, Hashem A, Zuberi BF, Onyekwere C, Lodhi I, Mounir M, Alkhowaiter S, Al Awadhi S, Naidoo VG, Hamada Y. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD). Expert Rev Gastroenterol Hepatol 2022;16:217-33. [PMID: 35184616 DOI: 10.1080/17474124.2022.2043744] [Reference Citation Analysis]
|
| 394 |
Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, Gu Y, Wei L, Yan C, Jin G. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroenterol Hepatol 2022;37:464-70. [PMID: 34862656 DOI: 10.1111/jgh.15751] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 395 |
Tsang SH, Avilés-Santa ML, Abnet CC, Brito MO, Daviglus ML, Wassertheil-Smoller S, Castañeda SF, Minnerath S, Talavera GA, Graubard BI, Thyagarajan B, Camargo MC. Seroprevalence and Determinants of Helicobacter pylori Infection in the Hispanic Community Health Study/Study of Latinos. Clin Gastroenterol Hepatol 2022;20:e438-51. [PMID: 33667677 DOI: 10.1016/j.cgh.2021.02.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 396 |
Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, Ye X, Yi Q, Song P, Rudan I; Global Health Epidemiology Research Group. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health 2022;6:185-94. [PMID: 35085494 DOI: 10.1016/S2352-4642(21)00400-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 397 |
Mori D, John JL, Sabri SIB, Shaharom SMB, Iha H, Yamaoka Y, Matsumoto T, Ahmed K. Seroepidemiological survey of the prevalence of Helicobacter pylori infection in Sabah, Malaysia. IJID Regions 2022;2:126-129. [DOI: 10.1016/j.ijregi.2021.12.012] [Reference Citation Analysis]
|
| 398 |
Mesfun MG, Gliga S, Fuchs A, Orth HM, Schönfeld A, Luedde T, Feldt T. Prevalence of H. pylori among asymptomatic HIV-positive and negative individuals in Central Ethiopia and efficacy of eradication therapy. IJID Regions 2022;2:169-174. [DOI: 10.1016/j.ijregi.2022.01.007] [Reference Citation Analysis]
|
| 399 |
Rowland M. The continuing decline in the prevalence of Helicobacter pylori infection. The Lancet Child & Adolescent Health 2022;6:139-140. [DOI: 10.1016/s2352-4642(22)00026-8] [Reference Citation Analysis]
|
| 400 |
Liu H, Qin Y, Yang J, Huang G, Wei X, Wang L, Li W. Helicobacter pylori Infection as a Risk Factor for Abnormal Serum Protein Levels in General Population of China. JIR 2022;Volume 15:2009-17. [DOI: 10.2147/jir.s355446] [Reference Citation Analysis]
|
| 401 |
Barzigar R, Mehran MJ, Haraprasad N, Kumar BYS, Fakrudin B. Transient recombinant expression of highly immunogenic CagA, VacA and NapA in Nicotiana benthamiana. Biotechnology Reports 2022;33:e00699. [DOI: 10.1016/j.btre.2021.e00699] [Reference Citation Analysis]
|
| 402 |
Suerbaum S, Coombs N, Patel L, Pscheniza D, Rox K, Falk C, Gruber AD, Kershaw O, Chhatwal P, Brönstrup M, Bilitewski U, Josenhans C. Identification of Antimotilins, Novel Inhibitors of Helicobacter pylori Flagellar Motility That Inhibit Stomach Colonization in a Mouse Model. mBio 2022;:e0375521. [PMID: 35227071 DOI: 10.1128/mbio.03755-21] [Reference Citation Analysis]
|
| 403 |
Hallur V, Panigrahi M, Sable M, Ghosh M, Mohanty S, Purkait S, Praharaj A. Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha. Indian Journal of Medical Microbiology 2022. [DOI: 10.1016/j.ijmmb.2022.02.008] [Reference Citation Analysis]
|
| 404 |
Merlotti D, Mingiano C, Valenti R, Cavati G, Calabrese M, Pirrotta F, Bianciardi S, Palazzuoli A, Gennari L. Bone Fragility in Gastrointestinal Disorders. Int J Mol Sci 2022;23:2713. [PMID: 35269854 DOI: 10.3390/ijms23052713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 405 |
Dzikowiec M, Lik P, Kiszałkiewicz J, Kuczyńska A, Mordalski M, Nejc D, Piekarski J, Brzeziańska-lasota E, Pastuszak-lewandoska D. Helicobacter pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer – A Pilot Study. Polish Journal of Microbiology 2022;0. [DOI: 10.33073/pjm-2022-004] [Reference Citation Analysis]
|
| 406 |
García-ferrús M, González A, Pina-pérez MC, Ferrús MA. Helicobacter pylori Is Present at Quantifiable Levels in Raw Vegetables in the Mediterranean Area of Spain. Agriculture 2022;12:339. [DOI: 10.3390/agriculture12030339] [Reference Citation Analysis]
|
| 407 |
Huang Y, Zhou H, Zou J, Wang D. GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma. Can J Gastroenterol Hepatol 2022;2022:9983351. [PMID: 35257007 DOI: 10.1155/2022/9983351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 408 |
Dargenio VN, Cristofori F, Dargenio C, Giordano P, Indrio F, Celano G, Francavilla R. Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review. Benef Microbes 2022;:1-22. [PMID: 35212258 DOI: 10.3920/BM2021.0151] [Reference Citation Analysis]
|
| 409 |
Sakaguchi T, Sugihara T, Ohnita K, Fukuda D, Honda T, Ogihara R, Kurumi H, Yashima K, Isomoto H. Pyloric Incompetence Associated with Helicobactor pylori Infection and Correlated to the Severity of Atrophic Gastritis. Diagnostics (Basel) 2022;12. [PMID: 35328125 DOI: 10.3390/diagnostics12030572] [Reference Citation Analysis]
|
| 410 |
Pichon M, Freche B, Burucoa C. New Strategy for the Detection and Treatment of Helicobacter pylori Infections in Primary Care Guided by a Non-Invasive PCR in Stool: Protocol of the French HepyPrim Study. J Clin Med 2022;11:1151. [PMID: 35268242 DOI: 10.3390/jcm11051151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 411 |
Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere (Groza) F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics 2022;12:508. [DOI: 10.3390/diagnostics12020508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 412 |
Huang Y, Gu M, Wu Q, Zhu J, Wu J, Wang P, Wang M, Luo J. Is Laryngeal Squamous Cell Carcinoma Related to Helicobacter pylori?. Front Oncol 2022;12:790997. [PMID: 35155235 DOI: 10.3389/fonc.2022.790997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 413 |
Fatemi Khader M, Pourmahdi Borujeni M, Moori Bakhtiari N, Avizeh R. An exploratory study on the presence of Helicobacter heilmannii and Helicobacter billis in the faces of companion dogs. Veterinary Medicine & Sci. [DOI: 10.1002/vms3.765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 414 |
Ho C, Liu T, Lin Y, Chen Y, Chen M, Wang H, Liou T. Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection. Microorganisms 2022;10:415. [DOI: 10.3390/microorganisms10020415] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 415 |
Dominique Valentina T, Celso Nilo DF, Guilherme Ribas T, Michelle Gusmão DA. Prevalence of gastric cancer precursor lesions in patients of a secondary care center in a state in south of Brazil. Arch Clin Gastroenterol 2022;8:003-007. [DOI: 10.17352/2455-2283.000105] [Reference Citation Analysis]
|
| 416 |
Artola-Borán M, Fallegger A, Priola M, Jeske R, Waterboer T, Dohlman AB, Shen X, Wild S, He J, Levesque MP, Yousefi S, Simon HU, Cheng PF, Müller A. Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells. Cell Rep 2022;38:110359. [PMID: 35139377 DOI: 10.1016/j.celrep.2022.110359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 417 |
Gobert AP, Wilson KT. Induction and Regulation of the Innate Immune Response in Helicobacter pylori Infection. Cell Mol Gastroenterol Hepatol 2022;13:1347-63. [PMID: 35124288 DOI: 10.1016/j.jcmgh.2022.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 418 |
Boyanova L, Hadzhiyski P, Markovska R, Gergova R. Investigation of multidrug-resistant Helicobacter pylori in pediatric patients: A Bulgarian study and literature data. Acta Microbiol Immunol Hung 2022. [PMID: 35107441 DOI: 10.1556/030.2022.01682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 419 |
Huang JG, Lim SYS, Aw MM, Quak SH. Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high-migrant Singaporean cohort. Helicobacter 2022;27:e12868. [PMID: 34958710 DOI: 10.1111/hel.12868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 420 |
Xu C, Wu Y, Xu S. Association between Helicobacter pylori infection and growth outcomes in children: A meta-analysis. Helicobacter 2022;27:e12861. [PMID: 34997950 DOI: 10.1111/hel.12861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 421 |
Shi H, Li Y, Dong C, Si G, Xu Y, Peng M, Li Y. Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta-analysis. Helicobacter 2022;27:e12865. [PMID: 34841620 DOI: 10.1111/hel.12865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 422 |
Zagari RM, Romano M, Frazzoni L, Marasco G, Dajti E, Arcidiacono PG, Armuzzi A, Biagi F, Cannizzaro R, Cavestro GM, Ciacci C, Monica F, Peralta S, Radaelli F, Bazzoli F. Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD. Helicobacter 2022;27:e12862. [PMID: 34766392 DOI: 10.1111/hel.12862] [Reference Citation Analysis]
|
| 423 |
Lerch JM, Pai RK, Brown I, Gill AJ, Jain D, Kővári B, Kushima R, Sheahan K, Slavik T, Srivastava A, Lauwers GY, Langner C. Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study. Pathology 2022. [DOI: 10.1016/j.pathol.2021.12.288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 424 |
Gallardo Padilla M, León Falconi JL, Sánchez-nebreda Arias R, Gómez Santos C, Muñoz Egea MDC, Orden Izquierdo EL. Impact of the use of molecular techniques (PCR) on detection and eradication success against Helicobacter pylori. Anales de Pediatría (English Edition) 2022. [DOI: 10.1016/j.anpede.2022.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 425 |
Li X, Zhu M, Zhao G, Zhou A, Min L, Liu S, Zhang N, Zhu S, Guo Q, Zhang S, Li P. MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 426 |
Chuah KH, Cheong SY, Lim SZ, Mahadeva S. Functional dyspepsia leads to more healthcare utilization in secondary care compared with other functional gastrointestinal disorders. J Dig Dis 2022;23:111-7. [PMID: 35050547 DOI: 10.1111/1751-2980.13082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 427 |
Szilagyi A. Relationships between Western Non Communicable Diseases and Geographic Pattern Modifiers Based on Latitude and Lactase Distributions. Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110797] [Reference Citation Analysis]
|
| 428 |
Ding SZ, Du YQ, Lu H, Wang WH, Cheng H, Chen SY, Chen MH, Chen WC, Chen Y, Fang JY, Gao HJ, Guo MZ, Han Y, Hou XH, Hu FL, Jiang B, Jiang HX, Lan CH, Li JN, Li Y, Li YQ, Liu J, Li YM, Lyu B, Lu YY, Miao YL, Nie YZ, Qian JM, Sheng JQ, Tang CW, Wang F, Wang HH, Wang JB, Wang JT, Wang JP, Wang XH, Wu KC, Xia XZ, Xie WF, Xie Y, Xu JM, Yang CQ, Yang GB, Yuan Y, Zeng ZR, Zhang BY, Zhang GY, Zhang GX, Zhang JZ, Zhang ZY, Zheng PY, Zhu Y, Zuo XL, Zhou LY, Lyu NH, Yang YS, Li ZS; National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology, and Chinese Alliance for Helicobacter pylori Study. Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition). Gut 2022;71:238-53. [PMID: 34836916 DOI: 10.1136/gutjnl-2021-325630] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 429 |
Zhu X, Zhao Y, Zhu C, Wang Y, Liu Y, Su J. Rapid detection of cagA-positive Helicobacter pylori based on duplex recombinase aided amplification combined with lateral flow dipstick assay. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 430 |
Matos R, Sousa HS, Nogueiro J, Magalhães A, Reis CA, Carneiro F, Amorim I, Haesebrouck F, Gärtner F. Helicobacter species binding to the human gastric mucosa. Helicobacter 2022;27:e12867. [PMID: 34967491 DOI: 10.1111/hel.12867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 431 |
Cao L, Wang S, Zhang L, Li J. mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3. Biomed Pharmacother 2022;146:112608. [PMID: 35062071 DOI: 10.1016/j.biopha.2021.112608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 432 |
Yip TC, Chan FK, Lui GC, Wong VW, Chan HL, Wong SH, Mak JW, Ng S, Hui DS, Wong GL. Use of Proton-Pump Inhibitor Is Not Associated with Adverse Clinical Outcomes in COVID-19 Patients: A Territory-Wide Cohort Study. GastroHep 2022;2022:1-13. [DOI: 10.1155/2022/8803862] [Reference Citation Analysis]
|
| 433 |
Zhang P, He Q, Song D, Wang Y, Liu X, Ding G, Xing W. Association of Helicobacter pylori Infection With Carotid Atherosclerosis in a Northern Chinese Population: A Cross-Sectional Study. Front Cardiovasc Med 2022;8:795795. [DOI: 10.3389/fcvm.2021.795795] [Reference Citation Analysis]
|
| 434 |
Matos R, Taillieu E, De Bruyckere S, De Witte C, Rêma A, Santos-sousa H, Nogueiro J, Reis CA, Carneiro F, Haesebrouck F, Amorim I, Gärtner F. Presence of Helicobacter Species in Gastric Mucosa of Human Patients and Outcome of Helicobacter Eradication Treatment. JPM 2022;12:181. [DOI: 10.3390/jpm12020181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 435 |
Araújo GRL, Marques HS, Santos MLC, da Silva FAF, da Brito BB, Correa Santos GL, de Melo FF. Helicobacter pylori infection: How does age influence the inflammatory pattern? World J Gastroenterol 2022; 28(4): 402-411 [DOI: 10.3748/wjg.v28.i4.402] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 436 |
Sun H, He T, Wu Y, Yuan H, Ning J, Zhang Z, Deng X, Li B, Wu C. Cytotoxin-Associated Gene A-Negative Helicobacter pylori Promotes Gastric Mucosal CX3CR1+CD4+ Effector Memory T Cell Recruitment in Mice. Front Microbiol 2022;13:813774. [DOI: 10.3389/fmicb.2022.813774] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 437 |
Wang Y, Zou J, Hu L, Liu Q, Huang R, Tang T, Yue Q, Sun Y, Xiao Q, Zeng X, Zeng Y. What is the general Chinese public’s awareness of and attitudes towards Helicobacter pylori screening and associated health behaviours? A cross-sectional study. BMJ Open 2022;12:e057929. [DOI: 10.1136/bmjopen-2021-057929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 438 |
Cao R, Tang L, Fang M, Zhong L, Wang S, Gong L, Li J, Dong D, Tian J. Artificial intelligence in gastric cancer: applications and challenges. Gastroenterology Report 2022;10. [DOI: 10.1093/gastro/goac064] [Reference Citation Analysis]
|
| 439 |
Akbari A, Ashtari S, Tabaiean SP, Mehrdad‐majd H, Farsi F, Shojaee S, Agah S. Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia‐Pacific region. Asia-Pac J Clncl Oncology. [DOI: 10.1111/ajco.13654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 440 |
Simon OA, Görbe A, Hegyi P, Szakó L, Oštarijaš E, Dembrovszky F, Kiss S, Czopf L, Erőss B, Szabó I. Helicobacter pylori Infection Is Associated With Carotid Intima and Media Thickening: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2022;11:e022919. [PMID: 35060390 DOI: 10.1161/JAHA.121.022919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 441 |
Wang K, Lou D, Dai W, Fu R, Ma Z. Comparison of sequential therapy with concomitant therapy in first-line treatment of Helicobacter pylori: an updated meta-analysis. J Med Microbiol 2022;71. [PMID: 35041577 DOI: 10.1099/jmm.0.001490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 442 |
Nizeyimana T, Rugwizangoga B, Manirakiza F, Laga AC. Occurrence of Helicobacter Pylori in Specimens of Chronic Gastritis and Gastric Adenocarcinoma Patients: A Retrospective Study at University Teaching Hospital, Kigali, Rwanda. East Afr Health Res J 2021;5:159-63. [PMID: 35036842 DOI: 10.24248/eahrj.v5i2.667] [Reference Citation Analysis]
|
| 443 |
Sarkar D, Vijayan R, Gourinath S, Sau AK. A unique aromatic cluster near the active site of H. pylori CPA is essential for catalytic function. Biophys J 2022;121:248-62. [PMID: 34932956 DOI: 10.1016/j.bpj.2021.12.020] [Reference Citation Analysis]
|
| 444 |
Jamil MZZ, Salman S, Akhtar M, Iqbal S, Bhalli A, Farooq H. Determining the Association Between Helicobacter pylori Infection and Treatment-Refractory Hypothyroidism. Cureus 2022. [DOI: 10.7759/cureus.21316] [Reference Citation Analysis]
|
| 445 |
Subsomwong P, Doohan D, Fauzia KA, Akada J, Matsumoto T, Yee TT, Htet K, Waskito LA, Tuan VP, Uchida T, Matsuhisa T, Yamaoka Y. Next-Generation Sequencing-Based Study of Helicobacter pylori Isolates from Myanmar and Their Susceptibility to Antibiotics. Microorganisms 2022;10:196. [DOI: 10.3390/microorganisms10010196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 446 |
Ismoilova FR, Rustamova MT. Polymorphisms of cytokine genes in the mechanisms of development of inflammatory and ultrasonic gastric damage. jour 2022. [DOI: 10.31146/1682-8658-ecg-196-12-134-138] [Reference Citation Analysis]
|
| 447 |
Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. World J Gastrointest Oncol 2022;14:55-74. [PMID: 35116103 DOI: 10.4251/wjgo.v14.i1.55] [Reference Citation Analysis]
|
| 448 |
Li J. Digestive cancer incidence and mortality among young adults worldwide in 2020: A population-based study. World J Gastrointest Oncol 2022;14:278-94. [PMID: 35116117 DOI: 10.4251/wjgo.v14.i1.278] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 449 |
Idris AB, Idris AB, Gumaa MA, Idris MB, Elgoraish A, Mansour M, Allam D, Arbab BM, Beirag N, Ibrahim EAM, Hassan MA. Identification of functional tumor necrosis factor-alpha promoter variants associated with Helicobacter pylori infection in the Sudanese population: Computational approach. World J Gastroenterol 2022; 28(2): 242-262 [DOI: 10.3748/wjg.v28.i2.242] [Reference Citation Analysis]
|
| 450 |
Fiori-Duarte AT, de Oliveira Guarnieri JP, de Oliveira Borlot JRP, Lancellotti M, Rodrigues RP, Kitagawa RR, Kawano DF. In silico design and in vitro assessment of anti-Helicobacter pylori compounds as potential small-molecule arginase inhibitors. Mol Divers 2022. [PMID: 34997872 DOI: 10.1007/s11030-021-10371-8] [Reference Citation Analysis]
|
| 451 |
Suzuki S, Kusano C, Horii T, Ichijima R, Ikehara H. The Ideal Helicobacter pylori Treatment for the Present and the Future. Digestion 2022;103:62-8. [PMID: 34662879 DOI: 10.1159/000519413] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 452 |
Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022. [PMID: 34988937 DOI: 10.1007/s42770-021-00675-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 453 |
Park SY, Jeong SH, Jung EJ, Ju YT, Jeong CY, Kim JY, Park T, Park J, Kim TH, Park M, Yang JW, Lee YJ. PHLPP1 Overexpression was Associated With a Good Prognosis With Decreased AKT Activity in Gastric Cancer. Technol Cancer Res Treat 2022;21:15330338211067063. [PMID: 34982011 DOI: 10.1177/15330338211067063] [Reference Citation Analysis]
|
| 454 |
Salinas Ibáñez ÁG, Vallés D, Adaro M, Barberis S, Vega AE. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori. Front Nutr 2021;8:699955. [PMID: 34977105 DOI: 10.3389/fnut.2021.699955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 455 |
Xiang W, Wang R, Bai D, Yu T, Chen X; on behalf of the SIGES Research Groups. Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES). Nutrition and Cancer. [DOI: 10.1080/01635581.2021.2022168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 456 |
Keikha M, Sahebkar A, Yamaoka Y, Karbalaei M. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr 2022;41:2. [PMID: 34980267 DOI: 10.1186/s41043-021-00280-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 457 |
Lai C, Lee O. Helicobacter pylori infection in a multi-ethnic population in east coast of Borneo, Malaysia: The effects of ethnicity. One Health Bull 2022;2:4. [DOI: 10.4103/2773-0344.345316] [Reference Citation Analysis]
|
| 458 |
Malfertheiner P, Moss SF, Daniele P, Pelletier C, Jacob R, Tremblay G, Hubscher E, Leifke E, Chey WD. Potassium-Competitive Acid Blocker and Proton Pump Inhibitor–Based Regimens for First-Line Helicobacter pylori Eradication: A Network Meta-Analysis. Gastro Hep Advances 2022;1:824-834. [DOI: 10.1016/j.gastha.2022.06.009] [Reference Citation Analysis]
|
| 459 |
Iannuzzi JP, King JA, Leong JH, Quan J, Windsor JW, Tanyingoh D, Coward S, Forbes N, Heitman SJ, Shaheen AA, Swain M, Buie M, Underwood FE, Kaplan GG. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis. Gastroenterology 2022;162:122-34. [PMID: 34571026 DOI: 10.1053/j.gastro.2021.09.043] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 460 |
Shi X, Li N. Research Progress in Infectious Agents of Malignant Tumors. Progress in China Epidemiology 2022. [DOI: 10.1007/978-981-19-2199-5_10] [Reference Citation Analysis]
|
| 461 |
Brown H, Cantrell S, Tang H, Epplein M, Garman KS. Racial Differences in Helicobacter pylori Prevalence in the US: A Systematic Review. Gastro Hep Advances 2022;1:857-868. [DOI: 10.1016/j.gastha.2022.06.001] [Reference Citation Analysis]
|
| 462 |
Das N, Ragavan ML, Mandal SK. Probiotics in the prevention and treatment of infections with Helicobacter pylori, Enterohemorrhagic Escherichia coli, and Rotavirus. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00001-5] [Reference Citation Analysis]
|
| 463 |
Khokhar A, Sharma P. Role of Environmental Factors in Increased Cancer Incidences and Health Impacts. Biotechnological Innovations for Environmental Bioremediation 2022. [DOI: 10.1007/978-981-16-9001-3_28] [Reference Citation Analysis]
|
| 464 |
Payami H. The many genomes of Parkinson's disease. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.07.007] [Reference Citation Analysis]
|
| 465 |
Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 2022;204:692. [PMID: 36344628 DOI: 10.1007/s00203-022-03314-w] [Reference Citation Analysis]
|
| 466 |
Dore MP, Graham DY. Modern approach to the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 2022;55 Suppl 1:S14-21. [PMID: 34989431 DOI: 10.1111/apt.16566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 467 |
Soond SM, Zamyatnin AA Jr. Helicobacter pylori and gastric cancer: a lysosomal protease perspective. Gastric Cancer 2022;25:306-24. [PMID: 34918208 DOI: 10.1007/s10120-021-01272-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 468 |
Gudeta AN, Andrén Aronsson C, Binagdie BB, Girma A, Agardh D. Incidence of celiac disease autoimmunity and associations with maternal tuberculosis and pediatric Helicobacter pylori infections in 4-year-old Ethiopian children followed up in an HLA genotyped birth cohort. Front Pediatr 2022;10:999287. [PMID: 36389354 DOI: 10.3389/fped.2022.999287] [Reference Citation Analysis]
|
| 469 |
Weiss JM. Executive Monkey Study. Encyclopedia of Animal Cognition and Behavior 2022. [DOI: 10.1007/978-3-319-55065-7_251] [Reference Citation Analysis]
|
| 470 |
Broekaert IJ, Borrelli O, Dolinsek J, Martin-de-Carpi J, Mas E, Miele E, Pienar C, Ribes-Koninckx C, Thomassen R, Thomson M, Tzivinikos C, Benninga M. An ESPGHAN Position Paper on the Use of Breath Testing in Paediatric Gastroenterology. J Pediatr Gastroenterol Nutr 2022;74:123-37. [PMID: 34292218 DOI: 10.1097/MPG.0000000000003245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 471 |
Scherbakova I, Chen RWS, Marcus DM, Rustgi A. Gastrointestinal and Nutritional Disorders. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_303] [Reference Citation Analysis]
|
| 472 |
Kathi PR, Babaria R, Banerjee B. Impact of helicobacter pylori on human physiology and digestive disorders. Nutrition and Functional Foods in Boosting Digestion, Metabolism and Immune Health 2022. [DOI: 10.1016/b978-0-12-821232-5.00021-5] [Reference Citation Analysis]
|
| 473 |
Hosseinpanahi A, Hedayati MA. Frequency of Helicobacter pylori virulence genes in water resources of western Iran by direct PCR. Reviews in Medical Microbiology 2022;33:e10-e15. [DOI: 10.1097/mrm.0000000000000286] [Reference Citation Analysis]
|
| 474 |
Yakupov E, Troshina Y, Trutneva N, Gainutdinova R. Evaluation of the efficacy and safety of Dolocox in patients with nonspecific back. Z nevrol psikhiatr im S S Korsakova 2022;122:94. [DOI: 10.17116/jnevro202212211194] [Reference Citation Analysis]
|
| 475 |
Hung CW, Chen SC, Ku LE, Sheu BS, Yang YJ. A Culture-Based Strategy Is More Cost Effective Than an Empiric Therapy Strategy in Managing Pediatric Helicobacter pylori Infection. Front Pediatr 2022;10:860960. [PMID: 35592847 DOI: 10.3389/fped.2022.860960] [Reference Citation Analysis]
|
| 476 |
Visaggi P, de Bortoli N, Barberio B, Savarino V, Oleas R, Rosi EM, Marchi S, Ribolsi M, Savarino E. Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases. J Clin Gastroenterol 2022;56:23-35. [PMID: 34739406 DOI: 10.1097/MCG.0000000000001629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 477 |
Kawai S, Wang C, Lin Y, Sasakabe T, Okuda M, Kikuchi S. Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study. Int J Cancer 2022;150:18-27. [PMID: 34449868 DOI: 10.1002/ijc.33773] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 478 |
Moreno-torres IC. Campylobacter and Helicobacter. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00103-8] [Reference Citation Analysis]
|
| 479 |
Howden CW, Spechler SJ, Vaezi MF, Fendrick AM, Atkinson C, Pelletier C, Jacob R, Brunton S. Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection. Gastro Hep Advances 2022;1:231-240. [DOI: 10.1016/j.gastha.2021.12.005] [Reference Citation Analysis]
|
| 480 |
Tshimpi A, Ngoma-kisoko PDJ, Beia A, Kalenga-ngomba T, Nkondi J, Bokabanja F, Mawalala H, Monsere T, Kengibe P, Nkanga MN, Longo-mbenza B. Assessing of the Therapeutic Efficacy of These 2 Treatment Regimens in the Management of <i>Helicobacter pylori</i> Infection at Kinshasa. OJGas 2022;12:71-87. [DOI: 10.4236/ojgas.2022.123008] [Reference Citation Analysis]
|
| 481 |
Sorokman TV, Sokolnyk SV, Moldovan PM, Chernei NY, Ostapchuk VG. IMPROVEMENT OF ERADICATION THERAPY IN CHILDREN WITH DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI. Wiad Lek 2022;75:215-222. [DOI: 10.36740/wlek202201212] [Reference Citation Analysis]
|
| 482 |
Fonseca DR, Moura A, Leiro V, Silva-Carvalho R, Estevinho BN, Seabra CL, Henriques PC, Lucena M, Teixeira C, Gomes P, Parreira P, Martins MCL. Grafting MSI-78A onto chitosan microspheres enhances its antimicrobial activity. Acta Biomater 2022;137:186-98. [PMID: 34634508 DOI: 10.1016/j.actbio.2021.09.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 483 |
Gonzalez I, Lindner C, Schneider I, Morales MA, Rojas A. Inflammation at the crossroads of Helicobacter pylori and COVID-19. Future Microbiol 2022;17:77-80. [PMID: 34915742 DOI: 10.2217/fmb-2021-0250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 484 |
Lim WM, Lawrentschuk N, Heriot AG. Benign Gastrointestinal Conditions. Men’s Health and Wellbeing 2022. [DOI: 10.1007/978-3-030-84752-4_14] [Reference Citation Analysis]
|
| 485 |
Corthay A, Haraldsen G. Inflammatory Biomarkers for Cancer. Biomarkers of the Tumor Microenvironment 2022. [DOI: 10.1007/978-3-030-98950-7_12] [Reference Citation Analysis]
|
| 486 |
Nayim P, Mbaveng AT, Kuete V. Anti-Helicobacter pylori activities of African medicinal plants. Advances in Botanical Research 2022. [DOI: 10.1016/bs.abr.2022.08.010] [Reference Citation Analysis]
|
| 487 |
王 秀. Advances in Gastric Cancer Screening. ACM 2022;12:11703-11710. [DOI: 10.12677/acm.2022.12121686] [Reference Citation Analysis]
|
| 488 |
沈 显. Clinical Value of Serology in Early Gastric Cancer Screening. ACM 2022;12:5426-5433. [DOI: 10.12677/acm.2022.126786] [Reference Citation Analysis]
|
| 489 |
Retnakumar R, Nath AN, Nair GB, Chattopadhyay S. Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.001] [Reference Citation Analysis]
|
| 490 |
Shin CM, Park K, Kim N, Won S, Ohn JH, Lee S, Park JH, Kang SJ, Kim JS, Lee DH. rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori-infected individuals: a genome-wide association study in the Korean population. Gastric Cancer 2022;25:573-85. [PMID: 35325318 DOI: 10.1007/s10120-022-01285-x] [Reference Citation Analysis]
|
| 491 |
Sonnenberg A. Epidemiology of Helicobacter pylori. Aliment Pharmacol Ther 2022;55 Suppl 1:S1-S13. [PMID: 34989430 DOI: 10.1111/apt.16592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 492 |
Shi L, Fan Q, Zhou B, Wu J, Jin M, Yu D, Zhang T, Song J, Liu H. The composition and functional profile of the microbial communities in human gastric cancer tissues and adjacent normal tissues. Acta Biochim Biophys Sin (Shanghai) 2022;54:47-54. [PMID: 35130625 DOI: 10.3724/abbs.2021010] [Reference Citation Analysis]
|
| 493 |
Nergiz D. Laparoskopik Sleeve Gastrektomi Materyallerinde Rutin Histopatolojik İncelemenin Önemi ve Preoperatif Üst Gastrointestinal Endoskopik Biyopsinin Rolü. Turkish Journal of Diabetes and Obesity 2021;5:325-332. [DOI: 10.25048/tudod.1009269] [Reference Citation Analysis]
|
| 494 |
López-Gómez M, García de Santiago B, Delgado-López PD, Malmierca E, González-Olmedo J, Gómez-Raposo C, Sandoval C, Ruiz-Seco P, Escribano N, Gómez-Cerezo JF, Casado E. Gastrointestinal tumors and infectious agents: A wide field to explore. World J Meta-Anal 2021; 9(6): 505-521 [DOI: 10.13105/wjma.v9.i6.505] [Reference Citation Analysis]
|
| 495 |
Lin AS, Shuman JHB, Kotnala A, Shaw JA, Beckett AC, Harvey JL, Tuck M, Dixon BREA, Reyzer ML, Algood HMS, Schey KL, Piazuelo MB, Cover TL. Loss of Corpus-Specific Lipids in Helicobacter pylori-Induced Atrophic Gastritis. mSphere 2021;6:e0082621. [PMID: 34817238 DOI: 10.1128/mSphere.00826-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 496 |
Sharafutdinov I, Knorr J, Soltan Esmaeili D, Backert S, Tegtmeyer N. Cortactin Promotes Effective AGS Cell Scattering by Helicobacter pylori CagA, but Not Cellular Vacuolization and Apoptosis Induced by the Vacuolating Cytotoxin VacA. Pathogens 2021;11:3. [PMID: 35055951 DOI: 10.3390/pathogens11010003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 497 |
Wang H, Li NS, He C, Xie C, Zhu Y, Lu NH, Hu Y. Discovery and Validation of Novel Methylation Markers in Helicobacter pylori-Associated Gastric Cancer. Dis Markers 2021;2021:4391133. [PMID: 34925643 DOI: 10.1155/2021/4391133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 498 |
Wang C, Yin Y, Wang L, Guo X, Liu L, Qi X. Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis. Postgrad Med J 2021:postgradmedj-2021-141127. [PMID: 34930813 DOI: 10.1136/postgradmedj-2021-141127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 499 |
Ko HJ, Lin YC, Chen CC, Chen MJ, Wu MS, Liu CJ, Huang CT, Yang HW, Shih SC, Yu LY, Kuo YC, Wang HY, Hu KC. Helicobacter pylori infection and increased diabetes prevalence were the risks of colorectal adenoma for adults: A systematic review and meta-analysis (PRISMA-compliant article). Medicine (Baltimore) 2021;100:e28156. [PMID: 34918670 DOI: 10.1097/MD.0000000000028156] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 500 |
Oliveira AKS, Silva LLL, Miguel MP, Blanco AJV, Carneiro LC, Barbosa MS. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION? Arq Gastroenterol 2021;58:468-75. [PMID: 34909852 DOI: 10.1590/S0004-2803.202100000-85] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 501 |
Zhang Y, Meng F, Jin J, Wang J, Gu BB, Peng JB, Ye LP. Ninety-four thousand-case retrospective study on antibacterial drug resistance of Helicobacter pylori. World J Clin Cases 2021; 9(35): 10838-10849 [DOI: 10.12998/wjcc.v9.i35.10838] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 502 |
Qin Y, Lao YH, Wang H, Zhang J, Yi K, Chen Z, Han J, Song W, Tao Y, Li M. Combatting Helicobacter pylori with oral nanomedicines. J Mater Chem B 2021;9:9826-38. [PMID: 34854456 DOI: 10.1039/d1tb02038b] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 503 |
Hoft SG, Noto CN, DiPaolo RJ. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity. Front Cell Dev Biol 2021;9:752346. [PMID: 34900999 DOI: 10.3389/fcell.2021.752346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 504 |
Yang TJ, Dhanasekar K, Bhandari R, Muraleedharan D, Chirindoth SS, Kaur H, Goswami R, Maiyani P, Desai M, Moradiya DV, Devani H, Patel AA. Association of Helicobacter Pylori With Development of Peptic Ulcer Disease Among Cirrhotic Patients: An Evidence From Population-Based Study. Cureus 2021;13:e19315. [PMID: 34900489 DOI: 10.7759/cureus.19315] [Reference Citation Analysis]
|
| 505 |
Tryapyshko AA, Dekhnich NN. Paradigm shift in the management of patients with <i>H. pylori</i> infection. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-109-113] [Reference Citation Analysis]
|
| 506 |
Bordin DS. Errors in the diagnosis and treatment of <i>Helicobacter pylori</i> infection: in anticipation of new conciliation documents. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-5-14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 507 |
Chheda PR, Cooling GT, Dean SF, Propp J, Hobbs KF, Spies MA. Decrypting a cryptic allosteric pocket in H. pylori glutamate racemase. Commun Chem 2021;4:172. [PMID: 36697800 DOI: 10.1038/s42004-021-00605-z] [Reference Citation Analysis]
|
| 508 |
Khosravi AD, Sirous M, Saki M, Seyed-Mohammadi S, Modares Mousavi SR, Veisi H, Abbasinezhad Poor A. Associations between seroprevalence of Helicobacter pylori and ABO/rhesus blood group antigens in healthy blood donors in southwest Iran. J Int Med Res 2021;49:3000605211058870. [PMID: 34875914 DOI: 10.1177/03000605211058870] [Reference Citation Analysis]
|
| 509 |
Tian D, Gou X, Jia J, Wei J, Zheng M, Ding W, Bi H, Wu B, Tang J. New diketopiperazine alkaloid and polyketides from marine-derived fungus Penicillium sp. TW58-16 with antibacterial activity against Helicobacter pylori. Fitoterapia 2021;156:105095. [PMID: 34896204 DOI: 10.1016/j.fitote.2021.105095] [Reference Citation Analysis]
|
| 510 |
Reyes D, Ortiz J, Fuentes-López E, Budnik S, Gandara V, Gallardo A, Seydewitz MF, Candia R, Ignacio Vargas J, Rollan MP, Godoy J, Rollan A, Mansilla R, Arenas A, Chahuán J, Espino A, Pizarro M, Riquelme A. Quadruple therapies are superior to standard triple therapy for Helicobacter pylori first-line eradication in Chile. Gastroenterol Hepatol 2021:S0210-5705(21)00320-4. [PMID: 34890721 DOI: 10.1016/j.gastrohep.2021.11.010] [Reference Citation Analysis]
|
| 511 |
Zhao Y, Yang Y, Aruna, Xiao J, Song J, Huang T, Li S, Kou J, Huang L, Ji D, Xiong S, Peng W, Xu S, Cheng B. Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial. Front Med (Lausanne) 2021;8:776955. [PMID: 34869495 DOI: 10.3389/fmed.2021.776955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 512 |
Du YL, Duan RQ, Duan LP. Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review. BMC Gastroenterol 2021;21:459. [PMID: 34876031 DOI: 10.1186/s12876-021-02036-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 513 |
Zhao XX, Wang RL, Liu MH, Huang XJ. Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study. Gastroenterol Res Pract 2021;2021:6696473. [PMID: 34868307 DOI: 10.1155/2021/6696473] [Reference Citation Analysis]
|
| 514 |
Cantero-fortiz Y, Murrieta-álvarez I, León-peña AA, López-trujillo MA, Córdova-ramírez AC, Rivera-álvarez M, Elias-de-la-cruz GD, Olivares-gazca JC, Ruiz-delgado GJ, Ruiz-argüelles GJ. Helicobacter pylori antibodies and multiple sclerosis: a single-center study and a short review of the literature. Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00419-9] [Reference Citation Analysis]
|
| 515 |
Jiao L, Wang J, Ma H. Analysis of Helicobacter pylori's Antibiotic Resistance Rate and Research on Its Eradication Treatment Plan. Comput Math Methods Med 2021;2021:6009602. [PMID: 34899967 DOI: 10.1155/2021/6009602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 516 |
Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms 2021;9:2502. [PMID: 34946105 DOI: 10.3390/microorganisms9122502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 517 |
Liu T, Song C, Zhang Y, Siyin ST, Zhang Q, Song M, Cao L, Shi H. Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study. Int J Cancer 2021. [PMID: 34855203 DOI: 10.1002/ijc.33891] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 518 |
Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, Rohit Reddy S, Vasquez Lopez ME, Zahid M, Busmail A, Mohammed L. The Efficacy of Probiotics in the Management of Helicobacter Pylori: A Systematic Review. Cureus 2021;13:e20483. [PMID: 35047301 DOI: 10.7759/cureus.20483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 519 |
Zhao H, Yan P, Zhang N, Feng L, Chu X, Cui G, Qin Y, Yang C, Wang S, Yang K. The recurrence rate of Helicobacter pylori in recent 10 years: A systematic review and meta-analysis. Helicobacter 2021;26:e12852. [PMID: 34510644 DOI: 10.1111/hel.12852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 520 |
Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflamm Res 2021;70:1015-26. [PMID: 34549319 DOI: 10.1007/s00011-021-01501-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 521 |
Lapidot Y, Reshef L, Cohen D, Muhsen K. Helicobacter pylori and the intestinal microbiome among healthy school-age children. Helicobacter 2021;26:e12854. [PMID: 34617641 DOI: 10.1111/hel.12854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 522 |
Suleiman AA, Shaban SA, Al-chalabi R. Genetic polymorphism relationship of four SNP in beta defensins genes 1 and 2 with susceptibility and effect of triple therapy of Helicobacter pylori infection in Iraq. Gene Reports 2021;25:101366. [DOI: 10.1016/j.genrep.2021.101366] [Reference Citation Analysis]
|
| 523 |
Bunchorntavakul C, Buranathawornsom A. Randomized clinical trial: 7-day vonoprazan-based versus 14-day omeprazole-based triple therapy for Helicobacter pylori. J Gastroenterol Hepatol 2021;36:3308-13. [PMID: 34622504 DOI: 10.1111/jgh.15700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 524 |
Kao JY, Almenoff JS, Portenier DD, Sheldon KL. Helicobacter pylori eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index. GastroHep 2021;3:426-434. [DOI: 10.1002/ygh2.494] [Reference Citation Analysis]
|
| 525 |
Rustgi SD, Oh A, Hur C. Testing and Treating Helicobacter pylori Infection in Individuals With Family History of Gastric Cancer is Cost-effective. Gastroenterology 2021;161:2051-2052.e4. [PMID: 34461053 DOI: 10.1053/j.gastro.2021.08.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 526 |
Collatuzzo G, Fiorini G, Vaira B, Violante FS, Farioli A, Boffetta P. The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review. Preventive Medicine Reports 2021;24:101527. [DOI: 10.1016/j.pmedr.2021.101527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 527 |
Etchegaray-Morales I, Jiménez-Herrera EA, Mendoza-Pinto C, Rojas-Villarraga A, Macías-Díaz S, Osorio-Peña ÁD, Munguía-Realpozo P, García-Carrasco M. Helicobacter pylori and its association with autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis and Sjögren syndrome. J Transl Autoimmun 2021;4:100135. [PMID: 34825158 DOI: 10.1016/j.jtauto.2021.100135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 528 |
Yan ZB, Zhang JY, Lv YP, Tian WQ, Shan ZG, Mao FY, Liu YG, Chen WY, Wang P, Yang Y, Cheng P, Peng LS, Liao YL, Yue GY, Xu XL, Zhao YL, Lü MH, Zhuang Y. Helicobacter pylori-induced REDD1 modulates Th17 cell responses that contribute to gastritis. Clin Sci (Lond) 2021;135:2541-58. [PMID: 34730176 DOI: 10.1042/CS20210753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 529 |
Dao LV, Dao HV, Nguyen HT, Vu VT, Tran ATN, Dat VQ, Hoang LB, Nguyen HTV, Nguyen TD. Helicobacter pylori infection and eradication outcomes among Vietnamese patients in the same households: Findings from a non-randomized study. PLoS One 2021;16:e0260454. [PMID: 34818349 DOI: 10.1371/journal.pone.0260454] [Reference Citation Analysis]
|
| 530 |
Botija G, García Rodríguez C, Recio Linares A, Campelo Gutiérrez C, Pérez-Fernández E, Barrio Merino A. Antibiotic resistances and eradication rates in Helicobacter pylori infection. An Pediatr (Engl Ed) 2021;95:431-7. [PMID: 34810153 DOI: 10.1016/j.anpede.2020.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 531 |
Hsieh MS, Kuo FC, Wu MC, Wang JW, Liu CJ, Chu NS, Tsai PY, Hsu PI, Wu IC, Wu JY, Wu DC, Yu FJ, Kuo CH. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. J Formos Med Assoc 2021:S0929-6646(21)00483-6. [PMID: 34836662 DOI: 10.1016/j.jfma.2021.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 532 |
Gollapalli P, Selvan G T, H M, Shetty P, Kumari N S. Genome-scale protein interaction network construction and topology analysis of functional hypothetical proteins in Helicobacter pylori divulges novel therapeutic targets. Microb Pathog 2021;161:105293. [PMID: 34800634 DOI: 10.1016/j.micpath.2021.105293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 533 |
Namyalo E, Nyakarahuka L, Afayoa M, Baziira J, Tamale A, Atuhaire GC, Kungu JM. Prevalence of Helicobacter pylori among Patients with Gastrointestinal Tract (GIT) Symptoms: A Retrospective Study at Selected Africa Air Rescue (AAR) Clinics in Kampala, Uganda, from 2015 to 2019. J Trop Med 2021;2021:9935142. [PMID: 34790241 DOI: 10.1155/2021/9935142] [Reference Citation Analysis]
|
| 534 |
Peixoto SV, Torres KCL, Teixeira-Carvalho A, Martins-Filho OA, Lima-Costa MF. [Seroprevalence and factors associated with chronic infections among community-dwelling elderly individuals]. Cien Saude Colet 2021;26:5109-21. [PMID: 34787203 DOI: 10.1590/1413-812320212611.3.37062019] [Reference Citation Analysis]
|
| 535 |
Zhang C, Zhou W, Wang J, Zhang J, Zhang C. Investigation of the quantitative detection of serum Helicobacter pylori antibody in clinical laboratories in China. J Clin Lab Anal 2021;:e24069. [PMID: 34783398 DOI: 10.1002/jcla.24069] [Reference Citation Analysis]
|
| 536 |
Yang X, Zhang T, Zhang H, Sang S, Chen H, Zuo X. Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia. Biomark Res 2021;9:84. [PMID: 34784961 DOI: 10.1186/s40364-021-00340-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 537 |
Caso GC, McClain MS, Erwin AL, Truelock MD, Campbell AM, Leasure CS, Nagel M, Schey KL, Lacy DB, Ohi MD, Cover TL. Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin. Infect Immun 2021;89:e0034821. [PMID: 34543122 DOI: 10.1128/IAI.00348-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 538 |
Kountouras J, Papaefthymiou A, Polyzos SA, Deretzi G, Vardaka E, Soteriades ES, Tzitiridou-Chatzopoulou M, Gkolfakis P, Karafyllidou K, Doulberis M. Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. Microorganisms 2021;9:2351. [PMID: 34835476 DOI: 10.3390/microorganisms9112351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 539 |
Guo CG, Jiang F, Cheung KS, Li B, Ooi PH, Leung WK. Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study. J Antimicrob Chemother 2021:dkab415. [PMID: 34791274 DOI: 10.1093/jac/dkab415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 540 |
Adejumo AC, Labonte P, Bukong TN. Relationship Between Recreational Cannabis Use and Helicobacter pylori Infection. Cannabis Cannabinoid Res 2021. [PMID: 34748370 DOI: 10.1089/can.2021.0139] [Reference Citation Analysis]
|
| 541 |
Choi J, Kang J. Concurrence of Helicobacter pylori Infection and Its Associated Factors in Korean Couples. Korean J Fam Med 2021. [PMID: 34736313 DOI: 10.4082/kjfm.21.0115] [Reference Citation Analysis]
|
| 542 |
Hosseini RS, Rahimian G, Shafigh MH, Validi M, Khaledi M, Gholipour A. Correlation between clarithromycin resistance, virulence factors and clinical characteristics of the disease in Helicobacter pylori infected patients in Shahrekord, Southwest Iran. AMB Express 2021;11:147. [PMID: 34731345 DOI: 10.1186/s13568-021-01310-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 543 |
Saracino IM, Pavoni M, Zullo A, Fiorini G, Saccomanno L, Lazzarotto T, Antonelli G, Cavallo R, Borghi C, Vaira D. Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy. J Clin Gastroenterol 2021;55:865-8. [PMID: 33136782 DOI: 10.1097/MCG.0000000000001457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 544 |
Min Soe A, Nyi Nyi K, Ei San P. Detection of Helicobacter pylori infection by 14 C urea breath test in asymptomatic adults: A pilot study in Kanbauk village tract. GastroHep 2021;3:359-365. [DOI: 10.1002/ygh2.485] [Reference Citation Analysis]
|
| 545 |
Haq MMU, Furqan M, Zia A, Khalil A, Kalwar HA. The efficacy of levofloxacin‐based sequential regimen to eradicate Helicobacter pylori infection. GastroHep 2021;3:384-387. [DOI: 10.1002/ygh2.482] [Reference Citation Analysis]
|
| 546 |
Jiang F, Guo CG, Cheung KS, Leung WK. Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study. Aliment Pharmacol Ther 2021;54:1162-9. [PMID: 34528716 DOI: 10.1111/apt.16604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 547 |
Win T, Aye K, Aye T. Gastric precancerous conditions in patients with chronic dyspepsia. GastroHep 2021;3:366-371. [DOI: 10.1002/ygh2.483] [Reference Citation Analysis]
|
| 548 |
Shah SC, Tepler A, Chung CP, Suarez G, Peek RM Jr, Hung A, Roumie C, Narula N. Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis. Gastroenterology 2021;161:1443-59. [PMID: 34358488 DOI: 10.1053/j.gastro.2021.07.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 549 |
Chen Y, Xu C, Xu H, Chen W, Wang H, Wang Z, Zhang J. Persistent Helicobacter pylori infection for more than 3 years leads to elevated serum homocysteine concentration: A retrospective cohort study based on a healthy Chinese population. J Gastroenterol Hepatol 2021;36:3077-83. [PMID: 34198362 DOI: 10.1111/jgh.15603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 550 |
Lorenzo D, Debourdeau A. L’hémorragie digestive en chiffres : qu’avons-nous gagné en 30 ans ? La Presse Médicale Formation 2021;2:460-465. [DOI: 10.1016/j.lpmfor.2021.10.016] [Reference Citation Analysis]
|
| 551 |
Kim A, Lai J, Merrell DS, Kim JH, Su H, Cha JH. Geographic diversity in Helicobacter pylori oipA genotype between Korean and United States isolates. J Microbiol 2021. [PMID: 34718962 DOI: 10.1007/s12275-021-1450-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 552 |
Chua TH, Punjabi LS, Khor LY. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens 2021;10:1410. [PMID: 34832566 DOI: 10.3390/pathogens10111410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 553 |
Esmaeilzadeh A, Goshayeshi L, Bergquist R, Jarahi L, Khooei A, Fazeli A, Mosannen Mozaffari H, Bahari A, Oghazian MB, Hoseini B. Characteristics of gastric precancerous conditions and Helicobacter pylori infection among dyspeptic patients in north-eastern Iran: is endoscopic biopsy and histopathological assessment necessary? BMC Cancer 2021;21:1143. [PMID: 34702194 DOI: 10.1186/s12885-021-08626-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 554 |
Binmaeil H, Hanafiah A, Mohamed Rose I, Raja Ali RA. Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy. Infect Drug Resist 2021;14:4129-45. [PMID: 34675558 DOI: 10.2147/IDR.S325056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 555 |
Keikha M, Karbalaei M. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterol 2021;21:388. [PMID: 34670526 DOI: 10.1186/s12876-021-01977-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 556 |
Yuan C, Lin XM, Ou Y, Cai L, Cheng Q, Zhou P, Liao J. Association between regular arrangement of collecting venules and Helicobacter pylori status in routine endoscopy. BMC Gastroenterol 2021;21:389. [PMID: 34670510 DOI: 10.1186/s12876-021-01960-w] [Reference Citation Analysis]
|
| 557 |
Zhang T, Chen H, Zhang Y, Yin X, Man J, Yang X, Lu M. Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study. J Cancer 2021;12:6695-705. [PMID: 34659559 DOI: 10.7150/jca.62734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 558 |
Bakhshipour A, Rafaiee R. Prevalence of Idiopathic Peptic Ulcer in Southeastern Iran. Zahedan J Res Med Sci 2021;In Press. [DOI: 10.5812/zjrms.119598] [Reference Citation Analysis]
|
| 559 |
Khan S, Sharaf M, Ahmed I, Khan TU, Shabana S, Arif M, Kazmi SSUH, Liu C. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34658307 DOI: 10.1080/14787210.2022.1990041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 560 |
Quéro L, Labidi M, Bollet M, Bommier C, Guillerm S, Hennequin C, Thieblemont C. Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma. World J Gastrointest Oncol 2021; 13(10): 1453-1465 [PMID: 34721777 DOI: 10.4251/wjgo.v13.i10.1453] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 561 |
Hansen JP, Ali WM, Sivadasan R, Rajeeve K. Bacteria-Cancer Interface: Awaiting the Perfect Storm. Pathogens 2021;10:1321. [PMID: 34684270 DOI: 10.3390/pathogens10101321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 562 |
Mao LQ, Zhou YL, Wang SS, Chen L, Hu Y, Yu LM, Xu JM, Lyu B. Impact of Helicobacter pylori eradication on the gastric microbiome. Gut Pathog 2021;13:60. [PMID: 34645495 DOI: 10.1186/s13099-021-00460-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 563 |
Noronha BP, Mambrini JVM, Torres KCL, Martins-Filho OA, Teixeira-Carvalho A, Lima-Costa MF, Peixoto SV. Chlamydia pneumoniae and Helicobacter pylori infections and immunological profile of community-dwelling older adults. Exp Gerontol 2021;156:111589. [PMID: 34637947 DOI: 10.1016/j.exger.2021.111589] [Reference Citation Analysis]
|
| 564 |
Ansari H, Tahmasebi-Birgani M, Bijanzadeh M. DNA vaccine containing Flagellin A gene induces significant immune responses against Helicobacter pylori infection: An in vivo study. Iran J Basic Med Sci 2021;24:796-804. [PMID: 34630957 DOI: 10.22038/ijbms.2021.54415.12227] [Reference Citation Analysis]
|
| 565 |
Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell 2021;39:1317-41. [PMID: 34506740 DOI: 10.1016/j.ccell.2021.08.006] [Cited by in Crossref: 92] [Cited by in F6Publishing: 26] [Article Influence: 46.0] [Reference Citation Analysis]
|
| 566 |
Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules 2021;26:6078. [PMID: 34641620 DOI: 10.3390/molecules26196078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 567 |
Mehrotra T, Devi TB, Kumar S, Talukdar D, Karmakar SP, Kothidar A, Verma J, Kumari S, Alexander SM, Retnakumar RJ, Devadas K, Ray A, Mutreja A, Nair GB, Chattopadhyay S, Das B. Antimicrobial resistance and virulence in Helicobacter pylori: Genomic insights. Genomics 2021;113:3951-66. [PMID: 34619341 DOI: 10.1016/j.ygeno.2021.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 568 |
Wang X, Jia Z, Zhang Y, Kou C, Jiang J. Association of Helicobacter pylori infection with estimated glomerular filtration rate in a Chinese population. Infect Genet Evol 2021;96:105102. [PMID: 34624541 DOI: 10.1016/j.meegid.2021.105102] [Reference Citation Analysis]
|
| 569 |
de Vegt F, Gommers JJJ, Groenewoud H, Siersema PD, Verbeek ALM, Peters Y, Broeders MJM. Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041. Int J Cancer 2022;150:420-30. [PMID: 34605022 DOI: 10.1002/ijc.33836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 570 |
Zou PY, Hu J, Zhao JT, Zhao Z, Mei H, Yang J, Zhu YJ, Zhang Y, Lan CH. 10-Day and 14-day high-dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis. Helicobacter 2021;26:e12833. [PMID: 34318966 DOI: 10.1111/hel.12833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 571 |
Ouyang Y, Zhu Z, Huang L, Zeng C, Zhang L, Wu WK, Lu N, Xie C. Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020. Helicobacter 2021;26:e12835. [PMID: 34258827 DOI: 10.1111/hel.12835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 572 |
Gong L, El-Omar EM. Application of molecular techniques in Helicobacter pylori detection: limitations and improvements. Helicobacter 2021;26:e12841. [PMID: 34333819 DOI: 10.1111/hel.12841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 573 |
Kowada A, Asaka M. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. Helicobacter 2021;26:e12837. [PMID: 34278663 DOI: 10.1111/hel.12837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 574 |
Guo R, Wu S, Guan L, Xie Y, Yang X, Li Z, Zhang Z. Dietary multivalent anti-Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients. Helicobacter 2021;26:e12843. [PMID: 34382297 DOI: 10.1111/hel.12843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 575 |
Gonzalez I, Araya P, Schneider I, Lindner C, Rojas A. Pattern recognition receptors and their roles in the host response to Helicobacter pylori infection. Future Microbiol 2021;16:1229-38. [PMID: 34615380 DOI: 10.2217/fmb-2021-0106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 576 |
Nguyen TH, Ho TTM, Nguyen-Hoang TP, Qumar S, Pham TTD, Bui QN, Bulach D, Nguyen TV, Rahman M. The endemic Helicobacter pylori population in Southern Vietnam has both South East Asian and European origins. Gut Pathog 2021;13:57. [PMID: 34593031 DOI: 10.1186/s13099-021-00452-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 577 |
Sousa C, Ferreira R, Azevedo NF, Oleastro M, Azeredo J, Figueiredo C, Melo LDR. Helicobacter pylori infection: from standard to alternative treatment strategies. Crit Rev Microbiol 2021;:1-21. [PMID: 34569892 DOI: 10.1080/1040841X.2021.1975643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 578 |
Durazzo M, Adriani A, Fagoonee S, Saracco GM, Pellicano R. Helicobacter pylori and Respiratory Diseases: 2021 Update. Microorganisms 2021;9:2033. [PMID: 34683354 DOI: 10.3390/microorganisms9102033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 579 |
Mohammadzadeh R, Soleimanpour S, Pishdadian A, Farsiani H. Designing and development of epitope-based vaccines against Helicobacter pylori. Crit Rev Microbiol 2021;:1-24. [PMID: 34559599 DOI: 10.1080/1040841X.2021.1979934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 580 |
Aziz F, Khan I, Shukla S, Dey DK, Yan Q, Chakraborty A, Yoshitomi H, Hwang SK, Sonwal S, Lee H, Haldorai Y, Xiao J, Huh YS, Bajpai VK, Han YK. Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer. Pharmacol Ther 2021;:107994. [PMID: 34571111 DOI: 10.1016/j.pharmthera.2021.107994] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 581 |
Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases 2021;9:66. [PMID: 34698140 DOI: 10.3390/diseases9040066] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 582 |
Huang M, Zhu L, Jin Y, Fang Z, Chen Y, Yao Y. Association between Helicobacter Pylori Infection and Systemic Arterial Hypertension: A Meta-Analysis. Arq Bras Cardiol 2021;117:626-36. [PMID: 34550168 DOI: 10.36660/abc.20200186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 583 |
Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, Martinez Tyson D, Tortolero-Luna G, Fedewa SA, Jemal AM, Siegel RL. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J Clin 2021;71:466-87. [PMID: 34545941 DOI: 10.3322/caac.21695] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 584 |
Lee Y, Lee SM, Choi J, Kang S, So S, Kim D, Ahn JY, Jung HY, Jeong JY, Kang E. Mitochondrial DNA Haplogroup Related to the Prevalence of Helicobacter pylori. Cells 2021;10:2482. [PMID: 34572132 DOI: 10.3390/cells10092482] [Reference Citation Analysis]
|
| 585 |
Ibrahim MA, Sallem OW, Abdelhassib MR, Eldahshan OA. Potentiation of anti-Helicobacter pylori activity of clarithromycin by Pelargonium graveolens oil. Arab J Gastroenterol 2021;22:224-8. [PMID: 34531132 DOI: 10.1016/j.ajg.2021.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 586 |
Miftahussurur M, Waskito LA, Fauzia KA, Mahmudah I, Doohan D, Adnyana IK, Khomsan A, Ratnasari N, Rezkitha YAA. Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence? Gut Liver 2021;15:653-65. [PMID: 32616679 DOI: 10.5009/gnl20019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 587 |
Wang C, Yan J, He B, Zhang S, Xu S. Hp-Positive Chinese Patients Should Undergo Colonoscopy Earlier and More Frequently: The Result of a Cross-Sectional Study Based on 13,037 Cases of Gastrointestinal Endoscopy. Front Oncol 2021;11:698898. [PMID: 34513677 DOI: 10.3389/fonc.2021.698898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 588 |
Hu D, Lu Y, Wang D, Nie C, Li Y. Glycosaminoglycan biosynthesis pathway in host genome is associated with Helicobacter pylori infection. Sci Rep 2021;11:18235. [PMID: 34521966 DOI: 10.1038/s41598-021-97790-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 589 |
Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
|
| 590 |
Pham YL, Beauchamp J. Breath Biomarkers in Diagnostic Applications. Molecules 2021;26:5514. [PMID: 34576985 DOI: 10.3390/molecules26185514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 591 |
Tshibangu-Kabamba E, Phuc BH, Tuan VP, Fauzia KA, Kabongo-Tshibaka A, Kayiba NK, Rosas-Aguirre A, Devleesschauwer B, Cimuanga-Mukanya A, Ngoma Kisoko PJ, Matsumoto T, Akada J, Disashi GT, Mumba Ngoyi D, Kido Y, Speybroeck N, Yamaoka Y. Assessment of the diagnostic accuracy and relevance of a novel ELISA system developed for seroepidemiologic surveys of Helicobacter pylori infection in African settings. PLoS Negl Trop Dis 2021;15:e0009763. [PMID: 34499649 DOI: 10.1371/journal.pntd.0009763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 592 |
Gao P, Cai N, Yang X, Yuan Z, Zhang T, Lu M, Jin L, Ye W, Suo C, Chen X. Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China. Int J Cancer 2021. [PMID: 34498732 DOI: 10.1002/ijc.33801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 593 |
Ndegwa N, Ploner A, Andersson AF, Zagai U, Andreasson A, Vieth M, Talley NJ, Agreus L, Ye W. Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations With Gastric Lesions. Clin Transl Gastroenterol 2020;11:e00191. [PMID: 32764211 DOI: 10.14309/ctg.0000000000000191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 594 |
Alexander SM, Retnakumar RJ, Chouhan D, Devi TNB, Dharmaseelan S, Devadas K, Thapa N, Tamang JP, Lamtha SC, Chattopadhyay S. Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes. Front Microbiol 2021;12:713955. [PMID: 34484153 DOI: 10.3389/fmicb.2021.713955] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 595 |
Rajabnia M, Sadeghi A, Abdi S, Găman M, Zali M, Salehi N, Yadegar A, Rahmani K. Effect of Statins on <b><i>Helicobacter pylori</i></b> Eradication Rate: A Systematic Review and Meta-Analysis. GE Port J Gastroenterol. [DOI: 10.1159/000518597] [Reference Citation Analysis]
|
| 596 |
Haseena, Khan A, Aslam F, Kanwal T, Shah MR, Khalil AAK, Shah SWA, Alshammari EM, El-Masry EA, Batiha GE, Baty RS. Enhanced Antibacterial Potential of Amoxicillin against Helicobacter pylori Mediated by Lactobionic Acid Coated Zn-MOFs. Antibiotics (Basel) 2021;10:1071. [PMID: 34572653 DOI: 10.3390/antibiotics10091071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 597 |
Kumar S, Mantero A, Delgado C, Dominguez B, Nuchovich N, Goldberg DS. Eastern European and Asian-born populations are prone to gastric cancer: an epidemiologic analysis of foreign-born populations and gastric cancer. Ann Gastroenterol 2021;34:669-74. [PMID: 34475737 DOI: 10.20524/aog.2021.0640] [Reference Citation Analysis]
|
| 598 |
Cheng H. Genetic variation of innate immune response and inflammation in susceptibility to Helicobacter pylori ‐related diseases. Adv in Digestive Med 2021;8:136-8. [DOI: 10.1002/aid2.13294] [Reference Citation Analysis]
|
| 599 |
Anis S, Farooqi SR, Niaz SK. Characterization of Domain V Mutations in Clinical Isolates of Helicobacter pylori in Pakistan and Their Effect on Clarithromycin MIC. Infect Drug Resist 2021;14:3393-403. [PMID: 34466005 DOI: 10.2147/IDR.S306878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 600 |
Rush CJ, Hoosien E, Villiers N, Clay C, Metz DC, Setshedi M, Thomson SR, Levin DA. Helicobacter pylori virulence factors and host genetic polymorphisms in a low gastric cancer incidence and high H pylori prevalence country. GastroHep 2021;3:277-282. [DOI: 10.1002/ygh2.488] [Reference Citation Analysis]
|
| 601 |
Bujanda L, Nyssen OP, Vaira D, Saracino IM, Fiorini G, Lerang F, Georgopoulos S, Tepes B, Heluwaert F, Gasbarrini A, Rokkas T, Bordin D, Smith S, Lamy V, Caldas M, Resina E, Muñoz R, Cosme Á, Puig I, Megraud F, O'Morain C, Gisbert JP; The Hp-EuReg Investigators. Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013-2020: Results of the European Registry on H. pylori Management (Hp-EuReg). Antibiotics (Basel) 2021;10:1058. [PMID: 34572640 DOI: 10.3390/antibiotics10091058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 602 |
Moussa IM, Eljakee J, Beder M, Abdelaziz K, Mubarak AS, Dawoud TM, Hemeg HA, Alsubki RA, Kabli SA, Marouf S. Zoonotic risk and public health hazards of companion animals in the transmission of Helicobacter species. Journal of King Saud University - Science 2021;33:101494. [DOI: 10.1016/j.jksus.2021.101494] [Reference Citation Analysis]
|
| 603 |
Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol 2021;18:613-29. [PMID: 34002081 DOI: 10.1038/s41575-021-00449-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 37.5] [Reference Citation Analysis]
|
| 604 |
Sukri A, Lopes BS, Hanafiah A. The Emergence of Multidrug-Resistant Helicobacter pylori in Southeast Asia: A Systematic Review on the Trends and Intervention Strategies Using Antimicrobial Peptides. Antibiotics (Basel) 2021;10:1061. [PMID: 34572643 DOI: 10.3390/antibiotics10091061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 605 |
Gaus OV, Livzan MA. “Gastrointestinal” comorbidity in irritable bowel syndrome. jour 2021;1:104-111. [DOI: 10.31146/1682-8658-ecg-190-6-104-111] [Reference Citation Analysis]
|
| 606 |
Kumar S, Patel GK, Ghoshal UC. Helicobacter pylori-Induced Inflammation: Possible Factors Modulating the Risk of Gastric Cancer. Pathogens 2021;10:1099. [PMID: 34578132 DOI: 10.3390/pathogens10091099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 607 |
Hodges P, Kelly P, Kayamba V. Helicobacter pylori infection and hypochlorhydria in Zambian adults and children: A secondary data analysis. PLoS One 2021;16:e0256487. [PMID: 34449790 DOI: 10.1371/journal.pone.0256487] [Reference Citation Analysis]
|
| 608 |
Ruan G, Huang A, Hu C, Xu N, Fan M, Zhang Z, Wang Y, Xing Y. CD4+ CD8αα+ T cells in the gastric epithelium mediate chronic inflammation induced by Helicobacter felis. Microb Pathog 2021;159:105151. [PMID: 34450200 DOI: 10.1016/j.micpath.2021.105151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 609 |
Wang S, Ye F, Sheng Y, Yu W, Liu Y, Liu D, Zhang K. Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III-IV in the Chinese High-Risk Gastric Cancer Population. Front Med (Lausanne) 2021;8:724566. [PMID: 34447771 DOI: 10.3389/fmed.2021.724566] [Reference Citation Analysis]
|
| 610 |
Milner E, Stevens B, An M, Lam V, Ainsworth M, Dihle P, Stearns J, Dombrowski A, Rego D, Segars K. Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases. Front Microbiol 2021;12:689958. [PMID: 34434175 DOI: 10.3389/fmicb.2021.689958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 611 |
Bonilla S, Bousvaros A, Cardini J, Estrella-pimentel L, Mitchell PD, Goldshine J, Hirsch R, Jonas M, Fox V. Lessons From a Quality Improvement Project to Standardize the Process of Gastric Biopsy Culture for Helicobacter pylori. JPGN Reports 2021;2:e116. [DOI: 10.1097/pg9.0000000000000116] [Reference Citation Analysis]
|
| 612 |
Mousavi T, Nikfar S, Abdollahi M. The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opin Pharmacother 2021;:1-27. [PMID: 34435515 DOI: 10.1080/14656566.2021.1959914] [Reference Citation Analysis]
|
| 613 |
Chung J, Min KW, Son BK, Kim DH, Kim HL. Association between histological severity of Helicobacter pylori infection and cardiovascular risk scores in the Korean population. Atherosclerosis 2021;333:124-30. [PMID: 34429194 DOI: 10.1016/j.atherosclerosis.2021.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 614 |
Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, Sitarz E, Portincasa P, Garruti G, Flieger M, Teresiński G. Helicobacter pylori Infection and Extragastric Diseases-A Focus on the Central Nervous System. Cells 2021;10:2191. [PMID: 34571840 DOI: 10.3390/cells10092191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 615 |
Fu J, Sun CF, He HY, Ojha SC, Shi H, Deng CL, Sheng YJ. The effect of CYP2C19 gene polymorphism on the eradication rate of Helicobacter pylori by proton pump inhibitors-containing regimens in Asian populations: a meta-analysis. Pharmacogenomics 2021;22:859-79. [PMID: 34414773 DOI: 10.2217/pgs-2020-0127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 616 |
Ailloud F, Estibariz I, Suerbaum S. Evolved to vary: genome and epigenome variation in the human pathogen Helicobacter pylori. FEMS Microbiol Rev 2021;45:fuaa042. [PMID: 32880636 DOI: 10.1093/femsre/fuaa042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 617 |
Yano Y, Etemadi A, Abnet CC. Microbiome and Cancers of the Esophagus: A Review. Microorganisms 2021;9:1764. [PMID: 34442842 DOI: 10.3390/microorganisms9081764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 618 |
Krzyżek P, Junka A, Słupski W, Dołowacka-Jóźwiak A, Płachno BJ, Sobiecka A, Matkowski A, Chodaczek G, Płusa T, Gościniak G, Zielińska S. Antibiofilm and Antimicrobial-Enhancing Activity of Chelidonium majus and Corydalis cheilanthifolia Extracts against Multidrug-Resistant Helicobacter pylori. Pathogens 2021;10:1033. [PMID: 34451497 DOI: 10.3390/pathogens10081033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 619 |
Hernández-Ochoa B, Navarrete-Vázquez G, Aguayo-Ortiz R, Ortiz-Ramírez P, Morales-Luna L, Martínez-Rosas V, González-Valdez A, Gómez-Chávez F, Enríquez-Flores S, Wong-Baeza C, Baeza-Ramírez I, Pérez de la Cruz V, Gómez-Manzo S. Identification and In Silico Characterization of Novel Helicobacter pylori Glucose-6-Phosphate Dehydrogenase Inhibitors. Molecules 2021;26:4955. [PMID: 34443540 DOI: 10.3390/molecules26164955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 620 |
Taxauer K, Hamway Y, Ralser A, Dietl A, Mink K, Vieth M, Singer BB, Gerhard M, Mejías-Luque R. Engagement of CEACAM1 by Helicobacterpylori HopQ Is Important for the Activation of Non-Canonical NF-κB in Gastric Epithelial Cells. Microorganisms 2021;9:1748. [PMID: 34442827 DOI: 10.3390/microorganisms9081748] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 621 |
He L, Wang W, Shi H, Jiang C, Yao H, Zhang Y, Qian W, Lin R. THBS4/integrin α2 axis mediates BM-MSCs to promote angiogenesis in gastric cancer associated with chronic Helicobacter pylori infection. Aging (Albany NY) 2021;13:19375-96. [PMID: 34390328 DOI: 10.18632/aging.203334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 622 |
Bahçeci İ, Yildiz İE. İlimizde helicobacter pylori sıklığının değerlendirmesi: yedi yıllık çalışma. Turkish Journal of Clinics and Laboratory 2021. [DOI: 10.18663/tjcl.954009] [Reference Citation Analysis]
|
| 623 |
Zóka A, Gönczi M, Kádár B, Steinhauser R, Baráth A, Bekő G. The potential impact of Helicobacter pylori seropositivity on recombinant, antigen-based Lyme serology. J Microbiol Methods 2021;188:106298. [PMID: 34364886 DOI: 10.1016/j.mimet.2021.106298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 624 |
Wei L, Ding HG. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? Medicine (Baltimore) 2021;100:e26706. [PMID: 34397807 DOI: 10.1097/MD.0000000000026706] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 625 |
Glover B, Teare J, Patel N. Assessment of Helicobacter pylori status by examination of gastric mucosal patterns: diagnostic accuracy of white-light endoscopy and narrow-band imaging. BMJ Open Gastroenterol 2021;8:e000608. [PMID: 34353822 DOI: 10.1136/bmjgast-2021-000608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 626 |
Azimirad M, Nadalian B, Alavifard H, Negahdar Panirani S, Mahdigholi Vand Bonab S, Azimirad F, Gholami F, Jabbari P, Yadegar A, Busani L, Asadzadeh Aghdaei H, Zali MR. Microbiological survey and occurrence of bacterial foodborne pathogens in raw and ready-to-eat green leafy vegetables marketed in Tehran, Iran. Int J Hyg Environ Health 2021;237:113824. [PMID: 34365294 DOI: 10.1016/j.ijheh.2021.113824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 627 |
Duarte N, Salazar V, Casanova G, Suárez P, Fernández-Delgado M. Occurrence of Helicobacter spp. and Fecal Bacterial Contamination in High-altitude Aquatic Environments from the Andes. Bull Environ Contam Toxicol 2021;107:433-40. [PMID: 34347116 DOI: 10.1007/s00128-021-03347-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 628 |
Johnson KS, Elgamoudi BA, Jen FE, Day CJ, Sweeney EG, Pryce ML, Guillemin K, Haselhorst T, Korolik V, Ottemann KM. The dCache Chemoreceptor TlpA of Helicobacter pylori Binds Multiple Attractant and Antagonistic Ligands via Distinct Sites. mBio 2021;12:e0181921. [PMID: 34340539 DOI: 10.1128/mBio.01819-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 629 |
Sasaki Y, Abe Y, Shoji M, Mizumoto N, Takeda H, Oizumi H, Yaoita T, Sawada N, Yamagishi K, Saito E, Watanabe M, Ishizawa K, Konta T, Kayama T, Tsugane S, Ueno Y, Inoue M. Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study. Sci Rep 2021;11:15605. [PMID: 34341428 DOI: 10.1038/s41598-021-95124-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 630 |
Zhou Y, Ye Z, Wang Y, Huang Z, Zheng C, Shi J, Tang W, Zhang P, Wang S, Huang Y. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children. Helicobacter 2021;26:e12809. [PMID: 33899288 DOI: 10.1111/hel.12809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 631 |
Miller AK, Williams SM. Helicobacter pylori infection causes both protective and deleterious effects in human health and disease. Genes Immun 2021;22:218-26. [PMID: 34244666 DOI: 10.1038/s41435-021-00146-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 632 |
Wang X, Shu X, Li Q, Li Y, Chen Z, Wang Y, Pu K, Zheng Y, Ye Y, Liu M, Ma L, Zhang Z, Wu Z, Zhang F, Guo Q, Ji R, Zhou Y. Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high-risk area for gastric cancer in northwest China: An all-ages population-based cross-sectional study. Helicobacter 2021;26:e12810. [PMID: 33904635 DOI: 10.1111/hel.12810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 633 |
Sorge F, Miller L. Consulta pediátrica de un niño adoptado. EMC - Pediatría 2021;56:1-13. [DOI: 10.1016/s1245-1789(21)45485-5] [Reference Citation Analysis]
|
| 634 |
Sipponen P. Prevalence rates of heathy stomach mucosa, chronic non-atrophic and atrophic gastritis in endoscopic biopsies in adults born in Finland in 1890-1977. Scand J Gastroenterol 2021;56:874-81. [PMID: 34056994 DOI: 10.1080/00365521.2021.1929451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 635 |
Liu Y, Qin W, Zhang F, Wang J, Li X, Li S, Qin X, Lu Y. Association between WNT-1-inducible signaling pathway protein-1 (WISP1) genetic polymorphisms and the risk of gastric cancer in Guangxi Chinese. Cancer Cell Int 2021;21:405. [PMID: 34330284 DOI: 10.1186/s12935-021-02116-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 636 |
Lee KJ. The Usefulness of Symptom-based Subtypes of Functional Dyspepsia for Predicting Underlying Pathophysiologic Mechanisms and Choosing Appropriate Therapeutic Agents. J Neurogastroenterol Motil 2021;27:326-36. [PMID: 34210898 DOI: 10.5056/jnm21042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 637 |
Nguyen TP, Luu HN, Nguyen MVT, Tran MT, Tuong TTV, Tran CTD, Boffetta P. Attributable Causes of Cancer in Vietnam. JCO Glob Oncol 2020;6:195-204. [PMID: 32045545 DOI: 10.1200/JGO.19.00239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 638 |
Chaithongyot S, Jantaree P, Sokolova O, Naumann M. NF-κB in Gastric Cancer Development and Therapy. Biomedicines 2021;9:870. [PMID: 34440074 DOI: 10.3390/biomedicines9080870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 639 |
Wu J, Zhu X, Guo X, Yang Z, Cai Q, Gu D, Luo W, Yuan C, Xiang Y. Helicobacter urease suppresses cytotoxic CD8 + T cell responses through activating Myh9-dependent induction of PD-L1. Int Immunol 2021:dxab044. [PMID: 34297096 DOI: 10.1093/intimm/dxab044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 640 |
Yang H, Hu B. Diagnosis of Helicobacter pylori Infection and Recent Advances. Diagnostics (Basel) 2021;11. [PMID: 34441240 DOI: 10.3390/diagnostics11081305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 641 |
González A, Casado J, Lanas Á. Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection. Front Cell Infect Microbiol 2021;11:709749. [PMID: 34354964 DOI: 10.3389/fcimb.2021.709749] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 642 |
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond) 2021. [PMID: 34288593 DOI: 10.1002/cac2.12197] [Cited by in Crossref: 78] [Cited by in F6Publishing: 94] [Article Influence: 39.0] [Reference Citation Analysis]
|
| 643 |
Bricker-Ford R. Novel "High-dose Quad" Salvage Therapy Approach for Helicobacter pylori Infection: A Case Report. J Pharm Pract 2021;:8971900211033143. [PMID: 34269127 DOI: 10.1177/08971900211033143] [Reference Citation Analysis]
|
| 644 |
Kim YS, Lee J, Shin A, Lee JM, Park JH, Jung HY. A Nationwide Cohort Study Shows a Sex-Dependent Change in the Trend of Peptic Ulcer Bleeding Incidence in Korea between 2006 and 2015. Gut Liver 2021;15:537-45. [PMID: 33071238 DOI: 10.5009/gnl20079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 645 |
Doohan D, Rezkitha YAA, Waskito LA, Yamaoka Y, Miftahussurur M. Helicobacter pylori BabA-SabA Key Roles in the Adherence Phase: The Synergic Mechanism for Successful Colonization and Disease Development. Toxins (Basel) 2021;13:485. [PMID: 34357957 DOI: 10.3390/toxins13070485] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 646 |
de Lima Silva LL, Oliveira AKS, Gama AR, Ramos AFPL, Silva AMTC, Blanco AJV, Vieira JDG, Rasmussem LT, Carneiro LC, Barbosa MS. Helicobacter pylori virulence dupA gene: risk factor or protective factor? Braz J Microbiol 2021. [PMID: 34255308 DOI: 10.1007/s42770-021-00553-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 647 |
Baradaran A, Dehghanbanadaki H, Naderpour S, Pirkashani LM, Rajabi A, Rashti R, Riahifar S, Moradi Y. The association between Helicobacter pylori and obesity: a systematic review and meta-analysis of case-control studies. Clin Diabetes Endocrinol 2021;7:15. [PMID: 34243821 DOI: 10.1186/s40842-021-00131-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 648 |
Buzás GM. Helicobacter pylori and non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2020;66:267-79. [PMID: 32724031 DOI: 10.23736/S1121-421X.20.02671-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 649 |
Wen J, Chen C, Luo M, Liu X, Guo J, Wei T, Gu X, Gu S, Ning Y, Li Y. Notch Signaling Ligand Jagged1 Enhances Macrophage-Mediated Response to Helicobacter pylori. Front Microbiol 2021;12:692832. [PMID: 34305857 DOI: 10.3389/fmicb.2021.692832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 650 |
Pritchard DM, Bornschein J, Beales I, Beresniak A, Salhi H, Malfertheiner P. Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK. BMJ Open Gastroenterol 2021;8:e000685. [PMID: 34244244 DOI: 10.1136/bmjgast-2021-000685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 651 |
Pourfarzi F, Zahirian Moghadam T, Zandian H, Malekzadeh R, Yazdanbod A. Cost-effectiveness analysis of two routine therapeutic methods for Helicobacter pylori eradication: a Persian cohort-based study. Gastroenterol Hepatol Bed Bench 2021;14:250-9. [PMID: 34221265] [Reference Citation Analysis]
|
| 652 |
Naushad VA, Purayil NK, Badi A, Chandra P, Abuzaid HO, Abuhmaira MM, Lutf A, Paramba F, Varikkodan I, Elzouki AY. Potential Predictors and Prevalence of Helicobacter pylori Infection Among Adult Patients With Dyspepsia: A Retrospective Study From Qatar. Cureus 2021;13:e16216. [PMID: 34367816 DOI: 10.7759/cureus.16216] [Reference Citation Analysis]
|
| 653 |
Alhalabi M, Alassi MW, Alaa Eddin K, Cheha K. Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial. BMC Infect Dis 2021;21:642. [PMID: 34218802 DOI: 10.1186/s12879-021-06356-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 654 |
Ribaldone DG, Zurlo C, Fagoonee S, Rosso C, Armandi A, Caviglia GP, Saracco GM, Pellicano R. A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy. Life (Basel) 2021;11:650. [PMID: 34357021 DOI: 10.3390/life11070650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 655 |
Bornschein J, Pritchard DM. Myths and misconceptions in the management of Helicobacter pylori infection. Frontline Gastroenterol 2022;13:245-53. [PMID: 35493626 DOI: 10.1136/flgastro-2021-101826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 656 |
Sharafutdinov I, Backert S, Tegtmeyer N. The Helicobacter pylori type IV secretion system upregulates epithelial cortactin expression by a CagA- and JNK-dependent pathway. Cell Microbiol 2021;:e13376. [PMID: 34197673 DOI: 10.1111/cmi.13376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 657 |
Valizadeh Toosi SM, Yaghobi M, Mohammad Pour RA. Prevalence of Helicobacter Pylori Infection in Patients with Dyspepsia in North of Iran. Middle East J Dig Dis 2021;13:230-6. [PMID: 36606221 DOI: 10.34172/mejdd.2021.230] [Reference Citation Analysis]
|
| 658 |
Shah SC, Peek RM Jr. Chemoprevention Against Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:519-42. [PMID: 34053637 DOI: 10.1016/j.giec.2021.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 659 |
Seo HS, Chin HS, Kim YH, Moon HS, Kim K, Nguyen LP, Yong D. Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank. Ann Lab Med 2021;41:424-8. [PMID: 33536363 DOI: 10.3343/alm.2021.41.4.424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 660 |
Kim J, Wang TC. Helicobacter pylori and Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:451-65. [PMID: 34053633 DOI: 10.1016/j.giec.2021.03.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 661 |
Lin Y, Zheng Y, Wang HL, Wu J. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030. Gastroenterology 2021;161:116-127.e8. [PMID: 33744306 DOI: 10.1053/j.gastro.2021.03.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 662 |
McNamara KM, Gobert AP, Wilson KT. The role of polyamines in gastric cancer. Oncogene 2021;40:4399-412. [PMID: 34108618 DOI: 10.1038/s41388-021-01862-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 663 |
Fathy El Sayed A, Magd Eldin Mohammad Sadek A, Ahmed Ragab Abdelhamid W. Comparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Trial. Middle East J Dig Dis 2021;13:223-9. [PMID: 36606218 DOI: 10.34172/mejdd.2021.229] [Reference Citation Analysis]
|
| 664 |
Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 665 |
Garcés-Durán R, Galdín-Ferreyra M, Delgado-Guillena PG, Cuatrecasas M, Córdova H, García-Rodríguez A, Rodrigo-Calvo MT, Jimeno-Ramiro M, Araujo IK, Ginès A, Llach J, Fernandez-Esparrach G. Diagnosis of Helicobacter pylori Infection by the Arrangement of Collecting Venules Using White Light Endoscopy: Evaluation of Interobserver Agreement. Dig Dis 2022;40:376-84. [PMID: 34348294 DOI: 10.1159/000518100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 666 |
Dos Santos Viana I, Cordeiro Santos ML, Santos Marques H, Lima de Souza Gonçalves V, Bittencourt de Brito B, França da Silva FA, Oliveira E Silva N, Dantas Pinheiro F, Fernandes Teixeira A, Tanajura Costa D, Oliveira Souza B, Lima Souza C, Vasconcelos Oliveira M, Freire de Melo F. Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape. Expert Rev Vaccines 2021;20:989-99. [PMID: 34139141 DOI: 10.1080/14760584.2021.1945450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 667 |
Kabir M, Ashfaq M, Saeed S, Arshad M, Asif H. Assessment of dietary intake among patients with peptic ulcer. DF 2021. [DOI: 10.54393/df.v3i01.29] [Reference Citation Analysis]
|
| 668 |
Attaran B, Salehi N, Ghadiri B, Esmaeili M, Kalateh S, Tashakoripour M, Eshagh Hosseini M, Mohammadi M. The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes. Gut Pathog 2021;13:43. [PMID: 34183046 DOI: 10.1186/s13099-021-00438-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 669 |
Akar M, Aydın F, Kayman T, Abay S, Karakaya E. Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing? Turk J Med Sci 2021;51:1445-64. [PMID: 33631868 DOI: 10.3906/sag-2101-69] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 670 |
Khoder G, Mina S, Mahmoud I, Muhammad JS, Harati R, Burucoa C. Helicobacter pylori Infection in Tripoli, North Lebanon: Assessment and Risk Factors. Biology (Basel) 2021;10:599. [PMID: 34203570 DOI: 10.3390/biology10070599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 671 |
Linn AK, Samainukul N, Sakdee S, Butnampetch C, Li HC, Angsuthanasombat C, Katzenmeier G. N-Terminally Added Tag Selectively Enhances Heterologous Expression of VacA Cytotoxin Variants from Helicobacter pylori. Protein Pept Lett 2021;28:643-50. [PMID: 33183185 DOI: 10.2174/0929866527666201112122831] [Reference Citation Analysis]
|
| 672 |
Lyu T, Cheung KS, Ni L, Guo J, Mu P, Li Y, Yang Q, Yu X, Lyu Z, Wu J, Guo H, Leung WK, Seto WK. High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study. J Antimicrob Chemother 2020;75:3391-4. [PMID: 32785699 DOI: 10.1093/jac/dkaa315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 673 |
Doulberis M, Pierre NT, Manzini G, Papaefthymiou A, Kountouras J, Klukowska-Rötzler J, Polyzos SA, Srivastava S, Exadaktylos AK, Knuchel J, Kuntzen T, Srivastava DS. Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients. Microorganisms 2021;9:1361. [PMID: 34201748 DOI: 10.3390/microorganisms9071361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 674 |
Steiner TM, Lettl C, Schindele F, Goebel W, Haas R, Fischer W, Eisenreich W. Substrate usage determines carbon flux via the citrate cycle in Helicobacter pylori. Mol Microbiol 2021. [PMID: 34164854 DOI: 10.1111/mmi.14775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 675 |
Jonaitis P, Kupcinskas J, Nyssen OP, Puig I, Gisbert JP, Jonaitis L. Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg). Medicina (Kaunas) 2021;57:642. [PMID: 34201428 DOI: 10.3390/medicina57070642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 676 |
Kumar M, Sikri N, Chahal S, Sharma J, Sharma B, Yadav P, Bhardwaj M, Vashishth D, Kadyan P, Kataria SK, Dalal S. Urease Inhibitory Kinetic Studies of Various Extracts and Pure Compounds from Cinnamomum Genus. Molecules 2021;26:3803. [PMID: 34206529 DOI: 10.3390/molecules26133803] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 677 |
Mehata S, Parajuli KR, Pant ND, Rayamajhee B, Yadav UN, Mehta RK, Jha P, Mehta N, Dhimal M, Singh DR. Prevalence and correlates of Helicobacter pylori infection among under-five children, adolescent and non-pregnant women in Nepal: Further analysis of Nepal national micronutrient status survey 2016. PLoS Negl Trop Dis 2021;15:e0009510. [PMID: 34153049 DOI: 10.1371/journal.pntd.0009510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 678 |
Rönsch H, Berndt K, Bauer A. Behandlungszufriedenheit bei chronischer Urtikaria unter leitliniengerechter Therapie. J Dtsch Dermatol Ges 2021;19:833-41. [PMID: 34139070 DOI: 10.1111/ddg.14415_g] [Reference Citation Analysis]
|
| 679 |
Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? Front Endocrinol (Lausanne) 2021;12:639856. [PMID: 34220702 DOI: 10.3389/fendo.2021.639856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 680 |
Tang L, Tang B, Lei Y, Yang M, Wang S, Hu S, Xie Z, Liu Y, Vlodavsky I, Yang S. Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis. Front Immunol 2021;12:675747. [PMID: 34220822 DOI: 10.3389/fimmu.2021.675747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 681 |
Wang Y, Guo J, Yu F, Tian Y, Wu Y, Cui L, Liu LE. The association between soy-based food and soy isoflavone intake and the risk of gastric cancer: a systematic review and meta-analysis. J Sci Food Agric 2021;101:5314-24. [PMID: 34032287 DOI: 10.1002/jsfa.11334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 682 |
Xue Z, Yang H, Su D, Song X, Deng X, Yu C, Sun C, He L, You Y, Gong Y, Fan D, Sun L, Han X, Fan R, Zhang M, Yan X, Qian J, Zhang J. Geographic distribution of the cagA, vacA, iceA, oipA and dupA genes of Helicobacter pylori strains isolated in China. Gut Pathog 2021;13:39. [PMID: 34130751 DOI: 10.1186/s13099-021-00434-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 683 |
Pimentel AM, Freitas LAR, Cruz RCR, Silva INN, Andrade LD, Marques PN, Braga JC, Fortes FML, Brito KRM, Fontes JAM, Almeida NP, Surlo VC, Rocha R, Lyra AC, Santana GO. Endoscopic and Histopathological Findings of the Esophagus, Stomach, and Duodenum in Patients with Crohn's Disease from a Reference Center in Bahia, Brazil. Clin Pract 2021;11:374-85. [PMID: 34203639 DOI: 10.3390/clinpract11020052] [Reference Citation Analysis]
|
| 684 |
Wang X, Zhang S, Chua EG, He Y, Li X, Liu A, Chen H, Wise MJ, Marshall BJ, Sun D, Li X, Tay CY. A re-testing range is recommended for 13C- and 14C-urea breath tests for Helicobacter pylori infection in China. Gut Pathog 2021;13:38. [PMID: 34118962 DOI: 10.1186/s13099-021-00435-3] [Reference Citation Analysis]
|
| 685 |
Szwed P, Gąsecka A, Zawadka M, Eyileten C, Postuła M, Mazurek T, Szarpak Ł, Filipiak KJ. Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications. J Clin Med 2021;10:2539. [PMID: 34201137 DOI: 10.3390/jcm10122539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 686 |
Jung HK, Kang SJ, Lee YC, Yang HJ, Park SY, Shin CM, Kim SE, Lim HC, Kim JH, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M; Korean College of Helicobacter and Upper Gastrointesinal Research. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. Korean J Intern Med 2021;36:807-38. [PMID: 34092054 DOI: 10.3904/kjim.2020.701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 687 |
Syam AF, Waskito LA, Rezkitha YAA, Simamora RM, Yusuf F, Danchi KE, Bakry AF, Arnelis, Mulya E, Siregar GA, Sugihartono T, Maulahela H, Doohan D, Miftahussurur M, Yamaoka Y. Helicobacter pylori in the Indonesian Malay's descendants might be imported from other ethnicities. Gut Pathog 2021;13:36. [PMID: 34088343 DOI: 10.1186/s13099-021-00432-6] [Reference Citation Analysis]
|
| 688 |
Huh KY, Chung H, Kim YK, Lee S, Bhatia S, Takanami Y, Nakaya R, Yu KS. Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. Br J Clin Pharmacol 2021. [PMID: 34080718 DOI: 10.1111/bcp.14934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 689 |
Melo J, Pinto V, Fernandes T, Malheiro AR, Osório H, Figueiredo C, Leite M. Isolation Method and Characterization of Outer Membranes Vesicles of Helicobacter pylori Grown in a Chemically Defined Medium. Front Microbiol 2021;12:654193. [PMID: 34149641 DOI: 10.3389/fmicb.2021.654193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 690 |
Santos S. Diagnosis and treatment of Helicobacter pylori infection with gastric ulceration: a case report. Gastrointestinal Nursing 2021;19:34-39. [DOI: 10.12968/gasn.2021.19.5.34] [Reference Citation Analysis]
|
| 691 |
Jung H, Kang SJ, Lee YC, Yang H, Park S, Shin CM, Kim SE, Lim HC, Kim J, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M, Korean College of Helicobacter and Upper Gastrointesinal Research. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. Korean J Med 2021;96:160-189. [DOI: 10.3904/kjm.2021.96.3.160] [Reference Citation Analysis]
|
| 692 |
Khosravi S, Amini R, Arabestani MR, Talebi SS, Jalilian FA. Isolation of a lytic bacteriophage for Helicobacter pylori. Gene Reports 2021;23:101107. [DOI: 10.1016/j.genrep.2021.101107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 693 |
Doe MJ, Bua E, Obbo JS, Bisso F, Olupot-Olupot P. Upper gastrointestinal endoscopy findings in Mbale Regional Referral Hospital, Eastern Uganda: a 10-year retrospective analysis. Afr Health Sci 2021;21:919-26. [PMID: 34795752 DOI: 10.4314/ahs.v21i2.54] [Reference Citation Analysis]
|
| 694 |
Xie W, Zhao W, Zou Z, Kong L, Yang L. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice. Helicobacter 2021;26:e12807. [PMID: 33847026 DOI: 10.1111/hel.12807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 695 |
Afra LG, Afkhami H, Khaledi M, Fathi J, Taghadosi R, Hoseini MHM, Afra MG, Heidari M. Detection of H. pylori in tissues with benign prostatic hyperplasia isolates from hospitalized patient in Qom, Iran. Gene Reports 2021;23:101193. [DOI: 10.1016/j.genrep.2021.101193] [Reference Citation Analysis]
|
| 696 |
Cho J, Prashar A, Jones NL, Moss SF. Helicobacter pylori Infection. Gastroenterol Clin North Am 2021;50:261-82. [PMID: 34024441 DOI: 10.1016/j.gtc.2021.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 697 |
Schubert JP, Gehlert J, Rayner CK, Roberts-Thomson IC, Costello S, Mangoni AA, Bryant RV. Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36:1450-6. [PMID: 33217029 DOI: 10.1111/jgh.15352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 698 |
Wu T, Wu L. The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer. Front Oncol 2021;11:655630. [PMID: 34136392 DOI: 10.3389/fonc.2021.655630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 699 |
Zhang Y, Feng XY, Li GQ, Xu F, Liu F, Li YY, Deng B. Epidemiological study of Helicobacter pylori infection and its relationship with pathologic changes of the antral mucosa in rural areas of Yangzhou. Shijie Huaren Xiaohua Zazhi 2021; 29(10): 550-556 [DOI: 10.11569/wcjd.v29.i10.550] [Reference Citation Analysis]
|
| 700 |
Lee JW, Kim SJ, Choi CW, Kim HJ, Kang DH, Kim HW, Park SB, Nam HS, Ryu DG. Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation. Medicine (Baltimore) 2021;100:e26133. [PMID: 34032763 DOI: 10.1097/MD.0000000000026133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 701 |
Padda J, Khalid K, Cooper AC, Jean-Charles G. Association Between Helicobacter pylori and Gastric Carcinoma. Cureus 2021;13:e15165. [PMID: 34168929 DOI: 10.7759/cureus.15165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 702 |
Gong M, Han Y, Wang X, Tao H, Meng F, Hou B, Sun BB, Wang G. Effect of Temperature on Metronidazole Resistance in Helicobacter pylori. Front Microbiol 2021;12:681911. [PMID: 34093508 DOI: 10.3389/fmicb.2021.681911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 703 |
Lee HL. Can Helicobacter pylori eradication affect long-term mortality? Korean J Intern Med 2021;36:539-40. [PMID: 34000761 DOI: 10.3904/kjim.2021.190] [Reference Citation Analysis]
|
| 704 |
Khatiwada AP, Shrestha S, Ozaki A, Shrestha R, Kc B. Self-medication and masking of early cancer symptoms: is there a role for pharmacist? Res Social Adm Pharm 2021;17:1858-9. [PMID: 34052104 DOI: 10.1016/j.sapharm.2021.05.008] [Reference Citation Analysis]
|
| 705 |
Li R, Zhang P, Hu Z, Yi Y, Chen L, Zhang H. Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25949. [PMID: 34106668 DOI: 10.1097/MD.0000000000025949] [Reference Citation Analysis]
|
| 706 |
Cho JH, Jeon SR, Jin SY, Park S. Standard vs magnifying narrow-band imaging endoscopy for diagnosis of Helicobacter pylori infection and gastric precancerous conditions. World J Gastroenterol 2021; 27(18): 2238-2250 [PMID: 34025076 DOI: 10.3748/wjg.v27.i18.2238] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 707 |
Vishnu P, Duncan J, Connell N, Cooper N, Lim W, Rodeghiero F, Tomiyama Y, Grace RF, Bakchoul T, Arnold DM; Platelet Immunology Scientific, Standardization Committee. International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee. J Thromb Haemost 2021;19:287-96. [PMID: 33070448 DOI: 10.1111/jth.15136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 708 |
Cui R, Song Z, Suo B, Tian X, Xue Y, Meng L, Niu Z, Jin Z, Zhang H, Zhou L. Correlation Analysis Among Genotype Resistance, Phenotype Resistance and Eradication Effect of Helicobacter pylori. Infect Drug Resist 2021;14:1747-56. [PMID: 34012273 DOI: 10.2147/IDR.S305996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 709 |
Chavez L, Mayrovitz HN. Assessing the Impact of Helicobacter pylori Infection and Inflammatory Bowel Disease on Pulse Wave Velocity and Arterial Stiffness. Cureus 2021;13:e14944. [PMID: 34123641 DOI: 10.7759/cureus.14944] [Reference Citation Analysis]
|
| 710 |
Boylan KE, Patrey S, McMullen PD, Tesic V, Weber CR, Hart J, Setia N. Objective Visual Analog Scale for Biopsy Diagnosis of Helicobacter pylori Infection in Clinical Practice. Am J Surg Pathol 2021;45:672-9. [PMID: 33534221 DOI: 10.1097/PAS.0000000000001681] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 711 |
Schmid MB, Brandt S, Bannwart F, Soldini D, Noske A. Giardia lamblia and Helicobacter pylori coinfection in gastrointestinal biopsies: A retrospective single-center analysis from Switzerland. Ann Diagn Pathol 2021;53:151756. [PMID: 33989960 DOI: 10.1016/j.anndiagpath.2021.151756] [Reference Citation Analysis]
|
| 712 |
Ramírez-Lázaro MJ, Lario S, Quílez ME, Montserrat A, Bella MR, Junquera F, García-Martínez L, Casalots À, Parra T, Calvet X. Droplet Digital PCR Detects Low-Density Infection in a Significant Proportion of Helicobacter Pylori-Negative Gastric Biopsies of Dyspeptic Patients. Clin Transl Gastroenterol 2020;11:e00184. [PMID: 32568476 DOI: 10.14309/ctg.0000000000000184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 713 |
Nelson A, Bi Y, Harris D. Helicobacter Pylori: a comprehensive review for primary care providers. Rom J Intern Med 2021;59:112-8. [PMID: 33565305 DOI: 10.2478/rjim-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 714 |
Ye SF, Zhang JM, Dai F, Lan CJ, Zhang XJ, Zhou LZ, Tang QQ, Meng F. Investigation of mutation of multidrug resistant Helicobacter pylori efflux pump gene based on whole genome sequencing. Shijie Huaren Xiaohua Zazhi 2021; 29(9): 455-460 [DOI: 10.11569/wcjd.v29.i9.455] [Reference Citation Analysis]
|
| 715 |
Hafeez M, Qureshi ZA, Khattak AL, Saeed F, Asghar A, Azam K, Khan MA. Helicobacter Pylori Eradication Therapy: Still a Challenge. Cureus 2021;13:e14872. [PMID: 34113506 DOI: 10.7759/cureus.14872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 716 |
Rönsch H, Berndt K, Bauer A. Treatment satisfaction in chronic urticaria during guideline-based therapy. J Dtsch Dermatol Ges 2021;19:833-40. [PMID: 33931937 DOI: 10.1111/ddg.14415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 717 |
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin 2021;71:209-249. [DOI: 10.3322/caac.21660] [Cited by in Crossref: 25703] [Article Influence: 12851.5] [Reference Citation Analysis]
|
| 718 |
González MF, Díaz P, Sandoval-Bórquez A, Herrera D, Quest AFG. Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development. Int J Mol Sci 2021;22:4823. [PMID: 34062919 DOI: 10.3390/ijms22094823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 719 |
Mahant S, Mehra S, Chhawchharia A, Karmakar BC, Paul S, Mukhopadhyay AK, Bose S, Das K, Das R. Prevalence of tumor necrosis factor alpha inducing protein (tipα) gene of Helicobacter pylori and its association with upper gastrointestinal diseases in India. 3 Biotech 2021;11:246. [PMID: 33968589 DOI: 10.1007/s13205-021-02804-w] [Reference Citation Analysis]
|
| 720 |
Hackett RJ, Preston SL. H.pylori infection, part I: clinical burden and diagnosis. Trends Urology & Men Health 2021;12:13-19. [DOI: 10.1002/tre.801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 721 |
Jung SJ, Shim SR, Kim BJ, Jung JM. Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. Ann Transl Med 2021;9:753. [PMID: 34268366 DOI: 10.21037/atm-20-7951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 722 |
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin 2021;71:209-249. [DOI: 10.3322/caac.21660] [Cited by in Crossref: 25703] [Article Influence: 12851.5] [Reference Citation Analysis]
|
| 723 |
Gravina AG, Priadko K, Granata L, Facchiano A, Scidà G, Cerbone R, Ciamarra P, Romano M. Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study. Front Pharmacol 2021;12:667584. [PMID: 33995097 DOI: 10.3389/fphar.2021.667584] [Reference Citation Analysis]
|
| 724 |
Mao X, Jakubovics NS, Bächle M, Buchalla W, Hiller KA, Maisch T, Hellwig E, Kirschneck C, Gessner A, Al-Ahmad A, Cieplik F. Colonization of Helicobacter pylori in the oral cavity - an endless controversy? Crit Rev Microbiol 2021;47:612-29. [PMID: 33899666 DOI: 10.1080/1040841X.2021.1907740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 725 |
Keough DT, Wun SJ, Baszczyňski O, Eng WS, Špaček P, Panjikar S, Naesens L, Pohl R, Rejman D, Hocková D, Ferrero RL, Guddat LW. Helicobacter pylori Xanthine-Guanine-Hypoxanthine Phosphoribosyltransferase-A Putative Target for Drug Discovery against Gastrointestinal Tract Infections. J Med Chem 2021;64:5710-29. [PMID: 33891818 DOI: 10.1021/acs.jmedchem.0c02184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 726 |
Marrero Rolon R, Cunningham SA, Mandrekar JN, Polo ET, Patel R. Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool. J Clin Microbiol 2021;59:e03040-20. [PMID: 33536295 DOI: 10.1128/JCM.03040-20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 727 |
Gao Y, Gupta N, Abdalla M. Recurrent Aphthous Stomatitis Improved after Eradication Therapy for Helicobacter pylori. Case Rep Gastrointest Med 2021;2021:5543838. [PMID: 33859848 DOI: 10.1155/2021/5543838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 728 |
Polyzos SA, Papaefthymiou A, Doulberis M, Mavridoglou G, Kountouras J. Helicobacter pylori infection and diabetes mellitus. Diabetes Metab Syndr 2021;15:845-6. [PMID: 33873053 DOI: 10.1016/j.dsx.2021.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 729 |
Tokunaga K, Suzuki C, Hasegawa M, Fujimori I. Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan. Clinicoecon Outcomes Res 2021;13:241-50. [PMID: 33889000 DOI: 10.2147/CEOR.S297680] [Reference Citation Analysis]
|
| 730 |
Kocsmár É, Buzás GM, Szirtes I, Kocsmár I, Kramer Z, Szijártó A, Fadgyas-Freyler P, Szénás K, Rugge M, Fassan M, Kiss A, Schaff Z, Röst G, Lotz G. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides. Nat Commun 2021;12:2255. [PMID: 33859206 DOI: 10.1038/s41467-021-22557-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 731 |
Hamdi Y, Abdeljaoued-Tej I, Zatchi AA, Abdelhak S, Boubaker S, Brown JS, Benkahla A. Cancer in Africa: The Untold Story. Front Oncol 2021;11:650117. [PMID: 33937056 DOI: 10.3389/fonc.2021.650117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 732 |
Di Palma A, Alhabdan S, Maeda A, Chetty R, Serra S, Quereshy F, Jackson T, Okrainec A. Preoperative Helicobacter pylori Screening and Treatment in Patients Undergoing Laparoscopic Sleeve Gastrectomy. Obes Surg 2020;30:2816-20. [PMID: 32030613 DOI: 10.1007/s11695-020-04436-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 733 |
Johnson KS, Elgamoudi B, Jen FE, Day C, Sweeney EG, Pryce ML, Guillemin K, Haselhorst T, Korolik V, Ottemann KM. The immunomodulatory dCache chemoreceptor TlpA of Helicobacter pylori binds multiple attractant and antagonistic ligands via distinct sites.. [DOI: 10.1101/2021.04.07.438267] [Reference Citation Analysis]
|
| 734 |
Abdulova MS, Igonina NA, Torshina IG, Chashchikhina EV, Kondrasheva EA, Gasilova NA, Lipilina PA, Nasonenko IV, Aksenova AV, Doludenko II. Evaluation of the estimated population prevalence of Helicobacter pylori infection and the frequency of achieving eradication after treatment based on the results of the 13C-urease breath test in individuals who applied to the federal network of the INVITRO laboratory (2019-2020, n=42,843). jour 2021. [DOI: 10.31146/1682-8658-ecg-186-2-47-51] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 735 |
Li J, Fan M, Ma F, Zhang S, Li Q. The effects of Helicobacter pylori infection on pregnancy-related diseases and fetal development in diabetes in pregnancy. Ann Transl Med 2021;9:686. [PMID: 33987384 DOI: 10.21037/atm-21-1209] [Reference Citation Analysis]
|
| 736 |
Hu Y, Ouyang Y, Zhu Y, Lu NH. Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. Helicobacter 2021;26:e12784. [PMID: 33534148 DOI: 10.1111/hel.12784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 737 |
Shah SC, Iyer PG, Moss SF. AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review. Gastroenterology 2021;160:1831-41. [PMID: 33524402 DOI: 10.1053/j.gastro.2020.11.059] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 738 |
Gersten O, Barbieri M. Evaluation of the Cancer Transition Theory in the US, Select European Nations, and Japan by Investigating Mortality of Infectious- and Noninfectious-Related Cancers, 1950-2018. JAMA Netw Open 2021;4:e215322. [PMID: 33843999 DOI: 10.1001/jamanetworkopen.2021.5322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 739 |
Kapadia S, Kaji AH, Hari DM, Ozao-Choy J, Chen KT. Helicobacter pylori and Gallstone Disease: Incidence and Outcomes in a Los Angeles County Population. J Gastrointest Surg 2021;25:887-9. [PMID: 33620634 DOI: 10.1007/s11605-021-04918-1] [Reference Citation Analysis]
|
| 740 |
Oh JH, Kwon JG, Jung H, Tae CH, Song KH, Kang SJ, Kim SE, Jung K, Kim JS, Park JK, Bang KB, Shin JE, Baeg MK, Shin CM, Lee JY, Lim HC; Functional Dyspepsia Research Group and Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for the Treatment of Functional Dyspepsia in Korea. Korean J Med 2021;96:116-38. [DOI: 10.3904/kjm.2021.96.2.116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 741 |
Domanovich-Asor T, Craddock HA, Motro Y, Khalfin B, Peretz A, Moran-Gilad J. Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny. Helicobacter 2021;26:e12782. [PMID: 33491828 DOI: 10.1111/hel.12782] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 742 |
Chautard R, Malka D, Samaha E, Tougeron D, Barbereau D, Caron O, Rahmi G, Barrioz T, Cellier C, Feau S, Lecomte T. Upper Gastrointestinal Lesions during Endoscopy Surveillance in Patients with Lynch Syndrome: A Multicentre Cohort Study. Cancers (Basel) 2021;13:1657. [PMID: 33916129 DOI: 10.3390/cancers13071657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 743 |
Muñoz AB, Trespalacios-Rangel AA, Vale FF. An American lineage of Helicobacter pylori prophages found in Colombia. Helicobacter 2021;26:e12779. [PMID: 33400833 DOI: 10.1111/hel.12779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 744 |
Axelrad JE, Cadwell KH, Colombel JF, Shah SC. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Therap Adv Gastroenterol 2021;14:17562848211004493. [PMID: 33868457 DOI: 10.1177/17562848211004493] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 745 |
Pezeshki SMS, Saki N, Ghandali MV, Ekrami A, Avarvand AY. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res 2021;56:38-43. [PMID: 33707351 DOI: 10.5045/br.2021.2020189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 746 |
Zhou X, Roujeinikova A. The Structure, Composition, and Role of Periplasmic Stator Scaffolds in Polar Bacterial Flagellar Motors. Front Microbiol 2021;12:639490. [PMID: 33776972 DOI: 10.3389/fmicb.2021.639490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 747 |
Tagoe EA, Awandare GA, Quaye O, Asmah RH, Archampong TN, Osman MA, Brown CA. Helicobacter Pylori Variants with ABC-Type Tyrosine Phosphorylation Motif in Gastric Biopsies of Ghanaian Patients. Biomed Res Int 2021;2021:6616059. [PMID: 33860041 DOI: 10.1155/2021/6616059] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 748 |
Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 749 |
Fitzgerald R, Smith SM. An Overview of Helicobacter pylori Infection. In: Smith SM, editor. Helicobacter Pylori. New York: Springer US; 2021. pp. 1-14. [DOI: 10.1007/978-1-0716-1302-3_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 750 |
Saito H, Nishikawa Y, Masuzawa Y, Tsubokura M, Mizuno Y. Helicobacter pylori Infection Mass Screening for Children and Adolescents: a Systematic Review of Observational Studies. J Gastrointest Cancer 2021;52:489-97. [PMID: 33761050 DOI: 10.1007/s12029-021-00630-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 751 |
Lu H, Han X, Ren J, Ren K, Li Z, Zhang Q. Metformin attenuates synergic effect of diabetes mellitus and Helicobacter pylori infection on gastric cancer cells proliferation by suppressing PTEN expression. J Cell Mol Med 2021;25:4534-42. [PMID: 33760349 DOI: 10.1111/jcmm.15967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 752 |
Tummanapalli SS, Willcox MD. Antimicrobial resistance of ocular microbes and the role of antimicrobial peptides. Clin Exp Optom 2021;104:295-307. [PMID: 32924208 DOI: 10.1111/cxo.13125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 753 |
Sánchez-Alonzo K, Belmar L, Parra-Sepúlveda C, Bernasconi H, Campos VL, Smith CT, Sáez K, García-Cancino A. Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans ATCC10231. Pathogens 2021;10:382. [PMID: 33806815 DOI: 10.3390/pathogens10030382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 754 |
Zhou Y, Chen S, Yang F, Zhang Y, Xiong L, Zhao J, Huang L, Chen P, Ren L, Li H, Liang D, Wu P, Chen H, Chen J, Gong S, Xu W, Geng L. Rabeprazole suppresses cell proliferation in gastric epithelial cells by targeting STAT3-mediated glycolysis. Biochem Pharmacol 2021;188:114525. [PMID: 33744226 DOI: 10.1016/j.bcp.2021.114525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 755 |
Lee SR, Kwon S, Choi EK, Jung JH, Han KD, Oh S, Lip GYH. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding. Cardiovasc Drugs Ther 2021. [PMID: 33730289 DOI: 10.1007/s10557-021-07170-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 756 |
Loh JT, Shum MV, Jossart SDR, Campbell AM, Sawhney N, McDonald WH, Scholz MB, McClain MS, Forsyth MH, Cover TL. Delineation of the pH-Responsive Regulon Controlled by the Helicobacter pylori ArsRS Two-Component System. Infect Immun 2021;89:e00597-20. [PMID: 33526561 DOI: 10.1128/IAI.00597-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 757 |
Jung HK, Kang SJ, Lee YC, Yang HJ, Park SY, Shin CM, Kim SE, Lim HC, Kim JH, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M; Korean College of Helicobacter and Upper Gastrointestinal Research. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020. Gut Liver. 2021;15:168-195. [PMID: 33468712 DOI: 10.5009/gnl20288] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 758 |
Yang J, Zhou X, Liu X, Ling Z, Ji F. Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment. Front Microbiol 2021;12:641322. [PMID: 33790881 DOI: 10.3389/fmicb.2021.641322] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 759 |
Im BN, Shin H, Lim B, Lee J, Kim KS, Park JM, Na K. Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy. Biomaterials 2021;271:120745. [PMID: 33740616 DOI: 10.1016/j.biomaterials.2021.120745] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 760 |
Bae S, Lim JW, Kim H. β-Carotene Inhibits Expression of Matrix Metalloproteinase-10 and Invasion in Helicobacter pylori-Infected Gastric Epithelial Cells. Molecules 2021;26:1567. [PMID: 33809289 DOI: 10.3390/molecules26061567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 761 |
Ding ZH, Xu XP, Wang TR, Liang X, Ran ZH, Lu H. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study. PLoS One 2021;16:e0248427. [PMID: 33711050 DOI: 10.1371/journal.pone.0248427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 762 |
Kang SJ, Jung H, Lee YC, Yang H, Park S, Shin CM, Kim SE, Lim HC, Kim J, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M; Korean College of Helicobacter and Upper Gastrointesinal Research. Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis. Korean J Helicobacter Up Gastrointest Res 2021;21:35-47. [DOI: 10.7704/kjhugr.2020.0056] [Reference Citation Analysis]
|
| 763 |
Kim L, Choe JC, Ahn JH, Lee HW, Oh JH, Choi JH, Lee HC, Cha KS, Hong TJ, Jeong YH, Park JS. Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial. J Clin Med 2021;10:1159. [PMID: 33802015 DOI: 10.3390/jcm10061159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 764 |
Kim SE, Jung H, Kang SJ, Lee YC, Yang H, Park S, Shin CM, Lim HC, Kim J, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M, Korean College of Helicobacter and Upper Gastrointesinal Research. A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis. Korean J Helicobacter Up Gastrointest Res 2021;21:48-58. [DOI: 10.7704/kjhugr.2020.0052] [Reference Citation Analysis]
|
| 765 |
Jonaityte IR, Ciupkeviciene E, Jonaitis P, Kupcinskas J, Petkeviciene J, Jonaitis L. Changes in the Seroprevalence of Helicobacter pylori among the Lithuanian Medical Students over the Last 25 Years and Its Relation to Dyspeptic Symptoms. Medicina (Kaunas) 2021;57:254. [PMID: 33803389 DOI: 10.3390/medicina57030254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 766 |
Portillo Miño JD, Araujo Prado LM, Melo Yepes JM, Carlosama Rosero YH. Características sociodemográficas e histopatológicas en pacientes con cáncer gástrico en una población con alto riesgo en Colombia. Rev colomb Gastroenterol 2021;36:18-23. [DOI: 10.22516/25007440.544] [Reference Citation Analysis]
|
| 767 |
Wu F, Chen C, Peng F. Potential Association Between Asthma, Helicobacter pylori Infection, and Gastric Cancer. Front Oncol 2021;11:630235. [PMID: 33763365 DOI: 10.3389/fonc.2021.630235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 768 |
Mao FY, Lv YP, Hao CJ, Teng YS, Liu YG, Cheng P, Yang SM, Chen W, Liu T, Zou QM, Xie R, Xu JY, Zhuang Y. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol 2021;12:395-425. [PMID: 33676046 DOI: 10.1016/j.jcmgh.2021.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 769 |
Scarpignato C, Hunt RH. Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers. Curr Treat Options Gastro 2021;19:94-132. [DOI: 10.1007/s11938-020-00330-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 770 |
Sallah N, Hayes A, Osei-tutu N, Butt J, Johnston WT, Asiki G, Waterboer T, Hibberd ML, Newton R. Antibody response patterns to Helicobacter pylori infection in a rural Ugandan population cohort.. [DOI: 10.1101/2021.03.01.433355] [Reference Citation Analysis]
|
| 771 |
Gobert AP, Boutaud O, Asim M, Zagol-Ikapitte IA, Delgado AG, Latour YL, Finley JL, Singh K, Verriere TG, Allaman MM, Barry DP, McNamara KM, Sierra JC, Amarnath V, Tantawy MN, Bimczok D, Piazuelo MB, Washington MK, Zhao S, Coburn LA, Wilson KT. Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis. Gastroenterology 2021;160:1256-1268.e9. [PMID: 33189701 DOI: 10.1053/j.gastro.2020.11.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 772 |
Yang K, Lu L, Liu H, Wang X, Gao Y, Yang L, Li Y, Su M, Jin M, Khan S. A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors. Expert Rev Gastroenterol Hepatol 2021;15:255-73. [PMID: 33121300 DOI: 10.1080/17474124.2021.1845140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 773 |
Zhang T, Chen H, Yin X, He Q, Man J, Yang X, Lu M. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study. Chin J Cancer Res 2021;33:11-26. [PMID: 33707924 DOI: 10.21147/j.issn.1000-9604.2021.01.02] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 774 |
Gholinia N, Shafikhani AA, Hajiaghamohammadi A. Comparing Regimens Based on Clarithromycin, Furazolidone, and Levofloxacin in Patients With Helicobacter Pylori Infection: A Clinical Trial. Int J Enteric Pathog 2021;9:15-20. [DOI: 10.34172/ijep.2021.04] [Reference Citation Analysis]
|
| 775 |
Ahmed AS, Al-Najjar AH, Alshalahi H, Altowayan WM, Elgharabawy RM. Clinical Significance of Helicobacter pylori Infection on Psoriasis Severity. J Interferon Cytokine Res 2021;41:44-51. [PMID: 33621131 DOI: 10.1089/jir.2020.0144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 776 |
Khani D, Hedayati MA, Nasseri S, Sheikhesmaeili F, Ghadiany R. ZAK Gene Expression in Patients with Helicobacter pylori Infection. J Gastrointest Cancer 2021. [PMID: 33620708 DOI: 10.1007/s12029-021-00611-3] [Reference Citation Analysis]
|
| 777 |
Haile K, Timerga A. Evaluation of Hematological Parameters of Helicobacter pylori-Infected Adult Patients at Southern Ethiopia: A Comparative Cross-Sectional Study. J Blood Med 2021;12:77-84. [PMID: 33654446 DOI: 10.2147/JBM.S294958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 778 |
Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? . World J Gastroenterol 2021; 27(7): 545-560 [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 779 |
Kang S, Kim Y, Ahn JY, Jung HY, Kim N, Na HK, Lee JH, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting. Antibiotics (Basel) 2021;10:214. [PMID: 33669969 DOI: 10.3390/antibiotics10020214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 780 |
Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? World J Gastroenterol 2021;27:545-60. [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Reference Citation Analysis]
|
| 781 |
Nakase K, Nakanishi-Yamasaki M, Harada K, Koizumi J, Yamada T, Ikoshi H, Nakaminami H, Noguchi N. Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori. J Infect Chemother 2021;27:957-61. [PMID: 33602640 DOI: 10.1016/j.jiac.2021.02.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 782 |
Park JY, Herrero R. Recent progress in gastric cancer prevention. Best Pract Res Clin Gastroenterol 2021;50-51:101733. [PMID: 33975687 DOI: 10.1016/j.bpg.2021.101733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 783 |
Luo P, Huang Y, Hang X, Tong Q, Zeng L, Jia J, Zhang G, Bi H. Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo. Antimicrob Agents Chemother 2021;65:e01921-20. [PMID: 33318002 DOI: 10.1128/AAC.01921-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 784 |
Mi M, Wu F, Zhu J, Liu F, Cui G, Wen X, Hu Y, Deng Z, Wu X, Zhang Z, Qi T, Chen Z. Heterogeneity of Helicobacter pylori Strains Isolated from Patients with Gastric Disorders in Guiyang, China. Infect Drug Resist 2021;14:535-45. [PMID: 33603417 DOI: 10.2147/IDR.S287631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 785 |
Camorlinga-Ponce M, Gómez-Delgado A, Aguilar-Zamora E, Torres RC, Giono-Cerezo S, Escobar-Ogaz A, Torres J. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México. Front Cell Infect Microbiol 2020;10:539115. [PMID: 33643927 DOI: 10.3389/fcimb.2020.539115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 786 |
Nyssen OP, Perez-Aisa A, Castro-Fernandez M, Pellicano R, Huguet JM, Rodrigo L, Ortuñ J, O, Gomez-Rodriguez BJ, Pinto RM, Areia M, Perona M, Nuñez O, Romano M, Gravina AG, Pozzati L, Fernandez-Bermejo M, Venerito M, Malfertheiner P, Fernanadez-Salazar L, Gasbarrini A, Vaira D, Puig I, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg investigators. European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice. United European Gastroenterol J 2021;9:38-46. [PMID: 33176617 DOI: 10.1177/2050640620972615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 787 |
Molaoa SZ. Prevalence of Helicobacter pylori infection and the incidence of the associated malignant and peptic ulcer disease (PUD) at Nelson Mandela Academic Hospital: a retrospective analysis. J Drug Assess 2021;10:57-61. [PMID: 34104536 DOI: 10.1080/21556660.2020.1854560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 788 |
Piscione M, Mazzone M, Di Marcantonio MC, Muraro R, Mincione G. Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship. Front Microbiol 2021;12:630852. [PMID: 33613500 DOI: 10.3389/fmicb.2021.630852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 789 |
Dey U, Sarkar S, Teronpi V, Yella VR, Kumar A. G-quadruplex motifs are functionally conserved in cis-regulatory regions of pathogenic bacteria: An in-silico evaluation. Biochimie 2021;184:40-51. [PMID: 33548392 DOI: 10.1016/j.biochi.2021.01.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 790 |
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-249. [PMID: 33538338 DOI: 10.3322/caac.21660] [Cited by in Crossref: 16539] [Cited by in F6Publishing: 19062] [Article Influence: 8269.5] [Reference Citation Analysis]
|
| 791 |
Nyholm D, Hellström PM. Effects of Helicobacter pylori on Levodopa Pharmacokinetics. J Parkinsons Dis 2021;11:61-9. [PMID: 33164946 DOI: 10.3233/JPD-202298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 792 |
Qumar S, Nguyen TH, Nahar S, Sarker N, Baker S, Bulach D, Ahmed N, Rahman M. A comparative whole genome analysis of Helicobacter pylori from a human dense South Asian setting. Helicobacter 2021;26:e12766. [PMID: 33073485 DOI: 10.1111/hel.12766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 793 |
Ke H, Li J, Lu B, Yang C, Wang J, Wang Z, Liu L, Chen Y. The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy. Helicobacter 2021;26:e12768. [PMID: 33089598 DOI: 10.1111/hel.12768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 794 |
Banga Ndzouboukou JL, Lei Q, Ullah N, Zhang Y, Hao L, Fan X. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori. Helicobacter 2021;26:e12758. [PMID: 33259676 DOI: 10.1111/hel.12758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 795 |
Li H, Xia XJ, Zhang LF, Chi JS, Liu P, Wu H, Xie XR, Tian DL, Kun KX, Gong RJ, Liu XM, Xu CX. Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study. Eur J Gastroenterol Hepatol 2021;32:194-200. [PMID: 32804837 DOI: 10.1097/MEG.0000000000001896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 796 |
Mežmale L, Polaka I, Rudzite D, Vangravs R, Kikuste I, Parshutin S, Daugule I, Tazhedinov A, Belikhina T, Igissinov N, Park JY, Herrero R, Leja M. Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan. Asian Pac J Cancer Prev 2021;22:597-602. [PMID: 33639679 DOI: 10.31557/APJCP.2021.22.2.597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 797 |
Kumar S, Metz DC, Kaplan DE, Goldberg DS. Low Rates of Retesting for Eradication of Helicobacter pylori Infection After Treatment in the Veterans Health Administration. Clin Gastroenterol Hepatol 2021;19:305-313.e1. [PMID: 32272245 DOI: 10.1016/j.cgh.2020.03.059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 798 |
Yuan C, Lin XM, Ou Y, Cheng Q, Cai L, Zhou P, Liao J. Gastric foveolar elongation causes invisibility of regular arrangement of collecting venules in chronic active and inactive gastritis. Helicobacter 2021;26:e12770. [PMID: 33185317 DOI: 10.1111/hel.12770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 799 |
Sharara AI. Confirmatory Testing for Eradication of Helicobacter pylori: Challenges and Opportunities. Clin Gastroenterol Hepatol 2021;19:232-4. [PMID: 32492481 DOI: 10.1016/j.cgh.2020.05.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 800 |
Guo H, Lam AY, Shaheen AA, Forbes N, Kaplan GG, Andrews CN, Laffin M, Singh S, Jairath V, Teriaky A, Lee JK, Ma C. Urban-Rural Disparities and Temporal Trends in Peptic Ulcer Disease Epidemiology, Treatment, and Outcomes in the United States. Am J Gastroenterol 2021;116:296-305. [PMID: 33105195 DOI: 10.14309/ajg.0000000000000997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 801 |
Arévalo-Galvis A, Otero-Regino WA, Ovalle-Celis GN, Rodríguez-Gómez ER, Trespalacios-Rangel AA. Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PLoS One 2021;16:e0245401. [PMID: 33503046 DOI: 10.1371/journal.pone.0245401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 802 |
Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, Peek RM Jr, Zaika AI. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Invest 2020;130:2422-34. [PMID: 32250340 DOI: 10.1172/JCI130015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 803 |
Cavadas B, Leite M, Pedro N, Magalhães AC, Melo J, Correia M, Máximo V, Camacho R, Fonseca NA, Figueiredo C, Pereira L. Shedding Light on the African Enigma: In Vitro Testing of Homo sapiens-Helicobacter pylori Coevolution. Microorganisms 2021;9:240. [PMID: 33503840 DOI: 10.3390/microorganisms9020240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 804 |
Rakha M, Saleh O, Abdelgawad MS, El Baiomy A. Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-020-00071-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 805 |
Zhao M, Jiang Y, Chen Z, Fan Z, Jiang Y. Traditional Chinese medicine for Helicobacter pylori infection: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24282. [PMID: 33546052 DOI: 10.1097/MD.0000000000024282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 806 |
Sáenz JB, Mills JC. Helicobacter pylori: preying on SIVA for survival in the stomach. J Clin Invest 2020;130:2183-5. [PMID: 32250343 DOI: 10.1172/JCI135508] [Reference Citation Analysis]
|
| 807 |
Li B, Cheung KS, Wong IY, Leung WK, Law S. Nonaspirin nonsteroidal anti-inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory-wide study. Cancer 2021;127:1805-15. [PMID: 33471380 DOI: 10.1002/cncr.33412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 808 |
Ghosh P, Bhakta S, Bhattacharya M, Sharma AR, Sharma G, Lee SS, Chakraborty C. A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics. Int J Pept Res Ther 2021;:1-18. [PMID: 33495694 DOI: 10.1007/s10989-020-10157-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 809 |
Gad H, Al-Sayed E, Ayoub I. Phytochemical discrimination of Pinus species based on GC-MS and ATR-IR analyses and their impact on Helicobacter pylori. Phytochem Anal 2021;32:820-35. [PMID: 33462938 DOI: 10.1002/pca.3028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 810 |
Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet 2021;397:233-48. [PMID: 33285139 DOI: 10.1016/S0140-6736(20)32594-0] [Cited by in Crossref: 196] [Cited by in F6Publishing: 98] [Article Influence: 98.0] [Reference Citation Analysis]
|
| 811 |
Xue K, Liu Y, Iversen KN, Mazidi M, Qu Z, Dong C, Jin T, Hallmans G, Åman P, Johansson A, He G, Landberg R. Impact of a Fermented High-Fiber Rye Diet on Helicobacter pylori and Cardio-Metabolic Risk Factors: A Randomized Controlled Trial Among Helicobacter pylori-Positive Chinese Adults. Front Nutr 2020;7:608623. [PMID: 33521037 DOI: 10.3389/fnut.2020.608623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 812 |
Ngnameko CR, Noubiap JJ, Simo Nemg FB, Galdima MA, Takuissu-nguemto GR, Ngo-boumso S, Njayou FN, Moundipa PF, Bigna JJ. Epidemiology and antibiotic resistance profile of Helicobacter pylori infection in Cameroon: a systematic review with meta-analysis.. [DOI: 10.1101/2021.01.13.21249766] [Reference Citation Analysis]
|
| 813 |
Cunha ES, Chen X, Sanz-Gaitero M, Mills DJ, Luecke H. Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 Å resolution. Nat Commun 2021;12:230. [PMID: 33431861 DOI: 10.1038/s41467-020-20485-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 814 |
Iijima K. Remaining Clinical Issues on <i>H. Pylori</i> Infection. J Jpn Soc Intern Med 2021;110:7-9. [DOI: 10.2169/naika.110.7] [Reference Citation Analysis]
|
| 815 |
Gallardo Padilla M, León Falconi JL, Sánchez-Nebreda Arias R, Gómez Santos C, Muñoz Egea MDC, la Orden Izquierdo E. [Impact of the use of molecular techniques (PCR) on detection and eradication success against Helicobacter pylori]. An Pediatr (Engl Ed) 2021:S1695-4033(20)30502-6. [PMID: 33431330 DOI: 10.1016/j.anpedi.2020.11.016] [Reference Citation Analysis]
|
| 816 |
Deng W, Jin L, Zhuo H, Vasiliou V, Zhang Y. Alcohol consumption and risk of stomach cancer: A meta-analysis. Chem Biol Interact 2021;336:109365. [PMID: 33412155 DOI: 10.1016/j.cbi.2021.109365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 817 |
Courtois S, Haykal M, Bodineau C, Sifré E, Azzi-Martin L, Ménard A, Mégraud F, Lehours P, Durán RV, Varon C, Bessède E. Autophagy induced by Helicobacter pylori infection is necessary for gastric cancer stem cell emergence. Gastric Cancer 2021;24:133-44. [PMID: 32940810 DOI: 10.1007/s10120-020-01118-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 818 |
El Gui R, Hechlaf H, Ed-day S, Akhouayri O, Boulbaroud S, Azzaoui F. Histo-epidemiological aspect of Helicobacter pylori chronic gastritis in a Moroccan population. E3S Web Conf 2021;319:01027. [DOI: 10.1051/e3sconf/202131901027] [Reference Citation Analysis]
|
| 819 |
Koulis A, Busuttil RA, Boussioutas A. Premalignant lesions of the stomach and management of early neoplastic lesions. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00013-7] [Reference Citation Analysis]
|
| 820 |
Jemilohun A, Ajani M, Solaja T, Uka A. Helicobacter pylori-associated gastritis phenotypes in a South-Western Nigerian population. Niger J Gastroenterol Hepatol 2021;13:6. [DOI: 10.4103/njgh.njgh_21_20] [Reference Citation Analysis]
|
| 821 |
Scherbakova I, Chen RWS, Marcus DM, Rustgi A. Gastrointestinal and Nutritional Disorders. Albert and Jakobiec's Principles and Practice of Ophthalmology 2021. [DOI: 10.1007/978-3-319-90495-5_303-1] [Reference Citation Analysis]
|
| 822 |
Mirković A, Savić N. Medical treatment and prevention of Helicobacter pylori infection. Sestrinska vizija 2021;5:10-13. [DOI: 10.5937/sestrviz2109010m] [Reference Citation Analysis]
|
| 823 |
Dings MP, Vermeulen L, Bijlsma MF. Systems biology and molecular characterization of subtypes to guide targeted therapies in gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00001-0] [Reference Citation Analysis]
|
| 824 |
Andreev D, Maev I, Umyarova R. Association of Helicobacter pylori infection and acne. Klin dermatol venerol 2021;20:33. [DOI: 10.17116/klinderma20212004133] [Reference Citation Analysis]
|
| 825 |
Jones DW, Zavros Y. In vivo and in vitro models of gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00003-4] [Reference Citation Analysis]
|
| 826 |
张 孟. Clinical Study of Hp Infection and Gastric Lesions in Adults of Different Ages in Qinghai. ACM 2021;11:4298-4309. [DOI: 10.12677/acm.2021.119629] [Reference Citation Analysis]
|
| 827 |
Romańczyk M, Ostrowski B, Marek T, Romańczyk T, Błaszczyńska M, Budzyń K, Bugajski M, Koziej M, Kajor M, Januszewski K, Zajęcki W, Waluga M, Hartleb M. Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia. J Gastroenterol 2021;56:651-8. [PMID: 33934197 DOI: 10.1007/s00535-021-01790-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 828 |
Odenwald MA, Kavitt RT. Is Routine Upper Endoscopy and H. pylori Testing Indicated in Advance of Bariatric Surgery? Difficult Decisions in Surgery: An Evidence-Based Approach 2021. [DOI: 10.1007/978-3-030-55329-6_14] [Reference Citation Analysis]
|
| 829 |
Noto JM, Ferrero RL. Helicobacter pylori-induced gastric carcinogenesis. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00004-6] [Reference Citation Analysis]
|
| 830 |
Jessurun J. Helicobacter pylori: an evolutionary perspective. Histopathology 2021;78:39-47. [PMID: 33382492 DOI: 10.1111/his.14245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 831 |
Liyen Cartelle A, Uy PP, Koehler TE, Yap JEL. Persistent Helicobacter pylori Infection: An Insight to the Limitations of Current Clinical Practice. Cureus 2020;12:e12309. [PMID: 33520508 DOI: 10.7759/cureus.12309] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 832 |
Caldas M, Pérez-Aisa Á, Castro-Fernández M, Bujanda L, Lucendo AJ, Rodrigo L, Huguet JM, Pérez-Lasala J, Molina-Infante J, Barrio J, Fernández-Salazar L, Lanas Á, Perona M, Domínguez-Cajal M, Ortuño J, Gómez-Rodríguez BJ, Almela P, Botargués JM, Núñez Ó, Modolell I, Gómez J, Ruiz-Zorrilla R, De la Coba C, Huerta A, Iyo E, Pozzati L, Antón R, Barenys M, Angueira T, Fernández-Bermejo M, Campillo A, Alcedo J, Pajares-Villaroya R, Mego M, Bermejo F, Dominguez-Jiménez JL, Titó L, Fernández N, Pabón-Carrasco M, Cosme Á, Mata-Romero P, Alcaide N, Ariño I, Di Maira T, Garre A, Puig I, Nyssen OP, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators. European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain. Antibiotics (Basel) 2020;10:13. [PMID: 33375717 DOI: 10.3390/antibiotics10010013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 833 |
Nagata R, Ohsumi T, Takenaka S, Noiri Y. Current Prevalence of Oral Helicobacter pylori among Japanese Adults Determined Using a Nested Polymerase Chain Reaction Assay. Pathogens 2020;10:10. [PMID: 33374353 DOI: 10.3390/pathogens10010010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 834 |
Rabaza A, Fraga M, Corbellini LG, Turner KME, Riet-Correa F, Eisler MC. Molecular prevalence of Coxiella burnetii in bulk-tank milk from bovine dairy herds: Systematic review and meta-analysis. One Health 2021;12:100208. [PMID: 33553561 DOI: 10.1016/j.onehlt.2020.100208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 835 |
Idowu OA, Arise RO. Ameliorative and Safety Characteristics of Argemone mexicana in Indomethacin-Induced Peptic Ulcer. Pharmaceutical Fronts 2020;02:e133-42. [DOI: 10.1055/s-0040-1722216] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 836 |
Yu X, Feng D, Wang G, Dong Z, Zhou Q, Zhang Y. Correlation Analysis of Helicobacter pylori Infection and Digestive Tract Symptoms in Children and Related Factors of Infection. Iran J Public Health 2020;49:1912-20. [PMID: 33346225 DOI: 10.18502/ijph.v49i10.4694] [Reference Citation Analysis]
|
| 837 |
Zhang F, Pu K, Wu Z, Zhang Z, Liu X, Chen Z, Ye Y, Wang Y, Zheng Y, Zhang J, An F, Zhao S, Hu X, Li Y, Li Q, Liu M, Lu H, Zhang H, Zhao Y, Yuan H, Ding X, Shu X, Ren Q, Gou X, Hu Z, Wang J, Wang Y, Guan Q, Guo Q, Ji R, Zhou Y. Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China. Trop Med Int Health 2021;26:290-300. [PMID: 33159827 DOI: 10.1111/tmi.13517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 838 |
Kolesnikova IY, Ivakhnenko IV, Ponomareva AV, Krayushkin SI. Modern aspects of eradication therapy. Spravočnik vrača obŝej praktiki (Journal of Family Medicine) 2020. [DOI: 10.33920/med-10-2012-05] [Reference Citation Analysis]
|
| 839 |
Blin P, Rouyer M, Guiard E, Zerbib F, Diquet B, Mégraud F, Tison F, Abouelfath A, Lassalle R, Droz-Perroteau C, Moore N. Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database. Therapie 2021;76:435-40. [PMID: 33334580 DOI: 10.1016/j.therap.2020.09.002] [Reference Citation Analysis]
|
| 840 |
Lettl C, Schindele F, Testolin G, Bär A, Rehm T, Brönstrup M, Schobert R, Bilitewski U, Haas R, Fischer W. Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes. Front Cell Infect Microbiol 2020;10:602958. [PMID: 33392108 DOI: 10.3389/fcimb.2020.602958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 841 |
Zarzecka U, Matkowska D, Backert S, Skorko-Glonek J. Importance of two PDZ domains for the proteolytic and chaperone activities of Helicobacter pylori serine protease HtrA. Cell Microbiol 2021;23:e13299. [PMID: 33277762 DOI: 10.1111/cmi.13299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 842 |
Yang T, Wang R, Liu H, Wang L, Li J, Wu S, Chen X, Yang X, Zhao Y. Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in Helicobacter pylori-induced chronic atrophic gastritis. Life Sci 2021;266:118903. [PMID: 33340526 DOI: 10.1016/j.lfs.2020.118903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 843 |
Kharel S, Bist A, Shrestha S, Homagain S. Helicobacter pylori healthy South Asians. JGH Open 2020;4:1037-46. [PMID: 33319035 DOI: 10.1002/jgh3.12426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 844 |
Sun D, Li H, Cao M, He S, Lei L, Peng J, Chen W. Cancer burden in China: trends, risk factors and prevention. Cancer Biol Med 2020;17:879-95. [PMID: 33299641 DOI: 10.20892/j.issn.2095-3941.2020.0387] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 845 |
Botija G, García Rodríguez C, Recio Linares A, Campelo Gutiérrez C, Pérez-Fernández E, Barrio Merino A. [Antibiotic resistances and eradication rates in Helicobacter pylori infection]. An Pediatr (Engl Ed) 2020:S1695-4033(20)30448-3. [PMID: 33334694 DOI: 10.1016/j.anpedi.2020.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 846 |
Sánchez-Alonzo K, Parra-Sepúlveda C, Vergara L, Bernasconi H, García-Cancino A. Detection of Helicobacter pylori in oral yeasts from students of a Chilean university. Rev Assoc Med Bras (1992) 2020;66:1509-14. [PMID: 33295401 DOI: 10.1590/1806-9282.66.11.1509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 847 |
Chaves de Souza MP, de Mattos NH, Pedreiro LN, Boni FI, Dos Santos Ramos MA, Bauab TM, Gremião MPD, Chorilli M. Design of Mucoadhesive Nanostructured Polyelectrolyte Complexes Based on Chitosan and Hypromellose Phthalate for Metronidazole Delivery Intended to the Treatment of Helicobacter pylori Infections. Pharmaceutics 2020;12:E1211. [PMID: 33327588 DOI: 10.3390/pharmaceutics12121211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 848 |
Jung H, Kang SJ, Lee YC, Yang H, Park S, Shin CM, Kim SE, Lim HC, Kim J, Nam SY, Shin WG, Park JM, Choi IJ, Kim JG, Choi M; Korean College of Helicobacter and Upper Gastrointestinal Research. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. Korean J Helicobacter Up Gastrointest Res 2020;20:261-87. [DOI: 10.7704/kjhugr.2020.0045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 849 |
Sabbah NA, Saoud CZ, Deeb M, Nasser SM. Helicobacter pylori Prevalence in Laparoscopic Sleeve Gastrectomy Specimen. Gastroenterol Res Pract 2020;2020:8843696. [PMID: 33381168 DOI: 10.1155/2020/8843696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 850 |
Di Fermo P, Di Lodovico S, Amoroso R, De Filippis B, D'Ercole S, Di Campli E, Cellini L, Di Giulio M. Searching for New Tools to Counteract the Helicobacter pylori Resistance: The Positive Action of Resveratrol Derivatives. Antibiotics (Basel) 2020;9:E891. [PMID: 33322025 DOI: 10.3390/antibiotics9120891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 851 |
Pizzato M, Carioli G, Bertuccio P, Malvezzi M, Levi F, Boffetta P, Negri E, La Vecchia C. Cancer mortality and predictions for 2020 in selected Australasian countries, Russia and Ukraine. Eur J Cancer Prev 2021;30:1-14. [PMID: 33273205 DOI: 10.1097/CEJ.0000000000000639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 852 |
Zhao J, Xu S, Gao Y, Lei Y, Zou B, Zhou M, Chang D, Dong L, Qin B. Accuracy of Endoscopic Diagnosis of Helicobacter pylori Based on the Kyoto Classification of Gastritis: A Multicenter Study. Front Oncol 2020;10:599218. [PMID: 33344250 DOI: 10.3389/fonc.2020.599218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 853 |
Chang S, Shih Y, Lee W, Kuo M, Tsay F, Kuo L, Huang W, Shie C. 14‐day reverse hybrid therapy vs 7‐day concomitant therapy in the first‐line treatment of Helicobacter pylori infection. Adv in Digestive Medicine 2022;9:38-43. [DOI: 10.1002/aid2.13243] [Reference Citation Analysis]
|
| 854 |
Owyang SY, Zhang M, El-Zaatari M, Eaton KA, Bishu S, Hou G, Grasberger H, Kao JY. Dendritic cell-derived TGF-β mediates the induction of mucosal regulatory T-cell response to Helicobacter infection essential for maintenance of immune tolerance in mice. Helicobacter 2020;25:e12763. [PMID: 33025641 DOI: 10.1111/hel.12763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 855 |
Al-amad S. Helicobacter pylori and gastric hyperacidity, and their association with recurrent aphthous stomatitis. International Journal of Oral and Maxillofacial Surgery 2020;49:1599-604. [DOI: 10.1016/j.ijom.2020.05.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 856 |
Song Z, Zhou L, Xue Y, Suo B, Tian X, Niu Z. A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial. Helicobacter 2020;25:e12762. [PMID: 33040439 DOI: 10.1111/hel.12762] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 857 |
Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, Yeoh KG, Hsu PI, Goh KL, Mahachai V, Gotoda T, Chang WL, Chen MJ, Chiang TH, Chen CC, Wu CY, Leow AH, Wu JY, Wu DC, Hong TC, Lu H, Yamaoka Y, Megraud F, Chan FKL, Sung JJ, Lin JT, Graham DY, Wu MS, El-Omar EM; Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 2020;69:2093-112. [PMID: 33004546 DOI: 10.1136/gutjnl-2020-322368] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 45.0] [Reference Citation Analysis]
|
| 858 |
Mahmoud A, Bakr A, Elsaid A, Wahba Y. Prevalence of Helicobacter pylori infection among children with primary nephrotic syndrome: a cross-sectional study. Afr Health Sci 2020;20:1624-31. [PMID: 34394223 DOI: 10.4314/ahs.v20i4.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 859 |
Alvarez CS, Florio AA, Butt J, Rivera-Andrade A, Kroker-Lobos MF, Waterboer T, Camargo MC, Freedman ND, Graubard BI, Lazo M, Guallar E, Groopman JD, Ramírez-Zea M, McGlynn KA. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 2020;25:e12756. [PMID: 33006810 DOI: 10.1111/hel.12756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 860 |
Eslick GD, Tilden D, Arora N, Torres M, Clancy RL. Clinical and economic impact of "triple therapy" for Helicobacter pylori eradication on peptic ulcer disease in Australia. Helicobacter 2020;25:e12751. [PMID: 32820568 DOI: 10.1111/hel.12751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 861 |
Shah SC, Canakis A, Peek RM Jr, Saumoy M. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States. Clin Gastroenterol Hepatol 2020;18:3026-39. [PMID: 32707341 DOI: 10.1016/j.cgh.2020.07.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 862 |
Șurlin P, Nicolae FM, Șurlin VM, Pătrașcu Ș, Ungureanu BS, Didilescu AC, Gheonea DI. Could Periodontal Disease through Periopathogen Fusobacterium Nucleatum be an Aggravating Factor for Gastric Cancer? J Clin Med 2020;9:E3885. [PMID: 33260439 DOI: 10.3390/jcm9123885] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 863 |
Gersten O, Barbieri M. The Epidemiologic Transition Theory and Evidence for Cancer Transitions in the US, Select European Nations, and Japan.. [DOI: 10.1101/2020.11.25.20238832] [Reference Citation Analysis]
|
| 864 |
Kahase D, Haile K. Helicobacter pylori Infection and Predictors Among Dyspeptic Adult Patients in Southwest Ethiopia: Cross-Sectional Study. Res Rep Trop Med 2020;11:141-7. [PMID: 33244288 DOI: 10.2147/RRTM.S282557] [Reference Citation Analysis]
|
| 865 |
Hu Y, Zhu Y, Lu NH. Recent progress in Helicobacter pylori treatment. Chin Med J (Engl). 2020;133:335-343. [PMID: 31929363 DOI: 10.1097/cm9.0000000000000618] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 866 |
Kim YI, Kim YA, Kim HJ, Kim SH, Hwangbo Y, Kim JG, Kim JJ, Choi IJ. Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes. Korean J Intern Med 2021;36:584-95. [PMID: 33232592 DOI: 10.3904/kjim.2019.428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 867 |
Ferrara P, Conti S, Agüero F, Albano L, Masuet-Aumatell C, Ramon-Torrell JM, Mantovani LG. Estimates of Cancer Mortality Attributable to Carcinogenic Infections in Italy. Int J Environ Res Public Health 2020;17:E8723. [PMID: 33255366 DOI: 10.3390/ijerph17238723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 868 |
Rahman MM, Kibria MG, Sultana N, Akhter M, Begum H, Haque MA, Haque R, Sarker SA, Ahmed F, Hasan M. Seroprevalence of Helicobacter pylori and its association with metabolic syndrome in a rural community of Bangladesh. JGH Ope |
